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A series of clinical studies evaluating the role of Nd:YAG laser
iridotorny in the management of angle closure glaucoma were
undertaken.
Baseline data on the outcome of peripheral iridectomy or drainage
surgery in 137 consecutive patients presenting with acute angle closure
glaucoma during the period 1980 to 1985 was obtained.
A prospective, randomised comparison of Nd:YAG laser iridotorny
and peripheral iridectomy was performed in 52 fellow eyes, with a mean
follow up period of 11.8 months. There was no significant change in
endothelial cell count 6 months after treatment in either group. There
were no significant differences in the visual acuity or glaucoma outcome
of the two groups. One laser patient developed acute angle closure
glaucoma.
A non randomised prospective comparison of Nd:YA6 laser
iridotorny, peripheral iridectomy and trabeculectomy was performed in
54 eyes with acute angle closure glaucoma. The mean total Nd:YAG laser
energy needed to create an iridotorny was greater in acute angle closure
glaucoma eyes than in fellow eyes. Serial ultrasound pachyrnetry was
used to measure the resolution of corneal oedema in 4 patients, in order
to assess the optimal timing of Nd:YAG laser iridotomy. Two patients
with a small patent Nd:YAG laser iridotomy developed acute angle closure
glaucoma during the follow up period arid this problem was investigated
further. A mathematical model of the minimum area of iris opening
needed to prevent angle closure glaucoma was developed. Photometric
measurements of Nd:YAG laser iridotomy size before and after pupil
1
dilation were made in 16 eyes. Pilocarpine/phenylephrine provocation
tests were performed in 47 eyes with a laser iridotomy, and 36 eyes
with a peripheral iridectomy. These investigations suggested that the
minimum "safe" iridotomy size is 150-200.U diameter.
A prospective study of Nd:YAG laser iridotorny in 16 patients with
chronic angle closure glaucoma showed improved glaucoma control in 7
patients.
The technique of argon laser pretreatment followed by Nd:YA6
laser iridotomy 4-6 weeks later was assessed in 10 patients. Argon
laser pretreatment was performed in the right eye, and primary Nd:YAG
laser iridotomy in the left eye. The mean total Nd:YA6 laser energy
needed to produce a patent iridotomy was significantly greater in
pretreated eyes, arid considerable pigment dispersion occurred at the
time of Nd:YAG laser iridotomy in pretreated eyes.
A comparison of argon laser iridotomy and Nd:YAG laser iridotomy
was made in a group of 33 Chinese patients in Singapore and 25
Caucasian patients in Edinburgh. Qualitative differences in iris tissue
responses to laser energy were noted.
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CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW
1.1 INTRODUCTION
Argon 1 and Nd:YAG 2 laser iridotorny have already largely
superseded surgical peripheral iridectomy 3 in the treatment of angle
closure glaucoma 4. Laser surgery is more convenient and less costly
than conventional surgery5. Rare but serious operative complications
such as endophthalmitis., fiat anterior chamber and malignant glaucoma
are completely eliminated. However laser surgery should not be regarded
as non invasive6 Corneal endothelium damage7"9, iris bleeding 10"13,
post-laser intraocular pressure elevation an(j focal lens
damage 14-57 have been reported following Nd:YA6 laser iridotomy.
Laser iridotomy represents a return to small iris openings, such as those
produced by surgical iridotomy 13"20 Very small iris openings may not
be as effective as larger openings in preventing iris bornbe and angle
closure glaucoma 20■•21.
Several studies have compared argon laser arid Nd:YA6 laser
iridotomy 5o,13,22,23 f^YAG laser iridotomy requires less laser energy,
produces fewer short term complications, and has a much lower rate of
delayed iridotomy closure than argon laser iridotomy 5oJ 2,22,23 j_3je
corneal decompensation has been reported following argon laser
iridotomy 24, but riot following Nd.YAG laser iridotomy.
Nd:YAG laser iridotomy has not been compared with surgical
peripheral iridectomy in a prospective study. Peripheral iridectomy is a
remarkably "safe" operation, with few short or long term complications
25 A series of studies comparing Q-switched Nd:YAG laser iridotorny and
operative peripheral iridectomy are reported in this thesis.
1.2 HISTORY OF THE USE OF LIGHT ENERGY TO PRODUCE
IRIS OPENINGS
Meyer-Schwickerath attempted to use xenon arc white light to
produce iridotornies in 1956 26. Zweng used a ruby laser to produce iris
burns in rabbits in 1964 27, and Perkins reported the results of ruby
laser iridotomy in humans in 197 1 28 Argon laser iridotomy was
introduced by Abraham in 1975 1. Argon lasers were already widely
available in ophthalmic departments for the treatment of retinal
diseases, and argon laser iridotomy rapidly became a popular alternative
to surgical peripheral iridectomy 1,29,30-33 pye iaser iridotomy was
reported by Bass in 1979 34.
These forms of light energy produce thermal destruction of tissue
35. However high energy laser pulses of very short duration produce
mechanical disruption of tissue -"photodisruption" 35>z&. Krasnov
described Q switched ruby laser iridotomy in 1977 3?, and Frankhauser
described Q switched Nd:YA6 laser iridotomy in 1981 2
Q switched Nd:YAG laser iridotomy was found to produce a lower
incidence of focal lens opacities and iridotomy re closure than argon
laser iridotomy 10,11,13,22,23 an(j 1S now preferred to argon laser
iridotorny 13.
1.3 HISTORY OF SURGICAL OPERATIONS FOR ANGLE
CLOSURE GLAUCOMA
Empirical surgical management of angle closure glaucoma by broad
iridectomy, introduced by Von Graefe in 1857 3S, pre dated an
understanding of the mechanism of action of surgery by many years.
4
In fact the pathogenesis of angle closure glaucoma was in part
elucidated by observing the effects of surgery. Curran noted deepening of
the anterior chamber following surgical iridotorny, and suggested that
some forms of glaucoma are due to obstruction of aqueous flow through
the pupil by the iris "hugging the lens over too great an extent"18 Barkan
emphasised a gonioscopic classification of glaucoma, and described
widening of the drainage angle following broad iridectomy 39 The action
of iridectomy was to "short circuit relative pupillary block, with ensuing
collapse of iris bombe" 40
Following Von Graefe's description of the broad iridectomy in
1857 38 Pfluger described a more conservative form of surgery, the
peripheral iridectomy, in 1893 41 but the operation did not come into
common use. Surgical iridotorny was introduced by Curran in 1920 1ST9-
20, and it is interesting to note that the size and shape of iris openings
produced by this operation were very similar to those obtained by Nd:YA6
laser iridotomy21.
Chandler popularised the peripheral iridectomy during the 1950's3,
and this operation became the preferred treatment of both acute 25,42 -46
and chronic 47-52 forms of angle closure glaucoma.
1.4 PATHOGENESIS OF ANGLE CLOSURE GLAUCOMA IN
RELATION TO SURGICAL MANAGEMENT
Chandler3 arid Barkan 40 recognised the role of pupil block in the
pathogenesis of angle closure glaucoma. Increased resistance to aqueous
flow through the pupil leads to iris bombe 3'40. Iris bombe leads to
iridocorneal contact 53-55 which initially occurs superiorly56.
Peripheral Iridectomy 57, or argon laser iridotorny 58 lead to an increase
in peripheral anterior chamber depth, with no change in central anterior
chamber depth 53-57.-58.-. iris bornbe is relieved, with no change in the
position of the lens. The rapid gush of aqueous into the anterior chamber
which occurs at the moment of iris penetration during Nd:YAG laser
iridotomy confirms the concept that a therapeutic iris opening bypasses
relative pupil block. The minimum size of iris opening needed to
equilibrate anterior and posterior chamber pressures has not been
defined.
Pupil block forces are primarily dependent on the position of the
anterior lens surface in relation to the iris - central anterior chamber-
depth, and on the tone of the dilator and sphincter muscles of the iris.
Patients with a central anterior chamber depth of less than 2.5 mm are
at risk of developing angle closure glaucoma 59. Shallow anterior
charnbers are found in : hypermetropes 60; the elderly, due to continued
increase in 1 ens thickness throughout life 60-63, and females, who have a
4% shallower anterior chamber than males 60.
The effect of iris muscle tone on pupil block forces has been
extensively investigated by Mapstone using pharmacological methods
64-72 However abnormalities of iris muscle tone in naturally occurring
angle closure glaucoma have not been defined. Mapstone found an
increased prevalence of diabetes rnellitus among angle closure glaucoma
patients 73
The degree of iris bornbe, and therefore peripheral anterior
charnber depth and narrowness of the angle, is dependent on the pupil
block force, and iris tone. Peripheral anterior chamber depth shows a
diurnal variation, and is shallowest in the evenings 74.
The relative positions of the cornea, iris and lens are important in
in choosing a safe site at which to perform a laser iridotomy. Mechanical
shock waves produced at the point of laser focus radiate outwards and
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may damage nearby tissues, notably the lens and corneal endothelium
(Figure 1.1). Eyes with angle closure glaucoma have a shallow central
anterior chamber depth 59>61 increasing the risk of lens damage, and a
shallow peripheral anterior chamber depth 57-'58-'61, increasing the risk of
corneal endothelium damage.
An iridotomy is best performed approximately 2/3 way from the
edge of the pupil to the iris base 11 (Figure 1.2). An iridotomy performed
too close to the pupil edge may result in lens damage (Figure 1.3). An
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position too peripheral -
corneal damage
Figures 1.1-1.4 modified from Schwartz et al n.
1.5 FORMS OF ANGLE CLOSORE GLAUCOMA IN RELATION TO
SURGICAL MANAGEMENT
The distribution of clinical presentations of angle closure
glaucoma in Britain has been documented by Leighton 75 50.61 of cases
were acute or subacute, 31.21 chronic, 7.81 intermittent, 6.51
associated with central retinal vein occlusion, thrombotic glaucoma or
absolute closed-angle glaucoma, and 3.91 induced by mydriatic eye
The term "angle closure glaucoma" encompasses a spectrum of
diseases which vary in clinical presentation and response to medical and
surgical treatment.
1.5.1 ACUTE ANGLE CLOSURE GLAUCOMA
The acute rise in intraocular pressure which occurs in acute angle
drops 75.
Q
closure glaucoma causes oedema and ischaernia of a number of ocular
structures. Surprisingly the duration of acute attack prior to medical
control has not been demonstrated to affect the eventual glaucoma
outcome following peripheral iridectomy25. However, prompt medical
control may be expected to minimise ischaemic damage of the corneal
endothelium 76^77-73 iris, lens and optic nerve head, and limit
goniosynechiae formation. Acutely raised intraocular pressure leads to
iris sphincter ischaemia, mydriasis, and a poor response to miotics 78
Oral or intravenous acetazolamide, followed by one drop of Pilocarpine
2% three hours later will control most episodes of acute angle closure
glaucoma 79 Strong miotics may in fact precipitate acute angle closure
glaucoma 42 •80
1.5.1.1 CORNEA
Corneal oedema normally clears within 2-12 days of initial
medical control of acute angle closure glaucoma 78 However, permanent
structural damage occurs during an acute attack, the severity of which is
related to the duration of the attack 76-77-'81. Corneal sensation is
reduced 77 and endothelial cell density is reduced 7&,si,s2,s3
Measurements of endothelial cell density made in acute angle closure
glaucoma eyes following medical control of intraocular pressure, but
prior to surgery, have shown a cell density 331. 78 and 9.71.81 lower than
that in the fellow eye. Surgical 81 ■•82 and argon laser 10 treatment can
further reduce endothelial cell density, and bullous keratopathy has been
reported following argon laser iridotorny 24.
1.5.1.2 IRIS
Sector iris atrophy may occur due to ischaemic damage during an
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episode of acute angle closure glaucoma S4. Oedema of the iris stroma is
often seen for several days following an acute attack.
1.5.1.3 LENS
A variety of lens changes may be seen following an episode of
acute angle closure glaucoma 85 Glaukorntlecken are typical, in addition
to anterior capsular, cortical and nuclear cataract. Following surgical
treatment it may be difficult to differentiate cataract caused by acute
angle closure glaucoma from cataract caused by surgery. However in
studies of patients in which both the acute and fellow eye have been
treated by peripheral iridectomy, cataract has been found more
frequently in the acute eye on follow up 25,43,46,86,8? Acute angle closure
glaucoma per se causes cataract.
1.5.1.4 TRABECULAR MESHWORK
Indentation gonioscopy has been used to differentiate oppositional
angle closure from goniosynechiae prior to surgery 88.-89..90 Normal
intraocular pressure without medication is much less likely to occur
following peripheral iridectomy if extensive goriiosynechiae are present
51,88,89 However even in the absence of goniosynechiae, eyes which have
had acute angle closure glaucoma have a higher intraocular pressure and
lower outflow facility than contralateral fellow eyes 91. Primary
trabecular rneshwork damage occurs during acute angle closure
glaucoma, in addition to goniosynechiae development.
1.5.1.5 OPTIC DISC
Ischaemic damage of the optic disc may occur rapidly during an
episode of acute angle closure glaucoma 92. Optic disc pallor is seen
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more frequently than glaucomatous cupping following acute angle closure
glaucoma, and may be associated with profound visual loss 92 Visual
field loss and colour vision defects following acute angle closure
glaucoma are more in keeping with ischaemic optic neuropathy than
glaucomatous damage 93. The visual evoked potential is abnormal
following acute angle closure glaucoma 94.
Ischaemic optic disc damage during acute angle closure glaucoma
appears to increase susceptibility to subsequent glaucomatous damage
due to raised intraocular pressure. Optic disc cupping and visual field
loss can develop very rapidly following peripheral iridectomy if the
intraocular pressure remains elevated 25.
1.5.2 INTERMITTENT (SUBACUTE) ANGLE CLOSURE
GLAUCOMA
The term "intermittent" and "subacute" angle closure glaucoma
have generally been used to describe mild, self limiting episodes of
acute angle closure glaucoma. Patients report episodes of pain, blurred
vision or haloes. Between episodes gonioscopy may show the angle partly
closed by apposition, or open but very narrow. However optic disc cupping
or visual field loss occurs in less than \0% of cases 49. The success of
surgical treatment must be measured by resolution of symptoms, as
these eyes usually have a normal intraocular pressure, optic disc,
appearance arid visual field prior to operation.
1.5.3 CHRONIC ANGLE CLOSURE GLAUCOMA
Mild degrees of pupil block may fail to precipitate acute angle
closure glaucoma. Gradual closure of the angle by iridocorneal apposition
47 beginning superiorly56 may lead to chronically raised intraocular
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pressure, with optic disc cupping and glaucomatous visual field loss 47
Prior to iridectomy oppositional angle closure may be
differentiated from synechial closure by the response to miotics 47-'54, or
by indentation gonioscopy 88>89. Iridectomy eliminates oppositional
closure, but synechial closure will persist 51. There has been some
debate as to whether synechiae develop by anterior spread onto the
trabecular meshwork - "creeping" angle closure glaucoma 48, or following
initial iridocorneal apposition, beginning superiorly53. Synechial closure
of more than 801 of the circumference of the trabecular meshwork is
frequently associated with advanced glaucomatous visual field loss 89
The presence of extensive goniosynechiae 49'51'89'95, optic disc
cupping 49'95 or visual field loss 49,52,89,95 reduce the likelihood of
successful glaucoma control by peripheral iridectomy alone. The
intraocular pressure with medication, and the presence or absence of
visual field loss prior to operation, have a greater predictive value than
optic disc cupping or the extent of goniosynechiae 95
Chronic angle closure glaucoma is often an asymmetrical disease,
and one eye may show no glaucomatous changes at the time of
presentation 48'75.
1.6 RACIAL DIFFERENCES
Race has a marked effect on both the prevalence of angle closure
glaucoma in a community, and the behaviour of angle closure glaucoma
when it does occur.
Angle closure glaucoma is more common than open angle glaucoma
in Chinese 96'97 and Eskimo 9S-99 populations. While acute angle closure
glaucoma is more common than chronic angle closure glaucoma in
Caucasians 75, the converse is found in Negro populations 100
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1.7 OUTCOME OF TREATMENT
The outcome of a laser or operative surgery procedure for angle
closure glaucoma may he measured in four ways:
1. Operative and early postoperative complications
2. Prevention of acute angle closure glaucoma
3. Long term glaucoma outcome
4. Long term visual acuity outcome
Various types of angle closure glaucoma have been included
together in assessing the outcome of a treatment in some studies 9'U
15,22,23,30,95,101-109 jhis approach is not entirely valid. Acute angle
closure glaucoma eyes might be expected to have more operative
complications and a less satisfactory visual acuity and glaucoma
outcome than fellow eyes. The glaucoma outcome of chronic angle
closure glaucoma eyes might be expected to be less satisfactory than
that of fellow eyes. In assessing a treatment the nature of the disease
under study must be carefully defined, in this case the form of angle
closure glaucoma present.
1.7.1 OPERATIVE AND EARLY POSTOPERATIVE
COMPLICATIONS
Complications following operative surgery or laser treatment for
angle closure glaucoma may or may not influence the visual acuity or
glaucoma outcome. While the overall incidence of complications related
to a procedure is of interest, only those complications which cause
significant morbidity or alter the long term outcome need influence the
choice of preferred procedure for routine clinical use.
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The most serious complications of surgical iridectomy are
malignant (ciliary block) glaucoma, and endophthalmitis. While these
complications do not occur following laser iridotomy, they are extremely
rare following peripheral iridectomy performed using modern
microsurgical techniques.
The most frequently reported operative and early postoperative
complications following peripheral iridectomy, argon laser iridotorny and
Nd:YAG laser iridotomy are shown in Tables 1.1-1.9. The majority of
reports refer to findings in chronic angle closure glaucoma eyes, and
fellow eyes.
Table 1.1 shows the reported incidence of focal corneal opacities

































incidence of focal corneal opacities following argon
laser iridotomy and Nd:¥A6 laser Iridotomy
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Short duration burn argon laser iridotorny has been found to cause
fewer corneal opacities than long duration burn iridotorny. 103d12'.
A persisting corneal opacity has been reported in one eye
following argon laser iridotorny 1, and in one eye following Nd:YAG laser
iridotomy 14. Iridocorneal adhesions overlying the treatment site have
been reported in three eyes following Nd:YAG laser iridotomy 14.
Localised stripping of Descemefs membrane has been reported in
3/110 (3%) eyes following operative peripheral iridectomy 101, but focal
corneal opacities have not been reported.
Table 1.2 shows reported endothelial cell density change following
operative peripheral iridectomy, argon laser iridotorny and Nd:YAG laser
iridotomy. Host studies have found no significant change in endothelial
cell density following treatment. However the number of eyes included in
these studies has been small, ranging from 4-28 eyes (Table 1.2).
Borderline reduction in cell density following argon laser iridotomy was
reported by Robin and Pollack 10, and following peripheral iridectomy by
Setala 81. Bullous Keratopathy has been described following argon laser
iridotomy 24 but not following peripheral iridectomy or Nd:YAG laser
iridotomy.
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Author Percentage decrease in Number
endothelial cell density of eyes
Peripheral iridectomy
Korey 115 MS 8




Robin 10 8+7% 17
Smith 114 NS 28
Nd:YAG Laser Iridotomy
Robin 10 NS 17
Wishart8 NS 6
Schrerns 115 NS 18
TABLE 1.2
Endothelial cell density change following operative or laser
treatment of angle closure glaucoma
MS = Not Significant
Table 1.3 shows the reported incidence of microscopic iris
bleeding following argon laser iridotorny and Nd:YAG laser iridotorny.
Iris bleeding is very unusual following argon laser iridotorny, but has
been reported in 15-90% of eyes following Nd:YAG laser iridotorny.
Macroscopic hyphaema has been reported in four cases following Nd:YAG
1 aser iridotorny12>x16 Macroscopic hyphaema foilowirig peripheral
iridectomy has been reported in 5/103 (5%) cases by Douglas 117 and
































incidence of iris bleeding following argon and Nd:VAG
laser iridotomy
Table 1.4 shows the incidence of iritis following argon laser iridotorny,
Nd.YAG laser iridotomy arid operative peripheral iridectomy. While
definitions of significant iritis vary, the comparative studies of Moster
23 and McAllister22 both found a lower incidence of iritis following
Nd:YAG laser iridotomy than argon laser iridotomy.
17




Flare or cells 4/38 (11 %)
3/25(12%)
YAG Laser Iridotomy







Luke 101 Flare or cells >2 weeks 2/28 (71)
TABLE 1.4
incidence of iritis following operative or iaser treatment of
angle closure glaucoma
Table 1.5 shows the reported prevalence of posterior synechiae
following argon laser iridotomy, Nd:YA6 laser iridotomy and operative
peripheral iridectomy. Posterior synechiae may have been under-reported
in some studies 2Z>Z0 as synechiae may only be reliably detected if the
pupil is dilated. Laser iridotomy appears to cause fewer posterior
syriechiae than peripheral iridectomy. Posterior synechiae are
particularly likely to develop when miotics are used in the presence of a












Moster 23 1/38 (2.71)
Peripheral Iridectomy
Phillips 120 (acute ACG)
Floman 87 (acute ACG)




20/63(321)Phillips 119 (mixed diagnoses)
TABLE 1.5
Prevalence of posterior synechiae following laser or
operative treatment of angle closure glaucoma
Table 1.6 shows the incidence of iridotomy closure following a
period of initial patency. While closure occurs in 15-201 of cases






Moster 23 6/38 (108)
Wise12 1/30(38)
Del Priore 13 9/43(218)
Harrad 105 2/47 (48)
Podos 30 10/45 (228)
Nd:YA6 Laser Iridotomy
McAllister 22 1 /25 (48)
Moster23 0/38
Wise 12 0/30
Del Priore 13 0/43
Schwartz 11 0/200







Incidence of iridotomy reclosure
Table 1.7 shows the incidence of early post treatment intraocular-
pressure elevation following argon laser iridotomy and Nd:VAG laser
iridotomy. A transient rise in intraocular pressure occurs in
approximately 308 of patients with either form of treatment.
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Author- Definition of Incidence of
elevation elevated 10P
Argon Laser Iridotomy
McAllister 22 >6 mm Hg rise 5/25 (20%)
Moster23 >8 mm Fig rise 13/38(34%)
Robin 10 > 10 mm Hg rise 7/20(35%)
Wise 12 Mean elevation 8.6 mm Hg rise
Pollock 110 >10 mm Hg rise 8/21(36%)
Nd.YAG Laser iridotomy
McAllister 22 >6 mm Hg rise 7/25(26%)
Moster 23 >8 mm Hg rise 12/38(32%)
Robin 10 >10 mm Hg rise 6/20 (30T,)
Wise 12 Mean elevation 7.3 mm Hg rise
Pollock 110 >10 mm Hg rise 6/21 (291)
Naveh 14 >10 mm Hg rise 17/40 (42%)
Robin 111 >6 mm Hg rise 9/44(20%)
Schwartz 11 >10 mm Hg rise 54/182 (30%)
Haut 107 iOP >25 mm Hg 11100 (1%)




Early post treatment intraocular pressure elevation
Table 1.8 shows the reported incidence of focal lens opacities
underlying argon arid Nd:YA6 laser iridotomy treatment sites. While focal
lens opacities occur in up to 50$ of cases following argon laser
iridotomy, they are very rare following Nd:YAG laser iridotomy. Focal
lens opacities have been reported to occur less frequently following
short duration burn argon laser iridotomy than following long duration
burn treatment 102,105,112 Focal opacities involve the anterior capsule or
anterior subcapsular area, and have not been reported to progress, or to
influence visual acuity outcome. Focal lens opacities have not been
reported following peripheral iridectomy.
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Author Focal lens opacities
Argon Laser Iridotomy
Harrad 105 21/47(45$)
McAllister 22 1/25 (4$)
Moster 23 1/38 (3%)
Pollock 110 9/21(43$)
Del Priore 13 23/43(53$)






Yamamoto 103 (Long Burn) 53/98(54$)
Yamarnoto 103 (Short burn) 1 /36(3$)
Nd:¥AG Laser Iridotomy
Berger 17 1 case report
Welch 122 ti (i 11
Montgomery 16
•1 11 ii
Naveh 14 11 11 II





Incidence of focal lens opacities following Argon and
Nd:¥AG laser iridotomy
Table 1.9 shows posterior segment complications which have been
reported following surgical or laser treatment for angle closure
glaucoma. Several authors have advocated the use of an Abraham +66
dioptre contact lens to focus laser light on the iris and minimise retinal
exposure during argon laser iridotomy 123,124,125 -plasma shielding"
during Nd:YAG laser iridotomy minimises posterior segment irradiation
37 (see page 34). Nd.YAG laser optical breakdown in the vitreous produces














Posterior segment complications following operative or laser
treatment for angle closure glaucoma
1.7.2 OPERATIVE AND EARLY POSTOPERATIVE
COMPLICATIONS OF DRAINAGE SURGERY
There have been few reports of primary drainage surgery for angle
closure glaucoma. Wilson reported that 24/112 (21%) of chronic angle
closure glaucoma eyes, 8/71 (11%) of acute angle closure glaucoma eyes
and 22/126 (17%) of open angle glaucoma eyes undergoing
trabeculectomy developed a shallow or flat anterior chamber during the
early postoperative period 13°. 3/71 (4%) of eyes undergoing trabecul¬
ectomy for acute angle closure glaucoma developed a hyphaema 130
Watson reported that 13/424 (3%) of eyes undergoing
trabeculectomy for a variety of indications developed a flat anterior
chamber during the early postoperative period 131.
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1.7.3 PREVENTION OF ACUTE ANGLE CLOSURE GLAUCOMA
Acute angle closure glaucoma following prophylactic peripheral
iridectomy in fellow eyes, or therapeutic peripheral iridectomy in
acutely affected eyes is very rare 25,42,43,11? However a number of cases
have been reported following argon laser iridotorny 132'133 and
Q-switched Nd:YAG laser iridotorny 15,8CM°6. Acute angle closure
glaucoma has not been reported following primary drainage surgery.
1.7.4 LONG TERM GLAUCOMA OUTCOME
The reported long term glaucoma outcome following treatment for
acute angle closure glaucoma is shown in Table 1.10. Peripheral
iridectomy results in normal intraocular pressure without additional
topical medication in approximately 70$ of cases. Primary drainage
surgery appears to give a better glaucoma outcome l3Ci>134 The results
following Nd:YAG laser iridotorny have been disappointing - 50$ of cases
were controlled by iridotorny alone in the study reported by Gray 80

































Wilson 130 1-7 years 65/71(93%)
Nd:YAG Laser Iridotomy
Gray80 0.5-3 years 19/38(50%)
TABLE 1.10
Long term glaucoma outcome following acute angle closure
glaucoma
25
Approximately i0% of fellow eyes develop raised intraocular
pressure during long term follow up., as shown in table 1.11.
Author Follow up period
Peripheral Iridectomy












Tomey 137 0.5-15 years
Glaucoma outcome -











Long term glaucoma outcome in fellow eyes
1.7.5 LONG TERM VISUAL ACUITY OUTCOME
Table 1.12 shows the reported long term visual acuity outcome
following treatment for acute angle closure glaucoma. Approximately
20-30% of eyes develop significantly reduced visual acuity due to
cataract development 2-5 years after peripheral iridectomy. The
incidence may be higher following primary drainage surgery 45 The cause
of reduced visual acuity may be unclear iri some eyes. While most authors
attribute visual acuity loss primarily to cataract development 2543,45,46,
88.'87, others give greater significance to ischaemic damage sustained by
the optic nerve head 92.
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Author Follow up Visual acuity outcome
Period
Peripheral Iridectomy
Playfair 25 at 5 years 8/68 (12$) needed cataract operati
(7 acute eyes. 1 fellow eye)
Krupin 88 52 months (mean) 19/49 (39$) VA reduced > 3 lines
Flornan 87 4.2 years (mean) 34/70 (51$) VA reduced > 2 lines
Lowe 43 at 5 years 5/26 (19$) had dense cataract
Sugar 45 6.6 years 24/78 (30.7$) VA < 6/18 due to
cataract (acute and fellow eyes)
Williams 46 0.5-16 years 6/86 (7$) VA reduced > 3 lines
Luke 101 4.4 years (mean) 8/36 (22$) had cataract
Primary Drainage (Iridencleisis)
Mackie 134 0.5-8 years 1/60 (2$) lost more than one line
of visual acuity due to cataract
progression
Sugar 45 7.8 years (mean) 7/17 (41$) developed cataract
Nd:¥AG Laser Iridotomy
Tomey 137 0.5-1.5 years 1/27 (4$) VA reduced by > 2 lines
TABLE 1.12
Long term visual acuity outcome following acute angle closure
glaucoma
The visual acuity outcome following prophylactic treatment of
fellow eyes may be more easily analysed (Table 1.13). 15-20$ of
fellow eyes develop some reduction in visual acuity due to cataract
development 2-5 years after peripheral iridectomy. The figure may be
slightly less for argon laser iridotorny 102- Long term results
following Nd:YA6 laser iridotomy are not yet available.










6/40 (15%) VA reduced > 3 lines
51/155 (33%) VA reduced > 2 lines






4/17 (23%) had cataract
1/45 (25%) VA reduced > 3 lines




Ghoshal135 1/29 (3%) VA reduced > 1 line
Douglas 117 0.5 - 2 years 1/103 (1%) VA reduced > 1 line
Argon Laser Iridotomy
Quigley 33 > 1 year
Robin 102 5 years
13/88 (15%) VA reduced > 2 lines
(fellow + "occludable angle" eyes)
6/98 (6%) VA reduced > 2 lines
(chronic angle closure glaucoma)
Nd:¥AG Laser Iridotomy
Torney137 0.5-1.5 years 8/61 (IDS) VA reduced > 2 lines
("occludable angle" eyes)
Schwartz 11 0.5-2.5 years 5/182 (3%) VA reduced > 2 lines
(chronic angle closure glaucoma)
TABLE 1.13
Long term visual acuity outcome in fellow eyes
1.7.6 TREATMENT OF CHRONIC ANGLE CLOSURE GLAUCOMA
The outcome of surgical treatment of chronic angle closure
glaucoma may be measured in terms of glaucoma control (medication
requirement, intraocular pressure, optic disc cupping, visual field), and
visual acuity outcome.
Iri measuring the glaucoma outcome, careful definition of the pre
operative glaucoma status is necessary. Preoperative intraocular
pressure with medication, visual field, outflow facility, cup : disc ratio,
and the extent of goniosynechiae influence the glaucoma outcome
following surgery 95.
The reported glaucoma outcome following surgical or laser
treatment for chronic angle closure glaucoma is summarised iri Table
1.14. Following peripheral iridectomy, argon laser iridotorny or Nd:VAG
laser iridotorny 70 - 90% of eyes with no visual field loss are
normotensive, although a proportion of these need additional glaucoma
medication, most frequently a 13 blocker 138 The results in eyes with
visual field loss prior to surgery are less good. 45-65% of eyes are
normotensive, with additional medication if required, following
peripheral iridectomy 49>52 Primary drainage surgery results in normal
intraocular pressure with or without additional medication in more than


















and i OP normal on
medication
angle closed >80%






























Argon Iridotomy 5/8 (63%)
Argon Iridotomy 7/9 (78%)
Argon Iridotomy 69/75 (92%)
Nd.VAG Iridotomy 169/187 (90%)
TABLE 1.14
Glaucoma outcome following operative or laser treatment of
chronic angle closure glaucoma
The visual acuity outcome following surgical or laser treatment of
chronic angle closure glaucoma has been less well documented than the
glaucoma outcome. Table 1.15 summarises the reported results. Surgical
peripheral iridectomy, argon laser iridotomy and Nd:YAG laser iridotomy
appear to have a similar outcome, but cataract development is more
frequent following drainage surgery.
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Author Follow up Operation Outcome
(Rate of cataract
development)
Gel her 52 12 month
(mean)
P.I. 5/40 (12.4$)
Trabecul ectorny 5/17 (29%)





Torney 127 6-18 months Nd:YAG laser 14/187 (7:7.)
iridotorny
TABLE 1.15
Visual acuity outcome following operative or laser treatment
of chronic angle closure glaucoma
•Includes a number of acute angle closure glaucoma patients
1.8 LASER TREATMENT OF ANGLE CLOSURE GLAUCOMA.
Q-SWITCHED Nd:YAG LASER iRIDOTOMY
The possibility of creating a hole in the iris using light energy was
first raised by Meyer-Schwickerath in 1956 26. Since then a variety of
laser energy sources have been used to produce iridotornies 1 >2>27>28;37. 0
switched Nd:YAG laser iridotorny is currently the preferred technique 1S.
1.9 THE PHYSICS OF LASER ENERGY
Laser (Light Amplification by Stimulated Emission of Radiation)
energy is produced by "pumping" electrons of atoms in the laser medium
to an excited state, using an external energy source 35,36,no Decay of
electrons to a low energy state releases photons, which stimulate the
release of further photons. A chain reaction of photon release occurs
within the laser cavity. Photons are contained within the laser cavity by
optical mirrors, and may be released continuously or in pulses140.
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The wavelength of the laser energy is determined by the nature of
the lasing medium 36 Examples are shown in Table 1.16.











Wavelengths of laser energy produced by commonly used laser
media
1.10 CHARACTERISTICS OF THE Q-SWITCHED Nd.YAG LASER
Short pulses of laser light may be produced by placing an optical
switch in the laser cavity 140 An electrically driven electro-optical
crystal (Pockels cell) is the most commonly used optical switch in
pulsed Nd:YAG lasers. The Pockels cell deflects light within the laser
cavity, reducing the "quality" of resonance in the cavity. When the
Pockels cell is turned off the quality of the resonater increases, and a
pulse of laser energy is rapidly generated. The term "Q switch" refers to
the quality switch effect produced by a Pockels cell 140 .
The characteristics of the Zeiss "Visulas" ophthalmic Q-switched
Nd:YA6 laser are shown in Table 1.17. As Nd:YAG laser light is infrared
and lies outwith the visible spectrum, a Helium-Neon aiming laser, which
produces visible red light is used for focusing. The objective lens of the
Zeiss Q switched Nd:YAG laser has a diameter of 40mm arid a focal length
of 125 mm, producing a cone of laser light, which subtends an angle of
18°.
Switch :
Wavelength of laser :




Neodymium doped yttrium aluminium
garnet crystal
Xenon flash, duration 20 rns
Elliptical reflecting cavity with laser rod
and xenon flash lamp aligned in parallel
Pockel cell Q switch
1064 nm
7 ns
Diameter of focussed spot: 30p.m





2 x 1012 watts rn "2
TABLE 1.17
Characteristics of an ophthalmic Q switched Nd:¥AG laser
During the period 1982 -1983 1 was involved in the development of
an ophthalmic 0 switched Nd:YAG laser using an attenuated continuous
wave Nd:YAG laser produced by Ferranti PLC. The prototype did not reach
the stage of clinical trials due to commercial factors.
1.11 LASER INTERACTIONS WITH TISSUES
Both the wavelength and time duration of laser pulses determine
their effects on various tissues 35-'36.
Absorbtiori of argon, krypton, ruby or dye laser energy by iris
pigment results in thermal damage at the treatment site 35 . Argon laser
energy is poorly absorbed by lightly pigmented irises, resulting in
difficulties when performing an iridotorny 12,23,30,105,121,141-144 j[-,e use
of shorter duration pulses, of 0.02 and 0.05 second duration, reduces
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thermal conduction within the treated tissue 35,112>145^ localising tissue
damage.
Very short duration laser pulses of pico and nanosecond duration
produce mechanical rather than thermal effects at the tissue treatment
site 35.d46 very high irradiarice results in "optical breakdown" at the
point of focus. This process is not dependent on absorbtion of laser
energy by pigment, and may occur in transparent media including air and
water 140 Photon absorption at the point of focus results in ionisation
and release of free electrons - "plasma" formation. The plasma absorbs
incident light, with the result that structures distal to the plasma are
not irradiated - "plasma shielding" 37. The characteristics of optical
breakdown of 0 switched Nd:VA6 laser pulses have been studied by
hydpophone analysis 147,148,149^ thermocouple measurements 37, and high
speed photography 147Vso
The very high temperature of the plasma results in rapid
expansion, producing a supersonic shock wave 140,147,148^ decays to
an acoustic wave after travelling approximately 100-200.U 140,147,148
The energy of the acoustic wave decays as an inverse function of the
distance from its origin, and produces pressure transients of 9-16 bar at
18mm 147
As the plasma cools the surrounding liquid is vapourised and a
bubble of 1.5 - 2.3 mm diameter is produced 147. Bubble expansion propels
debris 8 - 10 mm from the treatment site 14S'150, at speeds of greater
than 20 km/hr 150 While the predominant tissue effects are mechanical,
the plasma has a very high temperature. Krasnov has measured increases
in tissue temperature using a thermocouple 37, and analysis of energy
changes following Q switched Nd:VAG laser pulses shows that thermal
effects contribute to photodisruption 147
The mechanical effects of optical breakdown produced by
Q-switched Nd:YAG laser pulses delivered to the iris stroma and pigment
epithelium may be used to cut a full thickness hole in the iris.
1.12 OPHTHALMIC USES OF THE Q-SWITCHED Nd:YAG LASER
The Q-switched Nd:YAG laser has primarily been used for
performing posterior capsulotomy following extracapsular cataract
surgery 9'151 d52,153 antj jn,j0tomy in the management of angle closure
glaucoma 2--13. However a variety of less common indications for its use
have been described. These are summarised in Table 1.18.
Indication Author
1. "Malignant" glaucoma - ciliary block
glaucoma in phakic, aphakic and
pseudophakic eyes
2. Opening failed trabeculectomy site
Trabeculotomy
3. Puncture of miotic cysts
4. Removal of persistent pupillary membrane
5. Division of vitreous traction bands
6. Relief of vitreoretinal traction in
pneumati c reti nopexy
















Less common indications for the use of the Q-switched
Nd:¥AG laser
1.13 HISTQPATHOLOGICAL CHANGES IN THE IRIS
FOLLOWING Q SWITCHED Nd:YAG LASER IRIDOTOMY
Histopathological examination of iris specimens following Q
switched Nd.YAG laser iridotomy shows changes of mechanical rather
than thermal origin 16ii.
Operative iridectomy specimens containing a Nd:YAG laser
iridotomy site have been studied using light and electron microscopy
166,167 immediately following iridotomy stromal necrosis and blood
vessel disruption occur in a very localised area around the iridotomy 166
The area of pigment epithelium disruption is slightly greater than the
area of stromal disruption 166
Q switched Nd:YA6 laser iridotorny in cynomolgus monkeys
produces a wide area of pigment epithelium disruption, and iridotorny
closure due to pigment proliferation commonly occurs S10,168 in rabbits
pigment epithelium disruption is minimal and no inflammatory or
fibrotic reaction or stromal atrophy develops following Nd:YAG laser
iridotomy169'170.
1.14 INDIRECT TISSUE DAMAGE DUE TO Q-SWITCHED
Nd:YAG LASER IRIDOTOMY
0 switched Nd:YAG laser pulses delivered to the iris not only
disrupt iris tissue, but also damage adjacent ocular tissues.
1.14.1 CORNEA
Nd:YAG laser energy is not significantly absorbed by the cornea ,71.
However 0 switched Nd:YA6 laser pulses create a transient thermal
divergent lens effect within the corneal stroma, which could alter
focussing during rapidly delivered trains of laser pulses 172.
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The effects of Nd:YAG laser pulses on the corneal endothelium hav
been studied using specular microscopy and electron microscopy in
animals ?..1?3,i74 an,j j-,y specular microscopy in humans 7>8>9. Endothelial
damage can be produced by acoustic transients if optical breakdown is
produced in the aqueous within 1 mm of the corneal endothelium 175
However endothelial damage produced during Q switched Nd:YAG laser
iridotorny appears to be mainly due to high velocity debris from the iris
7'8>9 Punched out areas of bare Descemefs membrane are produced. Thes
are most frequent in the endothelium overlying the treatment site 7
Similar lesions are seen following posterior capsulotorny in aphakic
eyes. They are less frequent in pseudophakic eyes, and it is possible that
a lens implant shields the cornea from dispersed debris 7 The lesions
resolve over a 3-4 day period by spread of surrounding healthy
endothelial cells7.
1.14.2 TRANSIENT INTRAOCULR PRESSURE ELEVATION
Measurements of aqueous prostaglandin Es levels in rabbits
following Q switched Nd:YAG laser iridotomy have shown high levels 30
minutes after treatment, returning to normal after 6 hours 176 it has
been postulated that prostaglandins mediate the intraocular pressure
elevation which occurs following iridotorny. However other workers have
found only a small rise in PG F1 a and throboxane 62 levels following
iridotomy in rabbits 177. While pre-treatment with indomethacin \%
blocks the rise in PG Fla and TB 62 levels which normally occur in
rabbits following anterior capsulotorny, it does not prevent intraocular
pressure elevation 177
Particulate debris andelevated aque0us pr01ein 1 eve 1 s 10110wing
irid 010m y 177 p r0 bably c a useine reasedi n t ra 0 cu 1 ar p re s s u re b y
transiently reducing outflow facility at the trabecular rneshwork ,7a.
1.14.3 LENS DAMAGE
Focal 170 and diffuse 579 lens damage has been found to be minimal
following Q switched Nd:YAG laser iridotomy in rabbits. Latina detected
small areas of anterior capsule opacification and pigment deposition
following Q switched Nd.YAG laser iridotomy in rabbits, but the anterior-
capsule remained intact169 A similar pattern of injury has been found in
humans 122 In contrast focal lens opacities and anterior capsule rupture
frequently occurs following Q-switched Nd:YAG laser iridotomy in
cynomolgus monkeys 168
1.14.4 VITREOUS AND RETINA
0 switched Nd:YAG laser pulses do not produce detectable
physicochernical changes in the vitreous ,26. Retinal damage has only
been described when Nd:YAG laser pulses are delivered within 3mm of the
retina 580
1.15 CONTACT LENSES USED IN Nd:¥AG LASER 1RIDOTOMY
A contact lens may be used to eliminate corneal refraction,
eliminate reflection from the surface of the tear film, and reduce eye
movements during treatment. A convex contact lens converges light rays
and increases the cone angle of laser energy entering the eye. More laser
energy may then be focussed onto a smaller treatment spot 181.1S2,183. a
convex contact lens also magnifies the surgeon's image of the iris.
The Zeiss anterior segment YAG contact lens produces no increase
in laser cone angle, or magnification of the treatment area. While
orientation is facilitated by a wide field of view, critical focussing is
difficult.
In contrast, the Wise 103 dioptre iridotomy-sphincterotomy lens
increases laser cone angle, resulting in an irradience at the iris plane 7.8
times greater than that obtained using a piano contact lens 5b'3. The
diameter of the laser beam at the cornea is increased, reducing thermal
effects within the corneal stroma. The iris is magnified by a factor of
approximately x4, allowing more critical focussing of laser energy onto
iris structures. Increased irradience at the iris allows lower energy
Nd:YA6 laser pulses to be used without loss of optical breakdown.
Individual radial strands of the iris may be cut, resulting in better
control of iridotorny shape 10S. Corneal endothelium damage is
proportional to the amount of laser energy used in treatment 7 The use
of lower energy pulses in conjunction with a Wise 103 dioptre contact
lens may therefore produce less damage to the corneal endothelium.
1.16 OTHER FORMS OF LASER IRIDOTOMY
1.16.1 ARGON LASER IRIDOTOMY
Argon laser iridotomy was introduced into clinical use by Abraham
in 1975 ', and remained very popular until a series of comparative
studies showed that Q-switched Nd:YAG laser iridotomy produced more
satisfactory results 1043,22,23
Argon laser energy is absorbed by pigmented tissues, and acts by
producing thermal damage 35'ZG. The main disadvantages of argon laser
iridotomy have proved to be:
1. A high iridotomy reclosure rate 13,22,23,30 This may be related
to migration and proliferation of pigment epithelium cells, which occurs
several weeks following argon laser iridotomy 1S4, but does not occur
following Q-switched Nd:YAG laser iridotomy 166
39
2. A high incidence of focal lens opacities underlying the
treatment site ' ,'042,13,22,23,30,31,103,105,110,121
3. Poor response of lightly pigmented irises to argon laser energy.
While heavily pigmented irises readily absorb argon laser energy
12,105,112,132^ lightly pigmented irises fail to do so 12,23,30,105,121,141-144
Racial differences in iris pigmentation and structure may therefore
produce differing responses to argon laser energy.
1.16.2 RUBY LASER IRIDOTOMY
Zweng reported the use of a pulsed ruby laser used to produce
retinal burns and iridotomies in rabbits in 1964 27 The pulsed ruby laser
was later used by Perkins to produce iridotomies in humans 2'8,is5 while
the pigment epithelium was disrupted by this form of treatment, the
stroma proved resistant to ruby laser pulses, and multiple treatment
sessi 0ns were needed185. Beckrnan f0und t.ha11he ruby laser c0u 1 d
produce a patent iridotomy in brown irises, but not in blue irises ,44.
The 0 switched ruby laser was later used to produce iridotomies in
monkeys 1864s? ancj in humans 37,i46,iss However iris bleeding and
pigment dispersion is very marked following Q switched ruby laser
iridotomy ,ss. Higher energy pulses are needed to create a 0 switched
ruby laser iridotomy than a Q switched Nd:YAG laser iridotorny 104ss
1.16.3 DYE LASER 1R1D0T0MY
The first dye laser iridotomies were produced by Bass who found
that short duration pulses (l.us) using rhodamine 66 dye (wavelength
590nm), were most effective 34. However a prospective randomised
comparison of Nd:YA6 laser iridotorny arid dye laser iridotomy showed a
greater incidence of complications following dye laser iridotorny 15
1.16.4 FiBREOPTiC DELIVERY
Continuous wave Nd:YAG laser Iridotomy uses much higher energy
levels than 0 switched Nd:YA6 laser iridotomy 189. Less energy is needed
if the laser energy is delivered through a fibreoptic probe in contact
with the sclera 1y0-191. Erbium:'/AG laser energy delivered through a
fibreoptic probe 192 has also been used to produce an experimental
iridotomy.
1.17 AREAS OF UNDERSTANDING OF LASER IRIDOTOMY
WHICH REQUIRE FURTHER WORK
The widespread clinical use of Nd:YAG laser iridotomy has come
about relatively quickly, and its place in the management of angle
closure glaucoma has not yet been fully evaluated. In our research
p ro g ram rn e wehaveattemptedtoa nsw e r so rn e ou t s t and i n g questi uns.
1. How safe is Nd:YAG laser iridotomy? is it as safe as operative
peripheral iridectomy? While comparisons of argon laser iridotomy and
Nd:YAG laser iridotomy have been made50--13--22--23, no prospective
comparison of operative peripheral iridectomy and Nd:YAG laser
iridotomy has been carried out. We have performed such a study, using
the fellow eye of patients with acute angle closure glaucoma as a model
(chapter 4). Questions addressed by this study include :
1 s Nd: YAG lase r i ri d o t. om y more or 1 ess d a rn aging t o t he co rnea 1
endothelium than operative peripheral iridectomy?
What are the cornparitive risks of early post-treatment
intraocular pressure elevation, iris bleeding, iritis, posterior synechias
formation and focal lens damage?
!n the longer term is Nd:YAG laser iridotomy associated with a
higher or lower incidence of cataract development than operative
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penphera! iridectorny'?
2. Is Nd:YAG laser iridotomy as effective as operative peripheral
iridectomy in preventing the development of acute angle closure
glaucoma? This question is addressed in chapter 4 (fellow eyes), and
chapter 5 (acute angle closure glaucoma eyes). An analysis of factors
which may be responsible for the failure of very small iridotornies to
prevent acute angle closure glaucoma is given in chapter 6.
3. What is the place of Nd:YAG laser iridotomy in the management
of chronic angle closure glaucoma and narrow angle glaucoma? A
preliminary study of the outcome of Nd:YAG laser iridotomy in chronic
angle closure glaucoma and in narrow angle glaucoma is presented in
chapter 7.
4. Might the combined use of argon laser and Nd:YAG laser energy to
produce an iridotomy offer any advantages over the use of Nd:YAG laser-
energy alone? Controlled studies of combination treatment have not been
P erf o r rn ed. A n eva 1 uat i ori o f a rgon 1 aser p re treat rnen t 4-6 we e k s p r i or t o
Nd:YAG laser iridotomy is presented in chapter 8.
5. Are racial differences in iris pigmentation and structure
significant in performing Nd:YAG laser iridotomy or argon laser
iridotomy? A comparison of clinical experience in performing Nd:YA6
and argon laser iridotornies In Caucasian patients in Edinburgh, arid
Chinese patients in Singapore, is presented in chapter 9.
6. Are there any differences in the long term visual acuity or
glaucoma outcomes following operative peripheral iridectomy or Nd:YAG
laser iridotomy used in a variety of forms of angle closure glaucoma?
We are currently undertaking a long term prospective comparison
of operative peripheral iridectomy and Nd:YAG laser iridotomy in the
treatment of acute angle closure glaucoma. The results of this study will
be available in 7-8 years and will give more complete information on the
long term visual acuity and glaucoma outcome of Nd:¥AG laser iridotomy




A series of studies were designed with the aim of answering the
question "Is Nd:YAG laser iridotomy a satisfactory alternative form of
treatment to operative peripheral iridectomy in the management of angle
closure glaucoma?"
The component studies consisted of:
1. A retrospective analysis of the outcome of treatment of angle
closure glaucoma in Edinburgh during the years 1980 -1985. The
glaucoma and visual acuity outcome 5 years after treatment were
assessed using information obtained from the case records of 137
patients treated during the study period. Details of this study are given
in chapter 3.
2. A prospective comparison of Nd:YAG laser iridotomy and
operative peripheral iridectomy in the treatment of acute angle closure
glaucoma. A series of 70 consecutive patients presenting with acute
angle closure glaucoma during the period January 1987 - June 1989 were
studied prospectively. The acute eye was treated by Nd:¥A6 laser
iridotomy, operative peripheral or sector iridectomy, or drainage surgery
as judged appropriate by the consultant in charge of the case (details of
this study are given in chapter 5). Consent was obtained from 52 patients
to enter the fellow eye into a randomised prospective comparison of
Nd:YA6 laser iridotorny and operative peripheral iridectomy (details of
this study are given in chapter 4). The occurrence of acute angle closure
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glaucoma in 3 eyes with small patent iridotornies prompted an
investigation of factors responsible for this (details of this analysis are
given in chapter 6).
3. A group of 16 patients with a diagnosis of chronic angle closure
glaucoma, and 22 patients with a diagnosis of "narrow angle glaucoma",
who underwent Nd.YAG laser iridotomy during the period June 1986 to
March 1989 were recalled for a detailed follow up examination in order
to measure the glaucoma and visual acuity outcome of laser treatment
(details of this study are given in chapter 7).
4. The effect of argon laser treatment of the iris stroma 4-6
weeks prior to performing Nd:YAG laser iridotomy was assessed in the
right eye of 10 patients with chronic or intermittent angle closure
glaucoma. The left eyes were treated with primary Nd:YAG laser
iridotomy (details of this study are given in chapter 8).
5. A comparison of Nd:VAG laser iridotorny arid argon laser
iridotomy was made in a retrospective study of 31 Chinese patients-
treated in Singapore, and 25 Caucasian patients treated in Edinburgh.
Differences in the effects of laser energy on the irises of these two
groups were assessed (details of this study are given in chapter 9).
2.2 METHODS
The detailed methods of the component studies are described in
each chapter of this thesis.
In addition to clinical examination techniques, specialised
investigations were used where appropriate - endothelial cell density
rn e a s u remen tbyspecular rn i c rosc opy, ultras o u ri d pac h yme t ry
measurement of corneal thickness following acute angle closure
glaucoma, and photometric measurement of iridotomy area.
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2.2.1 ETHICAL APPROVAL
Approval of each clinical study was obtained from the unit ethical
committee. Approval to perform a randomised prospective comparison of
Nd:YAG laser iridotorny and operative peripheral iridectomy was obtained
from the regional surgical subspecialties ethical committee.
2.2.2 RANDOMISATION
Informed patient consent to inclusion in the randomised
comparison of Nd:YAG laser iridotomy and operative peripheral
iridectomy in the treatment of fellow eyes was obtained prior to
randomisation. Randomisation was stratified into a group aged more than
70 years., arid a group aged less than 70 years. Randomisation was carried
out by opening the top envelope in a container containing consecutively
numbered sealed envelopes. Each envelope contained a card marked
"surgery" or "laser", and the number of the envelope. The allocation of
"surgery" or "laser" to each number had been performed using a random
number generator computer programme prior to commencement of the
trial, and the cards were placed iri the envelopes by a person not involved
in the study.
2.2.3 TREATMENT TECHNIQUES
2.2.3.1 OPERATIVE PERIPHERAL IRIDECTOMY
Surgery was performed under local or general anaesthetic. BWF
personally performed all operative peripheral iridectomies in the
prospective comparison of Nd:YAG laser iridotorny and operative
peripheral iridectomy described in chapter 4. A corneal incision was
used. The peripheral iris was grasped with grooved forceps, and a
peripheral iridectomy was performed with scissors. No sutures were
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used. This technique minimised postoperative discomfort arid therefore
facilitated very early measurement of intraocular pressure.
Operative peripheral iridectomies were performed on acute angle
closure glaucoma eyes (chapter 5) by several experienced surgeons, in
most cases a corneoscleral incision was used. A fornix based
conjunctival flap was made., followed by a corneoscleral incision into the
anterior chamber. The peripheral iris was prolapsed using gentle
pressure to the posterior edge of the wound, and a peripheral iridectomy
was made with scissors. The corneoscleral and conjunctival wounds
were closed using 8/0 polyglactin ("vicryl") suture material.
2.2.3.2 NdiYAG LASER iRIDOTGMY
A Zeiss "Visulas" Nd:YA6 laser and Zeiss anterior segment YAG
contact lens were used. A treatment site was chosen in the superior iris,
between 10 and 2 o'clock, approximately 2/3 distance from the pupil
margin to the base of the iris. An iris crypt was used when present. A
single 5-10 rnJ pulse was delivered to the treatment site, if this pulse
did not penetrate the iris, further single pulses were delivered to the
same site until penetration was achieved. A gush of aqueous fluid from
the posterior chamber could be seen at the moment of penetration.
Patency was assessed by direct visualisation of the posterior chamber,
or anterior lens capsule.
BWF personally performed ail Nd:YAG laser iridotomies in the
prospective comparison of Nd:YAG laser iridotomy and operative
peripheral iridectomy described in chapter 4. Nd:YAG laser iridotomies
were performed on acute angle closure glaucoma eyes (chapter 5) and
chronic and narrow angle closure glaucoma eyes (chapter 7) by several
experienced surgeons. BWF personally performed ail argon laser and
Nd:YAG laser treatments described in chapter 8.
Several surgeons performed the argon and Nd:YAG laser iridotomies
described in the comparative study of laser techniques in Edinburgh and
Singapore described in chapter 9.
2.2.4 EXAMINATION METHODS AND DEFINITIONS
2.2.4.1 LASER INDUCED CORNEAL DAMAGE
Corneal damage evident on slit lamp examination 2 and 24 hours
following laser treatment was scored as:
0 = no damage evident
+ = focal granularity of the endothelium
++ r focal full thickness corneal oedema.
Figure 2.1 shows an example of grade ++ corneal damage.
Figure 2.1. Nd.YAG laser iridotomy. Grade ++ corneal damage. Focal
full thickness corneal oedema overlying the iridotomy treatment site is
indicated by the arrow.
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2.2.4.2 IRITIS
iritis was judged to be present if there were more than 5 white
cells per field using a 3mm long x 0.2mm wide slit beam focussed in the
central part of the anterior chamber. The presence of dispersed pigment
particles in the aqueous was not judged to be indicative of iritis.
2.2.4.3 INDENTATION GONSOSCOPV
Goldman indirect gonioscopy was performed in order to detect
iridocorneal contact. If any part of the angle appeared to be closed
Posner four mirror indentation gonioscopy was performed in order to
differentiate iridocorneal contact from iridotrabecular adhesion
(goniosynechiae). In the prospective studies described in chapters 4,5,6
arid 8 all pre treatment gonioscopy examinations were performed by BWF.
Follow up gonioscopy was performed by BWF, or by one of two
experienced research assistants (EW or EF). if there was any uncertainty
about the gonioscopy findings, the examination was repeated by BWF. A
variety of examiners performed gonioscopy examinations on the patients
with chronic and narrow angle closure glaucoma described in chapter 7.
2.2.4.4 OPTIC DISC APPEARANCES AND VISUAL FIELD
EXAMINATION
The observers who performed gonioscopy (see section 2.2.4.3) also
examined the optic discs. The vertical cup:disc ratio was recorded,
expressed as a decimal ratio.
Visual field examinations using a tangent screen or Friedman
Visual Field Analyser were performed where clinically indicated, but
were not an integral part of the studies.
49
2.2.4.5 PROVOCATION TESTS
Pilocarpine/phenylephrine provocation tests as described by
Mapstone 68, and modified by Harrad 105 were used. The intraocular
pressure was measured, one drop of 6. Phenylephrine 10? and one drop of
G. Pilocarpine 2? were instilled, and the intraocular pressure was
measured again one hour later. An intraocular pressure rise of more than
8 mm Hg, with angle closure on gonioscopy, was regarded as a positive
result. At the end of the test 6. Thymoxamine 0.5:? was instilled and the
patient was observed until the pupil became small.
2.2.4.6 POSTERIOR SYNECHiAE
The pupil was dilated using G. Phenylephrine 10? in order to
detect posterior synechiae, and allow examination of the lens and fundus.
G. Thymoxamine 0.5? was used to reverse pupil dilation.
2.2.5 ENDOTHELIAL CELL DENSITY MEASUREMENT
Specular microscopy was performed using a Keeler-Konan
Pocklington specular microscope before operative or laser treatment,
arid six months after treatment. Several central fields were
photographed and stored for later analysis.
Patients were coded by number, and endothelial cell counts were
performed by an observer unaware of the coding system. Using
standardised print magnification and a transparent grid, three
representative fields of 0.05 mm2 were chosen for each patient, and the
cells within these fields were counted. The mean value for the three
areas was then calculated, and the result multiplied by a factor of 20 iri
order to express the result in cells per mm2.
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Figure 2.2 shows an example of a specular micrograph taken 6
months following laser treatment. A representative 0.05 mm2 square is
marked for counting. The endothelial cell density in this case was 2240
cells per mm2.
Figure 2.2. Specular micrograph of the corneal endothelium 6
months following Nd.YAG laser iridotomy. A representative area of 0.05
rnrn2 is marked for counting. The endothelial cell density in this case was
2240 cells per mm2.
2.2.6 CORNEAL PACHYMETRY
Serial measurements of corneal thickness and intraocular pressure
were made following initial medical control of acute angle closure
I
51
glaucoma. Central corneal tissue thickness was measured using an
"Ophthasonic" ultrasound pachyrneter (Teknar inc). Three readings were
taken at the time of each measurement, and the average result recorded,
intraocular pressure was measured using a Goldman applanation
tonometer.
2/2.7 IRIDOTOMY AREA MEASUREMENT
A simple clinical measurement of iridotomy area was used in the
studies described in chapters 4,5,6,7 and 8. The area of the iridotomy or
iridectomy was measured using a Haag-Streit slit lamp. The 200u spot
size was focussed on the iris plane adjacent to the iridotomy. The
maximum diameter of the iridotomy in two axes was then estimated.
Most iridotomies approximated to an ellipse, and the area of iris patency


























and b are the
two diameters
of the ellipse
Figure 2.3. Calculation of the surface area of an ellipse.
2.2.7.1 CALIBRATION OF IRIS MEASUREMENTS
in order to calibrate measurements made in this way photometric
measurements of iridotomy area were made in 16 eyes of 11 patients.
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The horizontal corneal diameter was measured using a Haag-Streit
eyepiece graticule, which is marked in 100.U divisions. The cornea and
iris were then photographed using a Zeiss anterior segment camera.
Colour transparency photographs were projected onto a white screen. The
projected corneal diameter was measured in millimetres arid compared
with the measurement obtained using the slit lamp measuring eyepiece.
A magnification factor for the projected image was derived for each eye.
The magnification factor was approximately x80 in every case. The
diameter of the iridotomy in two axes was measured on the screen, and
the actual iridotomy diameters were calculated using the magnification
factor. Table 2.1 shows the results of iridotomy measurements made
using slit lamp measurements and photometry.





















Calibration of measurements of iridotomy diameters
There was only moderately good correlation between iridotomy
diameter rneasurements using the slit larnp spot and photometric
measurements (correlation coefficient r = 0.6252, t = 4.3872, pcO.QOI).
Iridotomy area measurements quoted in chapters 4-8 must therefore be
regarded as approximate measurements only. However these
measurements were adequate to detect whether an iridotomy was of very
small diameter - less than 100p., or whether it was moderately large -
greater than 200p. in diameter, and were therefore taken as adequate for
clinical assessment purposes.
2.2.8 EFFECTS OF PUPIL DILATION ON IR1DQTOMV SHAPE,
POSITION AND AREA.
The effects of pupil dilation on iridotomy position, shape and area
were also measured using the photometric technique described above. 16
eyes of 11 patients were used. The horizontal corneal diameter was
measured using a Haag-Streit slit lamp eyepiece graticule. Photographs
of the cornea and iris were taken before and after dilating the pupil with
Tropi c a rn i de If.. Me asu re rn ent s o f c o rnea 1 di ame te r, pupi 1 di a rn e t. e r,
iridotomy position in relation to the limbus, iridotomy shape and
iridotomy area were made from the projected images of these
photographs. Linear measurements were made using a millimetre rule,
and iridotomy area was measured by projecting the image onto
millimetre graph paper. These measurements were then converted to
"real" size using a magnification factor derived from the known corneal
diameter.
The cornea acts as a convex lens, resulting in a magnified image of
the pupil. While this magnification effect is less in the iris periphery, at
the site of an iridotomy, some error persists in measuring the absolute
area of an iridotomy. Relative comparison of iridotorny areas may be
made between eyes, but these measurements probably deviate slightly
from the area which would be measured if the cornea were not present.
Figures 2.4 a-d shows an example of photometric analysis of the
effect of pupil dilation on iridotomy area.
Figure 2.4a. Photometric analysis of the effect of pupil dilation
on iridotomy area. k7.6 magnification. Undilated pupil. Corneal diameter
11.8 mm. Pupil diameter 2.1 mm.
Figure 2.4b. Photometric analysis of the effect of pupil dilation
on iridotomy area. x7.6 magnification. Dilated pupil. Pupil diameter 6.3
mm.
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Figure 2.4c. Photometric analysis of the effect of pupil dilation
on iridotomy area, x 17.5 magnification. Undilated pupil, iridotomy
diameters 0.92 x 0.29 mm.
Figure 2.4d. Photometric analysis of the effect of pupil dilation
on iridotomy area. x17.5 magnification. Dilated pupil. Iridotomy
diameters 0.61 x 0.53 mm.
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2.3 STATISTICAL ANALYSIS
Stati stica 1 advice was sought pri or to commencement of the
studies, and during data analysis.
The unpaired Student t test was used to test the significance of
di f ferences between two g roups i n the rn e a n v a 1 ue o f a cont. i nuous
variable. The Wilcoxon rank sum test was also applied to confirm
significant findings in some analyses, although data approximated to a
normal distribution in most circumstances.
TheX2 test was used to test the significance of differences
between two groups in the distribution of discrete variables. Yate's
correction was applied to theX2 test when numbers were small - a total
of less than 100, or less than 10 items in any cell 193'194.
Linear regression analysis was used to quantify correlation
between continuous variables. For example regression analysis of
photometric measurements was used to detect factors which influence
changes in iridotorny area on dilating the pupil.
Statistical analyses were performed using a Texas instruments TI
30 STAT calculator, and Cricket software "Statworks" software with a
Mackintosh PI us mi crocomputer.
Statistical results are presented as a p value where a significant
difference was found, and "NS" where there was no significant difference
between groups.
In our studies of chronic angle closure glaucoma and narrow angle
glaucoma (chapter 7), only one eye from each patient was used for
statistical analysis, as the two eyes could not be considered to be
i ndependent variabl es.
CHAPTER 3.
A RETROSPECTIVE ANALYSIS OF THE OUTCOME OF
OPERATIVE SURGERY PROCEDURES FOR ANGLE CLOSURE
GLAUCOMA
3.1 SUMMARY
A retrospective analysis of the 2-5 year outcome of surgery for
angle closure glaucoma was performed using the case records of 137
patients treated in Edinburgh during the period 1980-1985. 20/71(281)
of operations for acute angle closure glaucoma were accompanied by
operative or early postoperative complications. There were no
significant operative or early postoperative complications among 59
fellow eyes. One eye treated by peripheral iridectomy for acute angle
closure glaucoma developed a recurrence of acute angle closure glaucoma
due to an imperforate iridectomy.
9/59 (15$) of fellow eyes required medication or had raised
intraocular pressure 2-5 years following peripheral iridectomy.
14/59 (24%) of fellow eyes lost 2 or more lines of visual acuity
due to cataract development 2-5 years following peripheral iridectomy.
9/15 (60S) of acute angle closure glaucoma eyes were
normotensive without medication 2-5 years following peripheral
iridectomy. 24/27 (89S) of acute angle closure glaucoma eyes were
normotensive without medication 2-5 years following iridencleisis or
trabeculectomy.
3/15 (20S) of acute angle closure glaucoma eyes lost 2 or more
lines of visual acuity 2-5 years following peripheral iridectomy. 3/27
(1 IS) of acute angle closure glaucoma eyes lost 2 or more lines of visual
acuity 2-5 years following iridencleisis or trabeculectomy. However
analysis of visual acuity results following acute angle closure glaucoma
may have been unreliable for a variety of reasons.
All the potential limitations of a retrospective study were
encountered., and the need for prospective evaluations of treatments for
acute angle closure glaucoma was recognised.
3.2 INTRODUCTION
The outcome of prophylactic peripheral iridectomy in the fellow
eye of acute angle closure glaucoma patients has been well documented.
Acute angle closure glaucoma following prophylactic peripheral
iridectomy is very rare 25,42,43,11? jfie reported long term incidence of
raised intraocular pressure following iridectomy in the fellow eye
ranges from 0 - 191 25,43,46,86,135 jn jj-ie |0rig term 2 - 41:1 of fellow
eyes lose 2 or more lines of visual acuity due to cataract development
following peripheral iridectomy 43,45,46,86,8?, 135
However, for a variety of reasons the outcome in eyes with acute
angle closure glaucoma is less well understood. It may be difficult to
differentiate tissue damage due to acute angle closure glaucoma from
the long term complications of surgery used in its treatment.
Peripheral iridectomy almost completely prevents recurrence of
acute angle closure glaucoma 25-43. Peripheral iridectomy following
acute angle closure glaucoma results in long term normal intraocular
pressure without medication in 70 - 76T of eyes 25,43,46,86,8?,95
Approximately 40% of eyes with acute angle closure glaucoma treated by
peripheral iridectomy lose two or more lines of visual acuity after 1 - 5
years 86 >87.
No cases of recurrence of acute angle closure glaucoma have been
reported following primary drainage surgery 13°034. Primary
iridencleisis 134 or trabeculectomy 130 for acute angle closure glaucoma
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results in long term normal intraocular pressure without medication in
more than 901 of eyes. Visual acuity loss due to cataract formation has
been reported in 4\% of eyes undergoing iridencleisis for acute angle
closure glaucoma, after a mean follow up period of 7 years 45
In order to obtain further information on the outcome of
conventional surgery for angle closure glaucoma in our department, and
assess whether our results are consistent with published studies, a
retrospective study of the five year outcome of surgery performed during
the period 1980 - 1985 was performed.
3.3 MATERIALS AND METHODS
The Ophthalmology department of Edinburgh Royal Infirmary was
the only department performing ophthalmic surgery in a region with a
population of approximately 900,000 during the study period. Each
consultant in the department adhered to a policy of performing
prophylactic peripheral iridectomy in the fellow eye. Treatment of the
acutely affected eye varied. Acute attacks of less than 48 hours duration
which responded promptly to medical treatment were treated by
peripheral or sector iridectomy. Acute attacks of more than 48 hours
duration, or attacks which responded poorly to initial medical treatment,
were treated by primary drainage surgery, in the form of iridencleisis,
sector iris inclusion, or trabeculectomy operation. Intermittent and
chronic angle closure glaucoma were treated by peripheral iridectomy.
The names and hospital numbers of all patients who had had a
peripheral iridectomy or sector iridectomy operation between January
1980 and December 1985, inclusive, were obtained from the operating
theatre records. As almost all patients with acute angle closure
glaucoma would have had a peripheral iridectomy performed in the fellow
eye, most cases would be detected in this way. This method of detecting
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cases was believed to be more reliable than use of the Lothian Health
Board diagnostic index, which has been found to be inaccurate in as many
as 40% of cases ly5.
Patients" age, sex and general health, the results of assessment at
presentation, assessment following initial medical treatment, operation
details, postoperative complications and the results of assessment five
years following surgery were recorded, if the patient had been followed
up for less than five years, the assessment at the last clinic visit was
recorded.
3.4 STATISTICAL ANALYSIS
Differences between groups were tested using the Unpaired
Student t test. When a significant difference was found the Wilcoxon
signed rank test was also applied. However in most instances the
distribution of variables approximated to normality.
Differences between groups in the distribution of discrete
variables were tested using theX2 test. Yates correction was applied as
numbers were relatively small 193.
3.5 RESULTS
182 patients underwent peripheral or sector iridectomy in at least
one eye during the study period. The case records of 45 patients (25%)
could not be traced. The case records of 137 patients were obtained. The
distribution of diagnoses of these patients is shown in Table 3.1.
Diagnosis Number of patients
Unilateral acute ACG 79
Bilateral acute ACG 5
Unilateral chronic ACG 14
Bilateral chronic ACG 18
Unilateral intermittent ACG 4
Bilateral intermittent ACG 7
Others, e.g. pupil seclusion 10
Total 137




97 patients had one eye which could be identified as a "fellow"
eye. These consisted of:
79 patients with unilateral acute angle closure glaucoma with an
asymptomatic "fellow" eye.
4 patients with unilateral symptoms of intermittent angle closure
glaucoma and an asymptomatic "fellow" eye.
14 patients with chronic angle closure glaucoma and a "fellow" eye
with no symptoms or signs of glaucoma.
69 of these patients had been followed up for at least 2 years, and
41 for 5 years. Of the remaining 28 patients, 9 had been discharged from
follow up within 6 months of presentation, and 2 between 6 months and 2
years of presentation. 3 had been transferred to another health district,
and 14 were lost to follow up, and could not be traced.
Of the 69 patients with a 2 - 5 years follow up, 59 had had a
peripheral iridectomy performed in the fellow eye, 9 were treated
conservatively arid one had had an iridencleisis operation.
The results of initial assessment of the 59 patients who
underwent prophylactic peripheral iridectomy in the fellow eye and were
available for follow up 2-5 years later are shown in Table 3.2.
Age, years
Male : Female ratio
Mean Intraocular Pressure, mm Hg











Retrospective study of patients undergoing peripheral
iridectomy in the fellow eye: initial findings
The intraocular pressure was greater than 21 mm Hg in 13 eyes - 7
eyes had an intraocular pressure of 22 - 25 mm Hg, 4 of 26 - 29 mm Hg,
and 2 eyes had an intraocular pressure greater than 30 mm Hg.
Following initial medical treatment the mean intraocular pressure
was 15.2+3.7 mm Hg, and 3 eyes had an intraocular pressure between 22
and 25 mm Hg.
3.5.1.1 OPERATION
Surgery was performed under local anaesthetic in 28 patients, and
general anaesthetic in 31 patients.
3.5.1.2 OPERATIVE COMPLICATIONS
One of the patients followed for less than 2 years developed an
aqueous leak from the wound postoperatively, which sealed
spontaneously. None of the 59 patients followed for 2 - 5 years had
significant operative or early post operative complications.
3.5.1.3 2 - 5 YEAR FOLLOW UP
No patient developed acute angle closure glaucoma following
peripheral i r i d e c t omy.
3.5.1.3.1 GLAUCOMA OUTCOME
9 (151) patients were using topical medication or had an
intraocular pressure greater than 21 mm Hg in the fellow eye at follow
up. One of these patients had developed pathological optic disc cupping
arid glaucomatous visual field loss during the follow up period, a second
patient, a 73 year old male with a history of ischaemic heart disease,
developed pathological optic disc cupping and glaucomatous visual field
loss despite apparently normal intraocular pressure readings.
However only 3 of these 9 patients had had acute unilateral angle
closure glaucoma with a norrnotensive fellow eye at presentation. 3 had
had unilateral angle closure glaucoma with raised intraocular pressure in
the fellow eye, 2 had had unilateral intermittent angle closure glaucoma
with a norrnotensive fellow eye, and one had had unilateral chronic angle
closure glaucoma with a normotensive fellow eye.
3.5.1.3.2 VISUAL ACUITY OUTCOME
The distribution of visual acuity change between presentation and
follow up is shown in Figure 3.1.
-6 -5 -4 -3 -2 -1 0 1 2 3 4
¥A change (lines)
Figure 3.1. Retrospective study of operative peripheral
iridectomy in the fellow eye. Distribution of visual acuity
change between initial presentation and 2-5 year follow up.
14/59 (24%) patients lost 2 or more lines of visual acuity, in 9
cases due to cataract development in previously clear lenses, and in 5
cases due to progression of pre existing cataract.
Two patients underwent cataract surgery during the follow up
period. One had had a clear lens prior to peripheral iridectomy, and one
had had nuclear cataract.
3.5.2 ACUTE ANGLE CLOSURE GLAUCOMA
Of the 84 patients with acute angle closure glaucoma, 71 were
treated with either peripheral iridectomy, iridencleisis, trabeculectomy
or sector iridectomy. Sector iris inclusion operations were included in
the iridencleisis group. Only one eye was used for statistical analysis in
bilateral cases, chosen by tossing a coin.
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The results of initial assessment of these 71 patients is shown in
Table 3.3. There was no significant difference between any pair of groups
in mean age or mean intraocular pressure, using the unpaired Student t
test. More patients in the peripheral iridectomy group had a visual acuity
of 6/12 or better, but the differences were not significant using the X2
test with Yate's correction. There was insufficient information in the




































Retrospective study. Assessment at presentation.
Acute angle closure glaucoma
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Table 3.4 shows the results of assessment following initial
medical control. The mean intraocular pressure of the peripheral
iridectomy group was significantly lower than that of the iridencleisis
group (p<0.05).. or trabeculectomy group (p<0.05), using the unpaired
student t test. However differences between the groups fell just short of
significance at the p=0.05 level using the Wilcoxori signed rank test. The
proportion of patients with miosed pupils following initial medical
treatment was significantly higher in the peripheral iridectomy group
than the iridencleisis group (pcO.OI) or the trabeculectomy group
(p<0.05), using the X2 test with Yate's correction. These findings confirm
that patients treated with peripheral iridectomy had a less severe form
of acute angle closure glaucoma than patients treated with iridencleisis
or trabeculectomy.
Number patients
Mean IOP, mm Hg



























Retrospective Study. Assessment following initial
medical control. Acute angle closure glaucoma
Operative complications are shown in Table 3.5. There were no
significant differences between the groups. One peripheral iridectomy
operation did not result in a full thickness iris opening. This was not
recognised, and the patient developed acute angle closure glaucoma three
days later.
Peripheral Iridencleisis Trabeculectomy Sector
I ri dectorny I ri dectorny
Iridectomy not
patent 1 0 0 0
Hyphaerna 1 3 0 2
TABLE 3.5
Retrospective Study. Operative Complications.
Acute angle closure glaucoma
Table 3.6 shows the complications which occurred during the first
week after operation. There were no statistically significant differences
betweeri t h e g roups, h owever nu rnbers were sma 11.
Peripheral Iridencleisis Trabeculectomy Sector
I ri dectorny I ri dectorny
Number patients 21 13 14
Acute ACS 1 0 0 0
I OP>21 mm Hg 3 1 o 0
Shallow AC 0 4 o 0
Flat AC o 1 0
Hyphaerna 1 o ii 2
Total 5 (24%) 8 (35:1) 5 (381) 2 (
TABLE 3.6
Retrospective Study. Complications during the first week
following operation. Acute angle closure glaucoma.
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3.5.2.1 2-5 YEAR FOLLOW UP
49 patients completed 2-5 years of follow up. 7 patients were
discharged after less than 2 years of follow up, 3 were transferred to a
different health district, and 12 were lost to follow up and could not be
traced.
3.5.2.1.1 GLAUCOMA OUTCOME
Table 3.7 shows the glaucoma outcome 2-5 years following
treatment. There was no significant difference between any pair of
groups in the mean intraocular pressure at follow up, using the unpaired
Student t test. 5/15 (401) of peripheral iridectomy patients required
some form of additional glaucoma treatment. 9/15 (601) remained
normotensive without medication. While the glaucoma outcome appeared
to be better than this in each of the other groups the differences did not
reach statistical significance using the X2 test with Yate's correction.
Pathological optic disc cupping and glaucomatous visual field loss
occurred in two peripheral iridectomy patients and one sector iridectomy
patient, but did not occur following drainage surgery.
Peripheral Iridencleisis Trabeculectomy Sector
i ri dectorny i ri dectomy
Number patients 15 17 10 7
Mean 10P mm Hg 15.5+4.0 15.0+3.5 15.4±2.5 17.2+2.1
I OP > 21 mm Hg 1 0 0 0
Cupped disc 2 0 0 1
Field loss 2 0 0 1
"Pale" disc 0 2 1 0
Drainage op. 3 0 0 0
Medical Rx 4 2 1 0
Any glaucoma
treatment 6(401) 2(121) 1(101) 0
TABLE 3.7
Retrospective Study. Glaucoma outcome 2-5 years
following treatment. Acute angle closure glaucoma.
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3.5.2.1.2 VISUAL ACUITY OUTCOME
Table 3.3 shows the visual acuity outcome 2-5 years following
treatment.
A lower proportion of peripheral iridectomy patients than
iridencleisis patients, trabeculectomy patients or sector iridectomy
patients had a visual acuity worse than 6/12. This difference was not
statistically significant using the X2 test with Yate's correction.
However as visual acuity at initial presentation was better in the
peripheral iridectomy group differences in visual outcome cannot be
attributed to the effects of surgery, using this form of analysis.
Peripheral iridencleisis Trabeculectomy Sector
1 ri dectomy i ri dectorny
Number patients 15 17 10 7








Retrospective Study. Causes of reduced visual acuity 2-5 years
following treatment of acute angle closure glaucoma







a more useful measure of visual acuity outcome is visual acuity
loss during the follow up period. The causes of visual acuity loss by two
or more lines of visual acuity are shown in Table 3.9. There were no
significant differences between the groups. An increased rate of
cataract development following drainage surgery compared to peripheral
or sector iridectomy was not demonstrated.
Peripheral Iridencleisis Trabeculectomy Sector






















Retrospective Study. Causes of loss of two or more lines of
visual acuity after 2-5 years follow up. Acute angle closure
glaucoma
BRVO - Branch retinal vein occlusion
3.5.3 CHRONIC ANGLE CLOSURE GLAUCOMA
Information in the case records was inadequate to make an
analysis of the outcome of peripheral iridectomy in chronic angle closure
glaucoma. While 32 patients had a diagnosis of chronic angle closure
glaucoma written in the case records, only 6 eyes of 4 patients had
documented raised intraocular pressure and a partly closed angle prior to
operation, underwent peripheral iridectomy, and were followed up for
more than 2 years.
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3.5.4 INTERMITTENT ANGLE CLOSURE GLAUCOMA
A 1-5 year follow up was available for 13 eyes of S patients
treated by peripheral iridectomy for symptoms of intermittent angle
closure glaucoma. At follow up one eye required medication to maintain
normal intraocular pressure. All other eyes were norrnoterisive without
medication. The visual acuity was 6/12 or better in every eye, all optic
discs were normal, all visual fields were full and all patients were
asymptomatic.
3.6 DiSCUSSiON
In common with many retrospective studies the reliability of
conclusions derived from this analysis is limited by several potential
sources of bias.
1. Case record retrieval was incomplete. 25:?. of case records could
not be obtained. Our case records are shared with other departments in
the hospital. It is possible that a proportion of unobtainable case records
had been lost following a patient's visit to a clinic in another
department. A higher proportion of unobtainable case records could have
belonged to patients in poor general health.
2. Recording of information in case records was incomplete. There
was considerable variation in the completeness of clinical examination
findings recorded.
3. Variation in indications for operations. There was no protocol by
which a particular operation was chosen for a particular clinical
situation. There was bias towards the use of peripheral iridectomy in
milder attacks of acute angle closure glaucoma, as indicated by a lower
mean intraocular pressure and a higher rate of miosis following initial
medical treatment in these cases. The results of the four types of
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operation used to treat acute angle closure glaucoma were therefore not
directly comparable.
4. Inadequate follow up. The number of patients followed up for 2 -
5 years was inadequate. Patients discharged within two years of surgery
may have had better vision and better glaucoma control than patients
who were kept under review. Lowe attempted to carry out a five year
follow up of 52 patients who had had surgery for angle closure
glaucoma 43 Only 26 {50%) were available for review. Of the 26 who did
not attend., 18 probably had died and 8 had been discharged from follow
up and could not be traced.
3.6.1 FELLOW EVES
Peripheral iridectomy completely prevented acute angle closure
glaucoma in our study, confirming tha results of previous studies
i'5 ,ot» ,o?
9/59 (15$) of patients in our study were using topical medication
or had an intraocular pressure greater than 21 mm Hg in the fellow eye
2-5 years following peripheral iridectomy. Previous studies have found 0
25,42,46 3;| 135^ ]2$ 86, 19$ 43 and 35$ 87 of fellow eyes needed
medication to maintain normal intraocular pressure 1-12 years after
peripheral iridectomy (see Table 1.11).
14/59 (24$) of patients in our study lost 2 or more lines of visual
acuity in the fellow eye due to cataract development 2-5 years following
peripheral iridectomy. Flornan found that 33$ of fellow eyes lost 2 or
more lines of visual acuity due to cataract development after a follow up
period of 2-4 years a7. Krupin found that 15$ of fellow eyes lost 3 or
more lines of visual acuity due to cataract development after a mean
follow up period of 52 months 86. Godel found that 40$ of fellow eyes
developed cataracts 1 - 4 years after peripheral iridectomy, compared to
8% in a control group treated conservatively 196 (see Table 1.12).
Our long term results of operative peripheral iridectomy in fellow
eyes are therefore comparable to previously published studies.
3.6.2 ACUTE ANGLE CLOSURE GLAUCOMA EYES
One case of recurrent angle closure glaucoma, due to an
imperforate peripheral iridectomy, occurred in our study. Acute angle
closure glaucoma in the presence of a patent peripheral iridectomy is
very unusual, and has not occurred in several large series 25,43,86,8?
We found that 60 % of acute angle closure glaucoma eyes treated
with peripheral iridectomy were norrnotensive without medication 2-5
years after surgery. In contrast 89% of eyes treated with primary
drainage surgery, in the form of either trabeculectomy or iridencleisis,
were norrnotensive without medication. There was no significant
difference between these outcomes using theX2 test with Yate's
correction.
Previous studies have found that 60 - 90% of acute angle closure
glaucoma eyes treated with peripheral iridectomy remain norrnotensive
without medication in the long term 25,43,44,46,86,87,135 (see table 1.10).
Most workers have reported a rate of 70 - 75% 25,43,46,86,8? (see table
1.10).
Primary drainage surgery for acute angle closure glaucoma has
been reported to result in normal intraocular pressure without
medication in more than 90% of eyes at follow up ,3Cb134 (see table
1.10). Our finding of 89% of eyes norrnotensive without medication is
comparable to the results of these studies.
Assessment of visual outcome following acute angle closure
glaucoma is difficult. The visual acuity prior to the acute attack is often
unknown, and vision is reduced for several days following the acute
75
attack. Visual acuity normally improves during the first four weeks
following the acute attack, due to resolution of corneal oedema,
stabilisation of intraocular pressure, resolution of intraocular
inflammation, and recovery of neuroretinal and optic nerve head function.
Residual visual acuity loss due to cataract could be attributed to either
the effects of acute angle closure glaucoma, or to the deleterious
effects of surgery.
We found that 70% of patients treated with primary drainage
surgery in the form of either iridencleisis or trabeculectomy, had a
visual acuity worse than 6/12 two to five years following surgery,
compared to 401 of patients treated with peripheral iridectomy. This
difference was not statistically significant, and in any case eyes treated
with primary drainage surgery had worse visual acuity before surgery
than eyes treated with peripheral iridectomy.
It is difficult to assess the state of the lens and measure visual
acuity during the interval between medical treatment of an acute attack
and definitive surgical treatment. Our figures for visual loss due to
cataract progression following surgery are probably unreliable. We found
that 3/15 (2030 of peripheral iridectomy patients, and 3/27 (11 1) of
primary drainage patients appeared to lose 2 or more lines of visual
acuity between the time of assessment following initial medical control,
and the 2-5 year follow up assessment. Reports of visual loss due to
cataract following acute angle closure glaucoma treated by peripheral
iridectomy vary. Floman found that 51 % of eyes lost 2 or more lines of
visual acuity after a mean follow up period of 4.2 years 87 Krupin found
that 391 of eyes lost 3 or more lines of visual acuity after a mean
follow up period of 52 months 86 . Playfair found that 12% of eyes had
needed cataract surgery during a 5 year follow up period -5. Lowe found
that 19:1 of eyes had developed a dense cataract after 5 years 43 (see
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Table 1.12). Visual acuity outcome has been found to be consistently
worse in the acute eye than in the fellow eye 25,43,46,86,87,101
The long term visual acuity outcome following primary drainage
surgery for acute angle closure glaucoma has not been adequately
documented. Sugar found that 7 of 17 eyes with acute angle closure
glaucoma treated with iridencleisis developed cataract after a mean
follow up period of 7.8 years 45
3.6.3 SUMMARY OF RESULTS
Peripheral iridectomy reliably prevents further episodes of acut
angle closure glaucoma in acutely affected and fellow eyes. 851 of
fellow eyes were norrnotensive without medication 2-5 years after
peripheral iridectomy. 24% of fellow eyes treated with peripheral
iridectomy lost two or more lines of visual acuity due to cataract 2-5
years after surgery. 60:1 of acute angle closure glaucoma eyes treated
with peripheral iridectomy were normotensive without medication 2 -
years after surgery, and Q9% of eyes treated with primary drainage
surgery were norrnotensive, although this difference was not
statistically significant. 20% of acute angle closure glaucoma eyes
treated with peripheral iridectomy lost 2 or more lines of visual acuiU
due to cataract 2-5 years after surgery. However, assessment of visual
acuity loss following acute angle closure glaucoma is unreliable.
While the limitations of a retrospective study have reduced the
reliability of these results, they indicate that the outcome of surgical
treatment of angle closure glaucoma in Edinburgh during the period
1980-1985 was similar to previously published results.
CHAPTER 4.
Nd:YAG LASER IRIDOTOMY IN FELLOW EYES.
A RANDOMISED, PROSPECTIVE COMPARISON OF ND:YAG
LASER IRIDOTOMY AND OPERATIVE PERIPHERAL IRIDECTOMY IN
THE FELLOW EYE OF PATIENTS WITH ACUTE ANGLE CLOSURE
GLAUCOMA
4.1 SUMMARY
A prospective, randomised comparison of Nd:YA6 laser iridotorny
and operative peripheral iridectomy in the fellow eye of 52 patients
presenting with acute angle closure glaucoma has been undertaken.
Nd:YAG laser iridotorny resulted in a significantly higher incidence of
iris bleeding at the time of treatment (p<0.05), higher intraocular
pressure one hour (p<0.02) arid three hours (p<0.02) following treatment,
arid a higher incidence of focal corneal oedema 24 hours following
treatment (pcO.OCH). One laser treated patient developed acute angle
closure glaucoma two weeks following treatment despite the presence of
a small patent iridotorny. After a mean follow up period of 11.8 months
there was no significant difference between the two groups in visual
acuity or intraocular pressure.
4.2 INTRODUCTION
While several studies have compared argon laser iridotomy and 0
switched Nd.YAG laser iridotorny '0,11,13,22,23 an(j one study has
compared argon laser iridotomy and operative peripheral iridectomy 95,
formal comparison of Nd:YAG laser iridotorny and operative peripheral
iridectomy has not been undertaken. We have performed a randomised,
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prospective comparison of the early post-treatment complications,
glaucoma outcome and visual acuity outcome of Nd:YAG laser iridotomy
arid operative peripheral iridectomy in the fellow eyes of a group of
patients presenting with acute angle closure glaucoma.
Fellow eyes are a particularly satisfactory "model" with which to
compare these two forms of treatment. Fellow eyes have, in general, no
preexisting disease, but are at risk of developing acute angle closure
glaucoma without prophylactic treatment 42 Unlike eyes which have
sustained an attack of acute angle closure glaucoma it may be assumed
that corneal endothelium changes 76>81>82, or cataract development
25,43,86,8? following prophylactic treatment will be due to the treatment
rather than the preexisting disease, allowing for normal ageing changes.
4.3 MATERIALS AND METHODS
Approval to perform a randomised prospective comparison of
Nd:YAG laser iridotomy arid operative peripheral iridectomy was obtained
from the regional surgical subspecialties ethical committee. Consecutive
patients presenting with acute angle closure glaucoma in one eye during
the period January 1987 to June 1989 were referred to the study if the
consultant in charge of the case believed the patient was suitable for
either Nd:YAG laser iridotomy or surgical peripheral iridectomy in the
fellow eye. If the fellow eye had an intraocular pressure greater than 21
mm Hg or a cup.disc ratio greater than 0.6 the patient was excluded
from the study. Informed patient consent to inclusion in the study was
obtained before randomisation. Randomisation was stratified into a
group aged more than 70 years, and a group aged less than 70 years.
Randomisation was carried out by opening the top envelope in a container
of consecutively numbered sealed envelopes. The envelope contained a
card marked "surgery" or "laser", and the number of the envelope. The
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allocation of "surgery" or "laser" to each number had been performed
using a random number generator computer programme prior to
commencement of the trial, and the cards were placed in the envelopes
by a person not involved in the trial.
initial examinations were performed by one observer (BWF), arid
included assessment of corrected visual acuity, intraocular pressure,
Goldman gonioscopy, slit lamp examination of the lens, and fundal
examination. Specular microscopy was performed using a Keeler-Konan
Pocklington specular microscope. Several central fields were
photographed and stored for later analysis.
48 hours prior to operative or laser treatment all systemic and
topical intraocular pressure lowering agents, other than G Pilocarpine
2%, were discontinued. One drop of G Pilocarpine 21 was instilled one
hour before treatment.
4.3.1 OPERATIVE SURGERY
Operative peripheral iridectomy was performed under general
anaesthetic, or subconjunctival local anaesthetic. Retrobulbar local
anaesthetic was not used, in order to avoid possible changes in
intraocular pressure induced by this procedure during the early
postoperative period. A corneal incision was performed, the peripheral
iris was grasped with grooved forceps, and a peripheral iridectomy was
made using scissors. The incision was not sutured, in order to minimise
postoperative irritation, and facilitate early measurement of intraocular
pressure.
4.3.2 LASER TREATMENT
Nd:Yag laser iridotomy was performed by one surgeon (BWF). A
Zeiss "Visulas" Nd:YAG laser and Zeiss anterior segment YAG contact lens
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were used in all treatments. A treatment site was chosen in the superior
iris, between 10 and 2 o'clock, approximately 2/3 distance from the
pupil margin to the base of the iris. An iris crypt was used when present.
A single 5-10 mJ pulse was delivered to the treatment site. If this pulse
did not penetrate the iris, further single pulses were delivered to the
same site until penetration was achieved. A gush of aqueous fluid from
the posterior chamber could be seen at the moment of penetration.
Patency was assessed by direct observation of the posterior chamber, or
anterior lens capsule.
4.3.3 POST TREATMENT ASSESSMENT
Goldman applanation tonometry was performed 1, 2, 3, 6 and 24
hours following treatment. A Perkins hand held applanation tonometer
was used to measure the early postoperative intraocular pressure in
some surgical patients who had had a general anaesthetic. Systemic arid
topical intraocular pressure lowering agents were withheld unless the
pressure rose above 40 mm Hg.
Twenty four hours after treatment the cornea was examined and
focal oedema scored as 0 = no abnormality, + = focal granular changes in
the corneal endothelium overlying the treatment site, or ++ - focal full
thickness corneal oedema, iritis was judged to be present if there were
more than 5 white cells per field using a 3 mm long, 0.2 mm wide slit
beam focussed in the central anterior chamber. The presence of dispersed
pigment particles in the aqueous was not judged to be indicative of
iritis. Intraocular pressure was measured, the iridotorny or iridectomy
inspected for patency, and the lens examined. No topical treatment was
given unless significant iritis was present, in which case
G. Betamethasone 0.1 % four times daily for one week was prescribed.
Mydriatics were not used.
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4.3.4 FOLLOW UP
Patients were assessed 1 week, 1 month, 6 months, 12 months and
then annually following treatment. Examinations were performed by one
of three observers (BWF, EW, or EF) in the iridotorny research clinic.
Corrected visual acuity, intraocular pressure, examination of the lens
and examination of the optic disc were carried out at every visit. The
vertical cup:disc ratio was recorded in decimal form. The pupil was
dilated using G. Phenylephrine 10$ one month following treatment in
order to detect posterior synechiae, and examine the lens and fundus.
Six months following treatment specular microscopy, gonioscopy
and provocation testing were performed. Goldman gonioscopy was
performed on all patients by BWF, EW or EF, followed by Posner 4 mirror
indentation gonioscopy by BWF if any part of the angle appeared to be
closed. Pilocarpine/phenylephrine provocation testing as described by
Mapstone 68 and modified by Harrad 105 was used. One drop of
G. Phenylephrine 10$ and one drop of G. Pilocarpine 2$ were instilled.
The intraocular pressure was measured one hour later. Visual field
examinations were performed when clinically indicated, but did not form
an integral part of the study. A Friedman visual field analyser was used.
4.3.5 SPECULAR MICROSCOPY ANALYSIS
Patients were coded by number, and endothelial cell counts were
performed by an observer unaware of the coding system. Using
standardised print magnification and a transparent grid, three
representative fields of 0.05 mm2 were chosen for each patient, and the
cells within these fields were counted. The mean value for the three
areas was then calculated.
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4.3.6 STATISTICAL ANALYSIS
Where appropriate the unpaired Student t test or the X2 test
with Vote's correction were used to test the significance of differences
between the two groups. Statistical results are presented as a "p" value
where a significant differences exists., and "NS" where there is no
signi fi cant di fference.
4.4 RESULTS
70 patients presented with acute or subacute angle closure
glaucoma during the study period. Two patients had bilateral acute angle
closure glaucoma. Thirteen patients were not thought to be equally
suitable for Nd:VAG laser iridotorny or operative peripheral iridectomy by
the consultant in charge of the case, or declined inclusion in the trial.
Three patients had an intraocular pressure greater than 21 mm Hg, or
pathological optic disc cupping in the fellow eye and were excluded from
the study.
52 patients were included in the study, 26 treated by Nd:YA6 laser
iridotomy and 26 treated by operative peripheral iridectomy. The
minimum follow up period was 6 months. Thirteen patients from the
surgical group and sixteen patients from the laser treated group had
completed one year of follow up at the time of analysis. The mean
follow up time for the surgical group was 11.7 ± 8.7 months, and that of
the laser treated group 16.1 ± 11.0 months (unpaired Student t test NS).
Two patients in the laser treated group died due to ischaemic heart
disease, in each case approximately nine months following treatment. No
patients were lost to follow up.
Details of initial assessment of the two groups are given in Tables
4.1 and 4.2 . The two groups were very similar in composition.
Surgery Laser P
Number 26 26
Male: Female 9:17 7:19
Age (years) 67.5+13.1 68.3± 12.6 NS
Age range 41- 88 40- 88
Right: Left 10:6 11:15
TABLE 4.1
Prospective comparison of operative peripheral Iridectomy and
Nd:YAG laser Iridotomy in fellow eyes. Patient Groups.
Figures are presented as mean ± one standard deviation. P = statistical p
value, NS = Not statistically significant.
Surgery Laser P
Corrected visual acuity worse
than 6/9 due to cataract 3 4
Intraocular pressure (mm Hg) 15.0+3.6 15.5+3.4 NS
Intraocular pressure, range 6-20 8-21
Gonioscopy (Goldman)
partly closed 6 6
Iris colour BrowmGrey 10:16 10:16
TABLE 4.2
Prospective comparison of operative peripheral iridectomy and
Nd:YAG laser iridotomy in fellow eyes. Initial Assessment.
A. patent laser iridotomy was obtained at the initial treatment
session in 25 patients. Treatment sessions on three consecutive days
were needed to obtain a patent iridotomy in one patient. A patent
iridectomy was produced in all surgical patients. A mean of 3.1 + 2.6
pulses (range 1-10) with a mean total energy of 25.8 ±21.4 rnJ (range
4.9-72.9 rnJ) was used in laser treatment. One pulse was sufficient to
create an adequate iridotomy in 11 patients, and less than 10 mJ total
energy was used in 10 patients. Slight iris bleeding occurred at the time
of treatment in 15 laser patients arid 7 surgical patients (X2 test with
Yate's correction p< 0.05). There were no other operative complications.
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4.4.1 IMMEDIATE POST-TREATMENT ASSESSMENT
The mean Intraocular pressure before treatment and 1,2,3 and 6
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Figure 4.1. Early post treatment intraocular pressure changes
in fellow eyes following operative peripheral iridectomy and
Nd:YAG laser iridotomy.
Complete data was available in 9 surgically treated patients and
15 laser treated patients. The groups were significantly different 1 hour
and 3 hours following treatment using the unpaired Student t test
(p<0.02 in each case). Two surgically treated patients {8%) developed an
intraocular pressure rise to between 20 and 25 mm Hg within 3 hours of
surgery. Seven laser treated patients {27%) developed an intraocular-
pressure rise to greater than 21 mm Hg. The intraocular pressure rose to
30-40 mm Hg in two patients, and above 40 mm Hg in two patients.
Of the 15 laser treated patients with complete intraocular
pressure data, the peak pressure occurred one hour following treatment
in 7, at two hours in 4, and at three hours in 4. In all but two cases the
intraocular pressure had returned to normal six hours following
treatment.
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4.4.2 ASSESSMENT 24 HOURS POST TREATMENT
The results of examination 24 hours following treatment are
shown in Table 4.3.
Surgery Laser P




mm Hg 11.1 ±3.1 12.2±4.0 NS
Iritis 11 6 NS
Patent 26 26
Focal lens opacities 6 Oi-
TABLE 4.3
Prospective comparison of operative peripheral iridectomy
and Nd:YAG laser iridotomy in fellow eyes.
Examination 24 hours following treatment.
P = statistical p value, NS = Not statistically significant.
Focal corneal damage was evident in 15/26 (58£.) of laser treated
patients, and in no surgical patients (X2 test with Yate s correction
pcO.OOl). In mild cases the appearance was of slight granularity of the
endothelium overlying the treatment site. However in grade ++ cases
focal full thickness corneal oedema was present. Focal corneal oedema
was most marked 24 hours following laser treatment, arid had fully
resolved after one week in all cases. Corneal changes were not seen
following operative peripheral iridectomy.
The total laser energy used to treat the 15 patients who
subsequently developed focal corneal oedema was 30.95 ±21.6 rnJ,
compared with 18.2 ±19.7 mJ in those who did not. This difference was
not statistically significant, using the unpaired Student t test.
The total laser energy used to treat the six patients who
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subsequently developed iritis was 39.75 ± 26.2 rnJ, compared with 20.7
+ 18.2 mJ in those who did not. Again this difference was not
statistically significant using the unpaired Student t test.
Six surgical patients were found to have minimal focal lens
opacities at the iridectomy site due to mild operative trauma affecting
the anterior lens capsule. These opacities were not progressive and did
not lead to visual loss during the follow up period. Two laser treated
patients developed focal lens opacities underlying the treatment site. In
one case a faint haze was present deep to the anterior capsule., which did
not progress and was riot associated with reduced visual acuity. The
second case developed polychromatic crystals in the anterior lens cortex
underlying the treatment site, and subsequently developed a nuclear
cataract with loss of one line of visual acuity, from 6/9 to 6/12.
4.4.3 1 MONTH FOLLOW UP
One laser treated patient developed acute angle closure glaucoma
three weeks following treatment. The patient had been using
cyclopentolate \% drops to the acutely affected eye following
trabeculectomy, and may have inadvertently contaminated the fellow eye.
Following treatment with pilocarpine 2% the intraocular pressure
returned to normal. The iridotorny was small (50.ux50.p.) but patent.
Further laser treatment was performed in order to enlarge the opening,
resulting in no further symptoms. Subsequent pilocarpine/phenylephrine
and cyclopentolate provocation tests were' negative. Further details of
this case are given in chapter 6, pages 133-136 (case 2).
One patient was found to have developed iridotorny closure two
weeks following treatment and further laser treatment to re open the
iridotorny was performed.
Posterior synechias developed in three surgical patients, arid three
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laser treated patients. Two of the surgical patients and one of the laser
treated patients had had iritis at the 24 hours post-treatment
examination. The adhesions were of minimal extent in all cases, did not
progress, arid were not associated with subsequent cataract development
or loss of visual acuity.
4.4.4 SIX MONTH FOLLOW UP
Table 4.4 summarises findings in the two groups six months
following treatment.
Surgery Laser P
Visual acuity loss of
two or more lines. 0 2 NS
Posterior synechias 3 3 NS
Intraocular pressure, mm Hg 14.5±2.7 15.0+3.2 MS
Gonioscopy -angle
partly closed 0 2 NS
Provocation test
positive 0 0 NS
TABLE 4.4
Prospective comparison of operative peripheral iridectomy
and Nd:YAG laser iridotomy in fellow eyes.
Examination 6 months following treatment.
When compared with pretreatment measurements visual acuity
was unchanged, or changed by only one line in all surgical patients.
However in the laser treated group visual acuity deteriorated by two or
more lines iri two patients. These patients had developed nuclear
cataract - one in a previously clear lens, arid one in a lens with pre
existing nuclear cataract.
The mean intraocular pressure was 14.5+2.7 mm Hg in the surgical
group and 15.0±3.2 mm Hg iri the laser treated group (unpaired Student t
test NS). One laser treated patient had an intraocular pressure of 25 mm
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Hg. All other patients had an intraocular pressure of less than or equal to
21 mm Hg, and no patient required topical medication.
All iridotomies and iridectomies were patent. Gonioscopy revealed
an open angle in all surgical patients, with focal goriiosynechiae adjacent
to the iridectomy in two patients.
Two laser treated patients had partly closed angles on Goldman
gonioscopy, but the angles were open on indentation. One of these
patients had focal areas of goniosynechiae adjacent to the iridotorny
site. The iridotomy size in these patients was not excessively small,
one measured 100px200.u and the other 100 px500 p.
No patient developed more than a ]()% change in the cup:disc ratio
during the follow up period. Pilocarpine/phenylephrine provocation tests
were performed on 14 surgical patients and 23 laser treated patients.
All tests were negative.
Satisfactory pretreatrnent and 6 month post-treatment specular
rnicrographs were obtained in 7 surgical patients and 9 laser treated
patients. The endothelial cell counts derived from the photographs are
shown in Table 4.5.
Surgery Laser P
Pre treatment density, mm"2 2470.3 + 522.7 2531.7 + 649.1 NS
Post treatment density, mm"2 2442.0 + 557.1 2188.0 ± 560.7 NS
Percentage change -3.6 + 3.95 -7.2 ± 10.6 NS
TABLE 4.5
Prospective comparison of operative peripheral iridectomy
and Nd:YAG laser iridotomy in fellow eyes.
Corneal Endothelium cell density.
P = statistical p value, NS = Not statistically significant.
The two groups did not significantly differ in mean endothelial
cell count either before or 6 months following treatment. There was no
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significant percentage change in endothelial cell count following
treatment in either group, and no difference between the two groups.
4.4.5 FINAL FOLLOW UP
At the final follow up examination an additional two laser treated
patients with initially clear lenses were found to have developed nuclear
cataract sufficient to cause two or more lines of visual acuity loss. A
total of four laser treated patients lost two or more lines of visual
acuity due to cataract. Lens changes sufficient to cause two or more
lines of visual acuity loss did not occur in any surgical patient (X2 NS).
The intraocular pressure at final follow up was 14.9+2.4 mm Hg in the
surgical group, and 14.3+2.4 mm Hg in the laser treated group (unpaired
Student t test NS). No patient had an intraocular pressure greater than 21
mm Hg, but one laser treated patient was using topical B blocker
medication to maintain normal intraocular pressure.
4.5 DISCUSSION
4.5.1 ACUTE ANGLE CLOSURE GLAUCOMA FOLLOWING
PROPHYLACTIC IRIDOTOMY OR IRIDECTOMY
One laser treated patient developed acute angle closure glaucoma
despite the presence of a small, patent iridotorny. Enlargement of the
iridotomy led to resolution of symptoms. Subsequent
pilocarpine/phenylephrine and cyclopentolate provocation tests were
negative.
Lowe found that conservative treatment of the fellow eye resulted
in a 50£ incidence of subsequent acute angle closure glaucoma 42.
However, acute angle closure glaucoma following prophylactic surgical
peripheral iridectomy is extremely rare 25,42,43,11? small argon xz2>133
or Nd:YA6 15,21 ,so,i06 ]aser iridotornies may, however, fail to prevent
acute angle closure glaucoma. The size of the iridotomy appears to be
crucial, as acute angle closure glaucoma has only been reported in
iridotornies less than 150.u in diameter 15,21,so,106,132,133 7fie problem
of acute angle closure glaucoma in eyes with a small, patent iridotomy is
discussed further in chapter 6.
One case developed closure of a previously patent iridotomy, two
weeks following treatment. This patient had not had significant iritis
following treatment. Nd:YAG laser iridotomy closure is uncommon
11,14,15,22,80,106 fate iridotorny closure, or partial closure, has been
reported in 10-20$ of cases following argon laser iridotomy
13,22,23,30,105
4.5.2 EARLY POST-TREATMENT COMPLICATIONS
Focal corneal endothelium damage, iris bleeding, iritis, transient
intraocular pressure elevation, and focal lens opacity have been reported
following Nd:YAG laser iridotomy 10-17,22,23,00,106,107,111,122
Focal corneal endothelium damage was evident in 58$ of our laser-
treated patients. More marked focal oedema occurred in 17$ of patients.
Other workers have reported that 4-30$ of eyes develop focal
endothelial changes following Nd:YAG laser iridotomy 10,11,13,14,22,80
(see Tabled).
Punctate areas of endothelial loss overlying treatment sites have
been attributed to damage caused by the dispersion of high velocity
particulate debris 7>9 . The endothelial granularity which we observed on
slit lamp examination would be compatible with this hypothesis.
Reduced endothelial cell count has been described by some workers
following argon laser iridotomy 10, but others have found no change 114
(see Table 1.2). We found no significant change in endothelial cell count
following Nd:YAG laser iridotomy, confirming previous studies s -1 u, 115
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No significant change in endothelial cell count following surgical
peripheral iridectomy was found in our study, again confirming the
results of other workers 8 a12,1 97 One previous study found a 5% reduction
in endothelial cell count81 (see Table 1.2). On the basis of existing data
Nd:VAG laser iridotorny would appear to be as safe as operative
peripheral iridectomy in the treatment of angle closure glaucoma
patients with co existing Fuch's endothelial dystrophy. However a much
larger study would be needed to detect a small difference in endothelial
cell loss produced by these two forms of treatment, if such a difference
does exist.
58% of laser treated patients developed iris bleeding at the time
of treatment, compared to 27% following operative surgery (X2 test with
Vate's correction p<0.05). Other workers have reported an incidence of
20-80% rnicrohyphaerna following Nd:YA6 laser iridotorny 10'11'12'13'
14,22,23,80,111 (see yable 1.3). Macrohyphaema did not occur in our series,
bleeding was transitory and did not appear to result in any adverse
effect.
The incidence of iritis was similar following Nd:YAG laser
iridotorny or operative peripheral iridectomy. Posterior synechiae
developed in three patients from each group. While synechiae were not
associated with cataract development and visual loss in our study,
posterior synechiae have previously been found to be associated with
cataract development following operative peripheral iridectomy87. Post
treatment topical steroid treatment is therefore indicated in all cases.
Mydriasis using G. Phenylephrine 10% has been found to carry minimal
risk of provoking acute angle closure glaucoma 19S.
Our finding of transitory, but very marked, intraocular pressure
elevation during the first three hours following treatment in a
proportion of patients confirms the findings of previous studies
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10,11,12,14,22,23,106 fSee jg^jg ] j) v/e now give acetazolamide 500 rng
orally one hour before treatment, and have had no further instances of
intraocular pressure rise above 21 mm Hg while treating 12 fellow eyes
since July 1989. Pilocarpine 1", Timolol k'00 and apraclonidine 201 have
been found to prevent the development of post-treatment intraocular
pressure elevation.
Studies in rabbits suggest that post iridotomy intraocular
pressure elevation is caused by mechanical blockage of the trabecular
meshwork by particulate debris and plasma proteins released from the
iris 177Jwhile raised aqueous prostaglandin levels have been found
following iridotomy 176, indornethacin does not prevent post iridotomy
intraocular pressure elevation 177. Our own findings following Nd:YAG
laser phacolysis in rabbits also suggests that elevated intraocular-
pressure following anterior segment laser surgery is caused by
mechanical blockage of the trabecular rneshwork by proteins 165 Nd:YAG
laser disruption of the lens nucleus did not cause raised introcular
pressure unless the lens capsule was disrupted. Capsule damage was
associated with escape of semi-liquid lens proteins into the aqueous,
and rapid elevation of intraocular pressure. While it was possible that
prostaglandins or other mediators were responsible for intraocular
pressure elevation, the time course suggested direct mechanical
blockage of the trabecular rneshwork 165
Iris tissue is physically removed from the eye during operative
peripheral iridectomy, but this does not occur during Nd:YA6 laser
iridotorny. Aqueous leakage from peripheral iridectomy wounds was not
evident, and the absence of intraocular pressure elevation following
operative peripheral iridectomy was probably due to the absence of
debris in the aqueous.
Focal lens opacities were found underlying the laser treatment
site in two patients. Focal opacities induced by Nd:YAG laser
photodisruption are rare 14-17,107,122^ in contrast to a much higher
incidence found following argon laser iridotorny 1,10,13,22,23,105,112 (see
Table 1.8). We found six cases of small focal lens opacities at the site of
operative peripheral iridectomy. Focal opacities, whether caused by
argon laser iridotorny, Nd:YAG laser iridotomy or operative peripheral
iridectomy have previously been found to be non-progressive, and not
associated with visual loss. However one of our laser treated patients
lost one line of visual acuity due to nuclear cataract development, having
sustained a focal opacity at the time of treatment.
4.5.3 LONG TERM GLAUCOMA OUTCOME
There was no significant difference in the mean intraocular
pressure of the two groups six months following treatment (14.5+2.7 mm
Hg in surgical patients, 15.0+3.2 mm Hg in laser treated patients,
unpaired Student t test NS), or at the time of most recent follow up
(14.9+2.4 mm Hg in surgical patients, 14.3+2.4 mm Hg in laser treated
patients, unpaired Student t test NS). Only one patient needed treatment
to maintain an intraocular pressure of less than 21 mm Hg. However
patients presenting with elevated intraocular pressure or pathological
optic disc cupping in the fellow eye were excluded from the study. The
reported long term incidence of raised intraocular pressure following
peripheral iridectomy in fellow eyes ranges from zero to )9%
25,43,46,86,135 ,;see fable 1.11). Our own retrospective study of the
outcome of peripheral iridectomy in fellow eyes found that i.5* of
patients required medication or had elevated intraocular pressure in the
fellow eye 2-5 years following treatment (see page 65).
The appearance of optic discs remained unchanged in all eyes, and
gonioscopic appearances six months following treatment were similar in
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the two groups. Two laser treated eyes had areas of angle closure which
could be opened on indentation. While the area of the iridotorny was not
excessively small in these cases, it was smaller than that normally
obtained by peripheral iridectomy. Wishart has reported progressive
angle narrowing in four eyes following Nd:YAG laser iridotorny, with
widening of the angle on performing a further laser iridotorny 15 It is
possible that small iridotomies do not fully overcome iris bombe.
4.5.4 LONG TERM VISUAL ACUITY OUTCOME
There was no significant difference in the visual acuity outcome
of the two groups six months following treatment, or at the final follow
up visit. While four laser treated patients lost two or more lines of
visual acuity due to cataract development and no surgical patients lost
vision, this difference was not statistically significant. Del Priore
reported progression of cataract following Nd:YAG laser iridotomy in
2/43 patients 13 On long term follow up 2-23a of fellow eyes subjected
to peripheral iridectomy were found to develops cataract sufficient to
reduce visual acuity by two or more lines 43,45,46,86,135 (see jable 1.13).
Flornan reported an incidence of4l;T among an Israeli population 87 These
figures compare with a prevalence of Q% among fellow eyes treated
conservatively 196
4.6 CONCLUSION
Outpatient Nd:YA6 laser iridotomy is more convenient and may be
cheaper than operative peripheral iridectomy 5 Our study shows that the
two treatments have a similar short term outcome in terms of efficacy
and complication rates. However the occurrence of acute angle closure
glaucoma in an eye which had a small but patent prophylactic Nd:YAG
laser iridotomy is disturbing.
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CHAPTER 5.
Nd:YAG LASER IRIDOTOMY IN ACUTE ANGLE CLOSURE
GLAUCOMA
5.1 SUMMARY
a non randomised prospective comparison of Nd:YAG laser
iridotomy, peripheral iridectomy., arid trabeculectomy has been
undertaken in 54 patients with acute angle closure glaucoma.
Iris bleeding occurred more frequently following Nd:YA6 laser
iridotomy than operative peripheral iridectomy (p<0.02). Focal corneal
oedema occurred in 4/19 (22%) eyes following Nd:YA6 laser iridotomy..
but did not occur following operative peripheral iridectomy or
trabeculectomy.
Acute angle closure glaucoma occurred in two laser treated
patients despite the presence of a patent iridotomy. The area of iris
opening was significantly greater following peripheral iridectomy than
following Nd:VA6 laser iridotomy (pcO.OOl).
84% of Nd:YAG laser iridotomy patients., 80% of peripheral
iridectomy patients, and 90% of trabeculectomy patients were
normotensive without medication at follow up. Trabeculectomy produced
a significant lowering of intraocular pressure (p<0.05), but this did not
occur following Nd:YA6 laser iridotomy or peripheral iridectomy.
There was no statistically significant difference in the visual
acuity outcome of the three groups, although there was a trend towards a
higher incidence of cataract development following trabeculectomy.
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CHAPTER 5a
A PROSPECTIVE COMPARISON OF ND:YAG LASER 1RIDOTQMY,
PERIPHERAL IRIDECTOMY AND TRABECULECTOMY IN THE
TREATMENT OF ACUTE ANGLE CLOSURE GLAUCOMA.
5a. 1 INTRODUCTION
Several reports describe the use of Nd:YAG Laser iridotomy In a
variety of forms of angle closure glaucoma4'11'14'104'137 . However
relatively little attention has been given to the special problems
involved in treating acute angle closure glaucoma 80 These eyes are
often hyperaernic, with some degree of corneal and iris oedema. Marked
pupil block effects are present.
The operative treatment of acute angle closure glaucoma remains
controversial. While many workers advocate peripheral iridectomy in all
cases 25, in the long term only 70-75% of eyes remain normotensive
without medication following this form of treatment 25,43,86,8?
Accurate prediction of which eyes will need further glaucoma treatment
following peripheral iridectomy is not possible25, arid some workers
have advocated primary drainage surgery 13Cb134. The policy of our
department has been to perform peripheral or sector iridectomy on eyes
which have had an acute attack of less than 48 hours duration, have
responded well to initial miotic treatment, and have not had extensive
goniosynechiae on gonioscopy. Eyes which have not met these criteria
have been treated by primary drainage surgery, in the form of
trabeculectomy, iridencleisis or sector iris inclusion operation.
In order to assess the safety and effectiveness of Nd:YAG laser
iridotomy in the treatment of acute angle closure glaucoma we have
undertaken a rion randomised prospective comparison of Nd:YAG laser
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iridotomy, operative peripheral iridectomy and trabeculectomy in a group
of 54 patients presenting to our department with acute angle closure
glaucoma between January 1987 and June 1989. The study was an open
pilot study designed to evaluate the feasibility of performing a larger
randomised comparison of Nd:YA6 laser iridotorny and operative
peripheral iridectomy in the treatment of acute angle closure glaucoma.
5a.2 MATERIALS AND METHODS
70 patients presented to the ophthalmology department of
Edinburgh Royal Infirmary with acute or subacute angle closure
glaucoma during the period January 1987 to June 1989. 54 of these
patients underwent Nd:YAG laser iridotorny, operative peripheral
iridectomy or trabeculectomy for acute angle closure glaucoma and were
observed prospectively. The remaining patients either had subacute
glaucoma and were excluded (7 patients), or were treated by an
alternative operation, such as iridencleisis or sector iris inclusion (9
patients).
Treatment of the acutely affected eye was not randomised.
Patients with acute angle closure glaucoma of more than approximately
48 hours duration or who responded less promptly to initial medical
control underwent primary trabeculectomy. Patients with marked
breathlessness due to cardiac or respiratory disease and the very elderly
were treated by Nd:YAG laser iridotomy. Some patients expressed a
preference for either laser treatment or conventional surgery, and were
treated accordingly.
58.2.1 INITIAL EXAMINATION
Initial examination was performed by a number of experienced
observers and included assessment of corrected visual acuity, the degree
of corneal oedema present, scored as 0, + or ++, intraocular pressure
measured by Goldman applanation tonometry, pupil size measured in
millimetres, and Goldman gonioscopy.
Patients were then treated with acetazolamide 500 rng
intravenously, one drop of G. Timolol 0.5$, and G. Pilocarpine 2% hourly.
The intraocular pressure was measured every 1-2 hours, until it had
fallen below 21 mm Hg.
Serial measurements of corneal thickness and intraocular pressure
were made in four patients following initial medical treatment. Central
corneal thickness was measured using an "Ophthasoriic" ultrasound
pachyrneter (Tekriar inc). Three readings were taken at the time of each
measurement, and the average result recorded. Intraocular pressure was
measured using a Goldman applanation tonometer. Measurements were
made at the time of initial medical treatment, and approximately 1 hour,
2 hours, 4 hours, 6 hours, 24 hours, 48 hours and 72 hours later.
Examination of all patients 24 hours after presentation was
performed by BWF, and included assessment of visual acuity, corneal
oedema, intraocular pressure, pupil size, Goldman gonioscopy, lens and
fundus appearances. The vertical cup:disc ratio was recorded in decimal
forrn.
Operative peripheral iridectomy, trabeculectomy or Nd:YA6 laser
iridotorny was performed 3-4 days later, by one of several experienced
surgeons.
5a.2.2 PERIPHERAL IRIDECTOMY
Operative peripheral iridectomy was performed under general or
local anaesthetic. A 2-3rnrn clear cornea incision was used in 5 patients.
The peripheral iris was grasped with grooved forceps, arid an iridectomy
performed with scissors. The incision was not sutured. In the remaining
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10 patients a corneoscleral incision was used. The peripheral iris was
prolapsed, and a peripheral iridectomy was performed with scissors. The
incision was closed with one 8/0 polyglactiri ("Vicryl") suture.
Postoperatively patients were treated with 6. Betamethasone 0.1$
four times daily and G. Tropicamide 1$ once daily, for one week.
50.2.3 TRABECULECTOMY
Trabeculectomy was performed under general anaesthetic or local
anaesthetic. A lirnbal or fornix based conjunctival flap was used. A
4 mm x 2 mm rectangular partial thickness scleral flap was fashioned,
and a 1mm x 2mm trabeculectomy block was excised. A small peripheral
iridectomy was made. The sclera and conjunctiva were sutured using 8/0
virgin silk.
5a.2.4 Nd:YAG LASER IRIDOTOMY
All patients were given acetazolamide 500rng orally one hour
before treatment. One drop of G. Pilocarpine 2$ was instilled 30 minutes
before treatment. A Zeiss visulas Nd:YAG laser and Zeiss anterior
segment YAG contact lens were used in all treatments.
A treatment site was chosen in the superior iris, between 10 and 2
o'clock, approximately 2/3 way from the pupil margin to the iris base. An
iris crypt was used where present. A single 5-10 rn.J pulse was delivered
to the treatment site. If this pulse did not penetrate the iris further
single pulses were delivered to the same site until penetration was
achieved. Patency was assessed by direct visualisation of the posterior
chamber, or anterior lens capsule.
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5a 2.5 POST TREATMENT ASSESSMENT
The intraocular pressure was measured and the cornea, anterior
chamber and iris were examined 2 hours and 24 hours after treatment.
5a.2.6 FOLLOW UP
Patients were examined 1 week, 1 month, 3 months, 6 months and
then 6 monthly after treatment. Visual acuity, intraocular pressure, lens
appearance and optic disc appearance were noted at every visit. Visual
fields were assessed using a Friedman visual field analyser if the
intraocular pressure was raised or the optic disc appearance was
abnormal.
Six months following treatment Goldman gonioscopy was
performed on laser iridotorny and peripheral iridectomy patients by one
of three experienced observers (BW, EW or EF). Posner 4 mirror
indentation gonioscopy was performed by BWF if any part of the angle
appeared to be closed. Pilocarpine/phenylephrine provocation testing as
described by Mapstone 68, and modified by Harrad 105 was then
performed. The intraocular pressure was measured, one drop of G.
Phenylephrine 10$ and one drop of 6. Pilocarpine 2$ were instilled, and
the intraocular pressure was measured again one hour later. An
intraocular pressure rise of more than 8 mm Hg, with angle closure on
gonioscopy, was regarded as a positive result.
At the final follow up visit the size of the iridotomy or iridectomy
was measured by comparison with the 200pi spot size produced by a
Haag-Streit slit lamp. The area of the iridotorny or iridectomy was then
calculated using the formula Diameter a x Diameter b x rf/4 (see Fig 2.3,
page 52). The pupil was dilated using G. Phenylephrine 10$ in all




70 patients presented with acute or subacute angle closure
glaucoma during the study period. 7 cases had subacute angle closure
glaucoma, with an intraocular pressure of less than 21 mm Hg at
presentation. These cases were excluded. The remaining 63 patients
presented with acute angle closure glaucoma.
Nine patients underwent iridencleisis or sector iris inclusion
surgery. The remaining 54 patients were included in the study. 19
underwent Nd:YAG laser iridotorny, 15 underwent operative peripheral
iridectomy, and 20 underwent trabeculectomy. One patient from the
peripheral iridectomy group and one patient from the laser treated group
had bilateral acute angle closure glaucoma. One eye was randomly chosen
for analysis by tossing a coin.
Details of the three patient groups are shown in Table 5.1.
Patients in the peripheral iridectomy group were younger than those in
the laser treated group (p < 0.02, unpaired Student t test), but there was
no significant difference in the mean age of the trabeculectomy group
and the laser treated group. The duration of the acute attack prior to
treatment was longer in the trabeculectomy group than in either the
peripheral iridectomy (p<0.05), or laser treated group (p<0.05, unpaired
Student t test). The duration of follow up was similar in the three groups





























Prospective study of the treatment of acute angle closure
glaucoma. Patient groups.





















Prospective study of the treatment of acute angle closure
glaucoma. Initial examination.
There were no significant differences between the three groups in
the mean intraocular pressure or proportion of patients with a visual
acuity of 6/12 or better at presentation.
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Table 5.3 gives the results of the examination performed after-
initial medical control.
Nd:YAG Laser Peripheral Trabeculectomy
Iridotomy Iridectomy
Number patients 19 15 20
Intraocular pressure.
mm Hg 10.8+4.2 11.8+3.1 23.1 + 14.0
No. patients with
10P < 21 mm Hg 19 (100%) 14 (93%) 10 (50%)
Pupil < 3mm 17 (89%) 14(93%) 5 (25%)
Corneal oedema present. 3 (15%) 3 (20%) 12 (60%)
Visual acuity
6/12 or better 7/15(47%) 1 1 (73%) 2/9 (22%)
Lens opacities
present 10 (52%) 2(13%) 12(60%)
TABLE 5.3
Prospective study of the treatment of acute angle closure
glaucoma. Examination after initial medical control.
The mean intraocular pressure following initial medical control
was higher in the trabeculectomy group than in the peripheral iridectomy
group (unpaired Student t test p<0.01), or laser treated group (pcO.OOl). A
significantly greater proportion of trabeculectomy patients (10/20) than
laser iridotorny patients (1/19) had an intraocular pressure greater than
21 mm Hg after initial medical control ( pcO.Ol,X2 test with Yate's
correction). The pupil became rniosed following initial medical treatment
in a significantly smaller proportion of trabeculectomy patients (5/20)
than peripheral iridectomy patients (14/15,"X2 with Yate's correction
pcO.OOl) or laser iridotorny patients (17/19,"X2 test with Yate's
correction pcO.OOl). No patient had pathological optic disc cupping.
Residual corneal oedema was present in a higher proportion of
trabeculectomy patients than peripheral iridectomy or laser iridotorny
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patients, but the differences were not statistically significant.
Significantly more peripheral iridectomy patients had a visual acuity of
6/12 or better (11/15), compared to trabeculectomy patients (2/9, X2
test with Yate's correction p<0.02). Fewer peripheral iridectomy patients
had cataract (2/15), compared to trabeculectomy patients (12/20,X2
test with Yate's correction p<0.02), or laser iridotorny patients (10/19,
X2 test with Yate's correction p<0.05).
In summary patients in the trabeculectomy group had a more
severe form of glaucoma at presentation, with less complete intraocular
pressure control, less pupil miosis, and greater residual corneal oedema
following initial medical control. While the peripheral iridectomy and
laser iridotomy groups had a similar severity of glaucoma, the
prevalence of cataract was lower in the peripheral iridectomy group.
This difference may have been related to the lower mean age of the
peripheral iridectomy group.
5a.3.1 CORNEAL PACHYMETRY RESULTS
Serial central corneal thickness and intraocular pressure
measurements were performed in four patients. The results of these
measurements are shown in Table 5.4.
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Acute eye Fellov eye
Patient Time I0P Pachymetry I0P Pachymetry
(Hours)
Patient 1 0 45 - 14 -
Age 81 1 20 - - -
*>
£_ 11 746 13 552
4 - 799 - -
6 - 753 - -
18 10 749 11 548
48 10 668 - -
72 8 588 - -
Patient 2 U 66 - 18 _
age 46 1 16 548 14 536
18 12 545 12 535
Patient 3 0 52 _ 19 _
Age 6? 1 12 552 12 517
40 8 510 1 1 470
Patient 4 0 45 _ 15 _
Age 71 17 11 526 9 513
TABLE 5.4
Serial intraocular pressure and pachymetry measurements
following acute angle closure glaucoma.
Time = time in hours from initial medical treatment
I OP = intraocular pressure
Pachymetry = ultrasound pachyrnetry readings of
central cornea, in micrometers.
Figure 5.1 shows changes in intraocular pressure following initial
medical control of acute angle closure glaucoma in the four patients
included in the study. The intraocular pressure fell to below 21 mm Hg
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Prospective study of the treatment of acute angle closure
glaucoma, intraocular pressure following initial medical
control, corneal pachymetry study
Figure 5.2 shows central corneal thickness following initial
medical control of acute angle closure glaucoma.
Central corneal thickness fell to within 10% of the thickness of
the fellow cornea within 24 hours in 3 patients. However resolution of
corneal oedema progressed much more slowly in one patient (Patient 1),























Prospective study of the treatment of acute angle
closure glaucoma. Central corneal thickness
following initial medical control.
5a.3.2 DURATION OF INPATIENT TREATMENT
The duration of in patient stay, treating both the acutely affected
eye and the fellow eye, was 5.9+3.8 days for laser treated patients,
7.9±2.8 days for peripheral iridectomy patients, and 7.9±3.5 days for
trabeculectomy patients. Differences were not significant using the
unpaired Student t test.
5a.3.3 Nd:VAG LASER IR1D0T0MY
8 patients in the laser iridotomy group had grey irises, and 11 had
brown irises.
Primary failure to achieve a patent iridotorny occurred in one
patient. This failure was not recognised and the patient developed acute
angle closure glaucoma three days later. Nd:YA6 laser iridotorny was
performed, resulting in a satisfactory opening in the iris.
The mean number of laser pulses required to create a patent
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iridotomy was 4.6+5.8. Six patients required only one pulse. There was no
significant difference in the number of pulses required to perforate
brown and grey irises (5.0±5.8 arid 4.4+6.0 respectively).
The mean power required to create a patent iridotomy was
35.6+40.6 rnJ (range 5 - 136 mJ). Brown irises did not differ from grey
irises, with levels of 40.5±44.7 mJ and 31.7+36.9 rnJ respectively. In six
patients less than 10 mJ energy was needed to create a patent, iridotomy.
Iri three patients treatment was performed at more than one site
before perforation of the iris was achieved.
Three patients had residual corneal oedema at the time of laser
treatment. However the mean number of pulses (1.3) and total power
(7.1 mJ) required to create an iridotomy in these patients was not
significantly different from that of the group as a whole.
Slight oozing of blood at the treatment site occurred in 8 patients,
compared to zero patients in the peripheral iridectomy group (X2 test
with Vate's correction p<0.02) A larger flow of blood, resulting in a blood
clot on the iris surface, occurred in one patient (Figure 5.3).
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Figure 5.3. Hyphaema following Nd:YAG laser iridotomy in
an eye with controlled acute angle closure glaucoma. The arrow
indicates the iridotomy site.
Transient elevation of intraocular pressure following treatment
did not occur, probably due to pretreatment with acetazolamide 500 mg
orally.
A significant degree of iritis occurred in one patient 24 hours
following treatment, but was readily controlled using topical steroid
medication.
Full thickness focal corneal oedema overlying the treatment site
was evident in four patients 24 hours after treatment. The mean total
energy used in treatment of these patients (75.6+69.2 mJ) was greater
than that used in treating patients who did riot develop focal corneal
oedema (24.7+19.7 rnJ, unpaired Student t test p<0.02).




The pigment epithelium of the iris was incompletely excised in 4
patients. This complication occurred in 3 of the 5 patients in whom a
corneal incision had been used. It is likely that iris oedema resulted in
separation of the iris stroma from the pigment epithelium when grasped
with grooved forceps. In one patient the pigment epithelium remained
intact following surgery. This was not recognised and the patient
developed acute angle closure glaucoma five weeks later. The
imperforate pigment layer was opened using the Nd:YAG laser. No other
operative or early postoperative complications occurred in the peripheral
iridectomy group.
5a.3.5 TRABECULECTOMY
Three patients developed small operative hyphaemas, which
cleared spontaneously during the first postoperative week. Seven
patients developed clinically significant iritis during the first
postoperative week, which was readily controlled using topical steroid
medication. This incidence was higher than that seen in either of the
other two groups, but the differences were not statistically significant.
Three patients had a shallow anterior chamber during the first 48 hours
following surgery, but in each case the chamber reformed to near normal
depth spontaneously. Three patients developed raised intraocular
pressure during the first week following surgery. In two cases the
pressure returned to normal using ocular massage, arid remained normal
thereafter. Revision of the trabeculectomy was needed in the third
patient.
One patient had persisting corneal oedema despite normal
intraocular pressure control following surgery. This patient was
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diabetic, and had a family history of Fuchs' endothelial dystrophy. The
fellow eye showed endothelial changes typical of early Fuchs' dystrophy,
with no overt oedema.
FOLLOW UP
5a.3.6 ACUTE ANGLE CLOSURE GLAUCOMA
One laser treated patient and one peripheral iridectomy patient
developed acute angle closure glaucoma in the early post treatment
period due to primary failure to produce an iris opening.
Two laser treated patients developed acute angle closure glaucoma
despite the presence of a patent iridotorny.
Case 1. A 75 year old man underwent Nd:YAG laser iridotomy for
acute closed angle glaucoma. The iridotorny was small (1 OOjixSOu), but
patent. One month after treatment he complained of painless blurring of
vision. At that time he was using no topical eye medication. Intraocular
pressure was 68 mm Fig, and gonioscopy revealed 300 degrees of angle
closure. Medical treatment with topical pilocarpine and timolol restored
normal intraocular pressure, with an open angle on goriioscopy.The
iridotomy was small but patent. Trabeculectomy was performed, leading
to normal intraocular pressure without medication.
Case 2. An 83 year old female presented with acute angle closure
glaucoma. Initial examination revealed a deep anterior chamber, and the
angle configuration on gonioscopy suggested plateau iris syndrome.
Nd:VAG laser iridotomy was performed, creating a moderately large,
patent iridotorny. Fourteen days later the patient returned with painful
loss of vision in the eye. G. Betamethasone QID and 6. Cyclopentolate \%
had been prescribed following laser iridotomy, and the patient was using
these drops at the time of developing recurrent symptoms. The
intraocular pressure was 50 mm Fig. Following topical pilocarpine and
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timolol treatment the intraocular pressure fell to 7 mm Hg. The
iridotorny was patent and moderately large (200.ux400.u). Indentation
gonioscopy showed the angle was closed by goniosynechiae over 150
degrees. A sector iridectomy was performed. On further follow up the
intraocular pressure was found to be 28 mm Hg with no medication, and
fell to 21 mm Hg on adding G. Timolol 0.5$ B.D.
These patients are discussed in greater detail in chapter 6, pages
132,133,136,137 (cases 1 and 3).
5a.3.7 GLAUCOMA OUTCOME
16/19 (34%) of laser iridotorny patients maintained normal
intraocular pressure without further glaucoma treatment during the
follow up period. Three patients required topical medication or had an
intraocular pressure greater than 21 mm Hg at follow up.
12/15 (80%) of peripheral iridectomy patients maintained normal
intraocular pressure without further glaucoma treatment during the
follow up period. Three patients required topical medication or had an
intraocular pressure greater than 21 mm Hg at follow up.
18/20 (90$) of trabeculectomy patients maintained normal
intraocular pressure without further glaucoma treatment during the
follow up period. One patient required topical medication to maintain
normal intraocular pressure, and one patient underwent repeat
trabeculectomy.
The mean intraocular pressure at follow up was 17.3±8.4 mm Hg in
the laser treated group, 16.0±3.7 mm Hg in the peripheral iridectomy
group, arid 15.2±3.5 mm Hg in the trabeculectomy group. These
differences were not statistically significant. However within the
trabeculectomy group the mean intraocular pressure at follow up,
15.2±3.5rnrn Hg, was significantly lower than the mean preoperative
intraocular pressure, 23.1 + 14.0 mm Hg ( p<0.05, paired Student t test).
Within the peripheral iridectomy group the mean intraocular pressure at
follow up, 16.0+3.7 mm Hg, was significantly higher than the mean
preoperative intraocular pressure, 11.8+3.1 mm Hg ( p<0.01, paired
Student t test). This was also the case within the Nd:YAG laser iridotomy
group, with a mean intraocular pressure at follow up of 17.3+8.4 mm Hg,
compared to 10.8+4.2 mm Hg before treatment (p<0.05, paired Student t
test).
No patient developed pathological optic disc cupping during the
follow up period.
5a.3.7.1 60NI0SC0PY
Goldman indirect gonioscopy was performed 6 months following
treatment, and, if any part of the angle was found to be closed Posner 4
mirror indentation gonioscopy was performed by PWF. Three peripheral
iridectomy patients were found to have areas of goniosynechiae on
indentation, and one of these patients required medication to maintain
normal intraocular pressure. Three laser treated patients had areas of
goniosynechiae, and one of these needed topical medication to maintain
normal intraocular pressure. A further two laser treated patients had
small areas of focal goniosynechiae.
Five laser treated patients showed marked pigmentation of the
trabecular meshwork interiorly, a finding not seen in peripheral
iridectomy patients. One of these patients required topical medication to
maintain normal intraocular pressure.
5a.3.7.2 PROVOCATION TESTS
Pilocarpine/phenylephrine provocation tests were performed on all
laser treated patients and peripheral iridectomy patients 6 months
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following treatment. All tests were negative. However a total of 4
patients had sustained a second episode of acute angle closure glaucoma
prior to provocation testing, two because of primary failure to obtain an
iris opening, and two despite the presence of a patent iridotorny, as
discussed above.
5a.3.7.3 IRIDOTOMY AREA
The mean surface area of iris patency following laser iridotorny
was 0.086 ±0.12 mm2. The mean surface area of operative iridectomies
was 1.22+0.95 mm2 (p<0.001, unpaired Student t test).
5a.3.8 VISUAL ACUITY OUTCOME
In many cases accurate assessment of corrected visual acuity
following initial medical treatment, prior to laser treatment or
operative surgery, was difficult. Residual corneal oedema, miosis due to
pilocarpine, arid possible residual optic nerve head dysfunction lead to
poor vision, it was therefore impossible to distinguish visual loss due to
acute angle closure glaucoma from visual loss as a complication of laser
treatment or surgery. Visual acuity one week after laser treatment or
surgery was consistently better than visual acuity immediately prior to
laser treatment or operative surgery. Only one laser treated patient, arid
two peripheral iridectomy patients, lost one or more line of visual acuity
during this interval. In each case this was due to cataract progression.
Assessment of reduced visual acuity at the final follow up visit was
therefore based on a comparison with the visual acuity one week after-
laser treatment or surgery, rather than with preoperative visual acuity.
At the final follow up examination one laser iridotorny patient was
found to have lost 2 lines of visual acuity due to the development of
cataract in a previously clear lens. Three peripheral iridectomy patients
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lost two or more lines of visual acuity. In two cases this was due to
cataract development in a previously clear lens, and in one case was due
to progression of pre existing cataract.
Six trabeculectomy patients lost two or more lines of visual
acuity during the follow up period. This was due to cataract development
in a previously clear lens in one case, progression of pre existing
cataract in four cases, and cystoid macular oedema following cataract
surgery in one case.
Differences between the groups in the incidence of visual acuity
loss by two or more lines during the follow up period were not
statistical 1 y significant.
5a.3.9 POSTERIOR SYNECHiAE
8/19 (42%) laser treated patients, 4/15 (27%) peripheral
iridectomy patients, and 8/20 (40%) trabeculectomy patients had
posterior synechiae at the time of the final follow up visit. The
differences between pairs of groups were not statistically significant. A
total of 20/54 (371.) of acute angle closure glaucoma eyes treated by
Nd:YA6 laser iridotorny, operative peripheral iridectomy or
trabeculectomy developed posterior synechiae. 4/10 (40:f.) of acute angle
closure glaucoma eyes treated by Nd.YAG laser iridotomy, operative
peripheral iridectomy or trabeculectomy who lost two or more lines of
visual acuity during follow up developed posterior synechiae.
7/19 (Z7%) laser treated patients received a mydriatic following
treatment, compared to 10/15 (67%) peripheral iridectomy patients (X2
with Yates correction MS), and 20/20 (1001) trabeculectomy patients
(X2 with Yate's correction p<0.001). This difference arose from concern
that a further attack of acute angle closure glaucoma might be provoked
by mydriasis in patients treated by Nd:YAG laser iridotomy.
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5a.4 DISCUSSION
This was not a randomised study, and the results are biased by
differences between the groups. The trabeculectomy group had a longer
mean duration of acute attack prior to treatment, and responded less
well to initial medical treatment than either the peripheral iridectomy
or Nd:YAG laser iridotorny group. One might therefore expect the visual
acuity and glaucoma outcome to be less good in this group.
Patients in the Nd:YAG laser iridotomy group were older than those
in the peripheral iridectomy group, and cataract was commoner in the
Nd:YAG laser iridotomy group. However the duration of acute attack prior
to treatment, and the response to initial medical treatment were very
similar in the peripheral iridectomy and Nd:YAG laser iridotomy groups,
allowing a valid comparison of the glaucoma outcome in these two
groups.
5a.4.1 CORNEALPACHYNETRY
Resolution of corneal oedema occurred rapidly in 3 of the 4
patients in whom serial measurements were made. Slow resolution of
oedema in one patient aged 81 years may have been related to low
endothelial cell density. Endothelial cell counts were not performed in
these patients. Corneal endothelial cell density becomes reduced with
increased age 202'203.
Residual corneal oedema at the time of performing Nd:YAG laser
iridotomy reduces visualisation of the iris. We have observed no adverse
corneal effects or higher laser energy requirements when performing
Nd:YAG laser iridotomy in the presence of corneal oedema. However it is
probably preferable to wait until corneal oedema has resolved before
proceeding with iridotomy.
117
5a 4.2 OPERATIVE AND EARLY POSTOPERATIVE
COMPLICATIONS
Full thickness focal corneal oedema occurred in 4/19 (22%) of
patients following Nd:YAG laser iridotomy. This incidence is similar to
that reported previously (see Table 1.1), and to our own findings in
fellow eyes (15$ of cases - see page 86). A higher mean total laser
energy (75.6+69.2 mJ) was used to treat eyes which developed focal
corneal oedema than in eyes which did not develop corneal oedema
(24.7+19.7 rnJ, unpaired Student t test p<0.02).
iris bleeding occurred more frequently following Nd:YAG laser
iridotomy (9/19,47$ eyes) than peripheral iridectomy (0/15 eyes,X2
test with Yate's correction p<0.02). Operative hyphaema occurred in 3
trabeculectomy patients, iris bleeding did not cause clinically apparent
adverse effects. The incidence of iris bleeding following Nd:YAG laser
iridotomy was similar to that reported previously (see Table 1.3), and to
our own findings in fellow eyes (57$ of cases - see page 84 ).
iritis occurred in 7/20 (35$) trabeculectomy patients, 1/19 (5$)
Nd:YAG laser iridotomy patients, and in 0/15 peripheral iridectomy
patients. A low incidence of iritis following peripheral iridectomy and
Nd:YAG laser iridotomy has been reported previously (see Table 1.5).
Transient intraocular pressure elevation following Nd:VA6 laser
iridotomy did not occur, demonstrating the effectiveness of
pretreatment with acetazolamide 500 rng orally.
5a.4.3 ACUTE ANGLE CLOSURE GLAUCOMA
Acute, angle closure glaucoma is rare following peripheral
iridectomy 25,42,43,117 an,j }-ias generally been attributed to plateau iris
syndrome. 204■■205. An anteriorly placed iris root results in peripheral iris
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bunching on pupil dilation, with occlusion of the trabecular meshwork.
One of our patients (case 2) probably had plateau iris syndrome, and
developed acute angle closure glaucoma despite the presence of a
relatively large, patent iridotomy.
The mechanism of failure of very small iridotornies may be
different. The mean surface area of laser iridotornies in our study was
fourteen times less than that of peripheral iridectomies. Acute angle
closure glaucoma has been described following argon laser iridotomy
13^,133 ancj |sid;YAG laser iridotomy 15-'80'106 when the iridotomy was very
small. One of our patients (case 1) developed acute angle closure
glaucoma in the presence of a small, patent iridotomy (IOOji x 50.u). The
mechanisms by which acute angle closure glaucoma may arise in the
presence of a small, patent iridotomy are discussed in chapter 6.
Pilocarpine/phenylephrine provocation tests six months
following treatment were negative in all cases. However two cases of
acute angle closure glaucoma following successful Nd:YAG laser
iridotomy occurred less than one month after treatment. One further
Nd:YAG laser iridotomy patient, and one peripheral iridectomy patient
developed acute angle closure glaucoma due to primary failure to produce
an iris opening. Other workers have reported negative
pilocarpine/phenylephrine provocation tests 2-6 months after
treatment15-80, but with a small number of spontaneous episodes of
acute angle closure glaucoma 2-4 weeks after production of a patent
Md:YAG laser iridotomy.
Combined administration of pilocarpine and phenylephrine in
theory produces maximal pupil block forces64. Pilocarpine/phenylephrine
tests performed very soon after iridotomy should detect cases in which
the iridotomy size is inadequate. The iridotomy might then be enlarged to
a more effective size. However a more satisfactory approach would
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probably be to produce an iridotomy of adequate size at the initial
treatment sessi on.
5a.4.4 GLAUCOMA OUTCOME
There were no significant differences in the glaucoma outcomes of
the three groups. 84% of Nd:YAG laser iridotomy patients, 80:1 of
peripheral iridectomy patients, and 901 of trabeculectomy patients had
normal intraocular pressure without medication at follow up. There were
no significant differences between the mean intraocular pressures of the
three groups at follow up: 17.3±8.4 mm Hg in the Nd:YA6 laser iridotomy
group, 16.0+3.7 mm Hg in the peripheral iridectomy group, and 15.2+3.5
mm Hg in the trabeculectomy group.
However the mean intraocular pressure after initial medical
control was significantly higher in the trabeculectomy group (23.0+14.0
mm Hg) than in the peripheral iridectomy (11.8+3.1 mm Hg) or Nd:YA6
laser iridotomy (10.8+4.2 mm Hg) group. Within the trabeculectomy group
the mean intraocular pressure at follow up (15.2+3.5 mm Hg) was
significantly lower than the mean preoperative intraocular pressure
(23.1 + 14.0 mm Hg, P < 0.05, unpaired Student t test). Trabeculectomy
therefore had a measureable intraocular pressure lowering effect. This
was in contrast to the peripheral iridectomy and Nd:VA6 laser iridotomy
groups, within which the mean intraocular pressure at follow up
(16.0+3.7 and 15.2+3.5 mm Hg respectively) was significantly higher than
the mean preoperative intraocular pressure (11.8+3.1 and 10.8+4.2 mm Hg
respectively, p < 0.01 arid P < 0.05 respectively, unpaired Student t test).
Miotics were being administered at the time of measurement of
preoperative intraocular pressure.
Previous studies of peripheral iridectomy in acute angle closure
glaucoma have found that 70-76% of eyes remain norrnotensive without
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medication 25,43,46,86,87,95 (see Table 1.10). Gray found 50% of eyes
remained normotensive without medication following Nd:YAG laser
iridotomy80 Primary drainage surgery in the form of iridencleisis 134 or
trabeculectomy 130 has been reported to result in normal intraocular
pressure without medication in 90-95% of cases.
Five laser treated patients had marked pigmentation of the
inferior part of the trabecular rneshwork six months following
treatment, but this had no effect on intraocular pressure control. Argon
laser iridotomy in cynomolgus monkeys resulted in pigment deposition in
the inferior part of the trabecular meshwork, which was cleared by bulk
aqueous flow and phagocytosis 178 Pigment deposition does not appear to
produce clinically significant effects.
Apart from these changes gonioscopic appearances were similar in
the peripheral iridectomy and Nd:YAG laser iridotomy groups. Nd:YA6
laser iridotomy appears to be as effective as peripheral iridectomy in
maintaining an open drainage angle following acute angle closure
glaucoma.
5a.4.5 VISUAL ACUITY OUTCOME
Six trabeculectomy patients, three peripheral iridectomy patients
and one laser iridotomy patient lost two or more lines of visual acuity
due to cataract progression during the follow up period. These
differences were not statistically significant. It is difficult to
differentiate visual loss due to surgical or laser treatment from visual
loss due to the effects of acute angle closure glaucoma. Patients in the
trabeculectomy group had uncontrolled intraocular pressure for a longer
period prior to initial medical treatment, and might therefore have been
expected to have a worse visual acuity outcome. Patients in the
peripheral iridectomy group were younger than patients in the
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trabeculectomy or Nd:YAG laser iridotorny groups, and might therefore
have been expected to have a better visual acuity outcome. The numbers
of patients in our study groups were too few to detect trends in visual
acuity outcome.
Roman found two or more lines of visual acuity loss due to
cataract in 38S of eyes 1-3 years following operative peripheral
iridectomy for acute angle closure glaucoma 87 Krupin found three or
more lines of visual acuity loss due to cataract in 39S of patients after
a mean follow up period of 52 months 86 Williams found two or more
lines of visual acuity loss in 19S of eyes six months to 16 years
following operative peripheral iridectomy for acute angle closure
glaucoma and in 6.9:1 of cases the visual loss was attributed to
cataract 48. Lowe found that 19S of eyes had a dense cataract five years
after peripheral iridectomy for acute angle closure glaucoma 43 Luke
found that 22% of eyes developed cataract following peripheral
iridectomy for acute angle closure glaucoma, after a mean follow up
period of 4.4 years 101 (see Table 1.12).
Sugar found a higher prevalence of cataract among eyes treated by
iridencleisis for acute angle closure glaucoma (4IS), than among the
fellow eyes of the same patients treated by peripheral iridectomy
(23S) 45 38:1 of eyes developed cataract 6-22 years after a trephine or
iridencleisis operation for open angle glaucoma, compared with 8S of
unoperated control patients206. 20S of cataracts developed soon after-
surgery, arid SOS at a later stage206. Watson found that cataract
progression following trabeculectomy for open angle glaucoma occurred
in 23S of cases treated with an "anterior" opening into the anterior
chamber, and 6S of cases with a "posterior" opening 131.
No studies of the long term visual acuity results of Nd:YA6 laser
iridotorny for acute angle closure glaucoma have been published to date.
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Del Priore found a loss of two or more lines of visual acuity due to
cataract in 2/43 eyes undergoing Nd:YAG laser iridotomy for chronic
angle closure glaucoma, after a mean follow up period of 27 months 13
Focal lens opacities underlying the treatment site were not
detected in any of our patients. Focal lens opacities following Nd:YAG
laser iridotomy are very unusual 1 ° -13,14,15,22,23,107 pocai opacities are
much more commonly seen following argon laser iridotomy
1,10,13,22,23,105,112
Posterior synechiae developed in 20/54 (371) of acute angle
closure glaucoma eyes, treated by Nd.YAG laser iridotomy, peripheral
iridectomy, or trabeculectomy, compared to 6/52 (121) of eyes in out-
fellow eye study (see Table 4.4).
Among acute angle closure glaucoma eyes posterior synechiae
occurred more commonly following Nd:YAG laser iridotomy(42!) than
peripheral iridectomy (271), possibly due to our reluctance to use post
treatment mydriatics. The iridotomy provides an alternative channel
through which aqueous may by-pass the pupil, allowing adhesions to
readily develop between the iris and lens 119420 posterior synechiae are
particularly frequent following the administration of miotics 119
Posterior synechiae were more frequently seen following
trabeculectomy (401) than peripheral iridectomy (271). This finding may
have been related to the higher incidence of iritis seen among
trabeculecto rnypatients.
Previous studies s?4 '9 have reported a similar prevalence of
posterior synechiae following peripheral iridectomy for acute angle
closure glaucoma, and have also found a higher prevalence of posterior
syriechiae among acute angle closure glaucoma eyes than among fellow
eyes 87 We found a higher prevalence of posterior synechiae following
Nd:YAG laser iridotomy than has previously been reported zZ. However, in
our study pupil dilation was carried out in order to detect posterior
synechiae. Previous studies in which this was not done may have
under-reported the true incidence of posterior synechiae 23
Flornan found two or more lines of visual acuity loss due to
cataract in 561 of acute angle closure glaucoma eyes treated by
operative peripheral iridectomy with posterior synechiae.. compared to
271 of eyes without posterior synechiae 87 However it is difficult to
ascertain whether posterior synechiae cause cataract per se, or whether
they are merely associated with other potentially cataractogenic factors
such as operative or laser induced lens trauma, or iritis.
We found that 20/54 (371) of acute angle closure glaucoma eyes
treated by Nd:YAG laser iridotomy, operative peripheral iridectomy or
trabeculectomy developed posterior synechiae. 4/10 (401) of acute angle
closure glaucoma eyes treated by Nd:¥AG laser iridotorny, operative
peripheral iridectomy or trabeculectomy who lost two or more lines of
visual acuity during follow up developed posterior synechiae, a
proportion almost identical to the prevalence of posterior synechiae
among the whole group. While our numbers are relatively low, these




COMPARISON OF ACUTE ANGLE CLOSURE GLAUCOMA EYES
AND FELLOW EYES
5b. 1 MATERIALS AND METHODS
52 of the 70 patients presenting with acute angle closure
glaucoma during the period January 1987 to June 1989 were randomly
allocated to Nd:YAG laser iridotorny or operative peripheral iridectomy in
the fellow eye. The choice of procedure in the acutely affected eye was
made using a variety of clinical factors. 36 patients were treated with
the same procedure in each eye and were observed prospectively in order
to compare the outcome in the acutely affected eye and the fellow eye.
5.b.2 RESULTS
21 patients underwent bilateral Nd:YA6 laser iridotomy and 15
patients underwent bilateral operative peripheral iridectomy during the
study period. One laser treated patient had bilateral acute angle closure
glaucoma and was excluded from the study.
The characteristics of the 35 patients included in the study are
shown in Table 5.6.
Number of patients 35
Age., years 65+11.6
Male : female ratio 10:25
Duration acute attack, hours 31.0+17.2
Mean I OP acute eyes, mm Hg 47.5+14.2
Mean I OP fellow eyes, mm Hg 17.8±6.7
TABLE 5.5
Prospective study of the treatment of acute angle
closure glaucoma Comparison of acute and
fellow eyes - Initial characteristics.
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Intraocular pressure was significantly higher in acute eyes at
presentation (paired Student t test pcO.OOl).
29/35 (83:?) of fellow eyes and 20/35 (57%) of acutely affected
eyes had a visual acuity of 6/12 or better following initial medical
control, but prior to surgical or laser treatment, X2 test with Yate's
correction p<0.05.
5b.2.1 OPERATIVE COMPLICATIONS
5b.2.1.1 OPERATIVE COMPLICATIONS: Nd:YAG LASER
IRIDOTOMY
The mean total laser energy used to produce an iridotomy in acute
eyes was 35.6+33.0 rnJ, compared to 20.0+17.6 rnJ in fellow eyes. This
difference did not reach statistical significance using the paired Student
t test.
Iris bleeding occurred in 9 acute eyes and 10 fellow eyes. Focal
corneal oedema overlying the treatment site was seen in 6 acute eyes
and 5 fellow eyes (X2 test with Yate's correction NS).
5b.2.1.2 OPERATIVE COMPLICATIONS: OPERATIVE
PERIPHERAL IRIDECTOMY
Operative hyphaema occurred in one acute eye and three fellow
eyes. A patent iridectomy was not produced in one acute eye due to
separation of the iris stroma from the pigment epithelium.
5b.2.2 FOLLOW UP




The mean intraocular presssure at follow up was 15.6+3.6 mm Hg
in acutely affected eyes and 14.8±3.3 mm Hg in fellow eyes (paired
Student t test NS).
26/35 {74%) of acute eyes had normal intraocular pressure
without medication following Nd:YAG laser iridotorny or operative
peripheral iridectomy. 5 eyes had normal intraocular pressure at follow
up following additional medical (3 eyes) or surgical (2 eyes) treatment. 4
eyes which had received no additional medical or surgical treatment had
an intraocular pressure greater than 21 mm Hg at follow up.
31/35 (89%) of fellow eyes had normal intraocular pressure with
no medication at follow up. 4 eyes were being treated with topical
medication at the time of follow up. The difference in glaucoma outcome
between acutely affected eyes and fellow eyes was not statistically
significant, using"X2 test with Yate's correction.
5b.2.2.2 VISUAL ACUITY OUTCOME
6/35 (17%) acutely affected eyes lost 2 or more lines of visual
acuity due to cataract during the follow up period - 3 due to cataract
development in previously clear lenses and 3 due to progression of pre
existing cataract. 1/35 (3%) fellow eye lost 2 or more lines of visual
acuity due to cataract development in a previously clear lens. This
difference was not significant using theX2 test with Yate's correction.
5b.3 DISCUSSION
The mean total laser energy needed to produce a Nd:YAG laser
iridotorny in acute eyes and in fellow eyes was not significantly
different. Complications such as iris bleeding and focal corneal oedema
were seen equally frequently in acute eyes and fellow eyes. Resolving
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corneal and iris oedema, and ocular hyperaernia following acute angle
closure glaucoma did not significantly affect Nd:¥AG laser iridotorny
procedures.
75:1 of the acute eyes were normotensive without medication at
follow up, a figure which is comparable to the results of previous
studies 25,43,46,86,8? ^see xable 1.10). 89% of fellow eyes were
normotensive without medication, a result which is also similar to
previously published results (see Table 1.11). The number of patients in
our study was relatively small, and differences in the glaucoma outcome
of acute eyes and fellow eyes were not statistically significant.
6/35 (17%) of acutely affected eyes arid 1/35 (3%) of fellow eyes
lost 2 or more lines of visual acuity due to cataract progression during
the follow up period. These figures are comparable with previously
reported results (see Tables 1.12 and 1.13). Again the number of patients
in our study was relatively small, and no statistically significant
difference in the visual acuity outcome of acute eyes and fellow eyes
was obtained.
Patients with acute angle closure glaucoma of prolonged duration
or which responded poorly to initial medical control were treated by
primary trabeculectomy during the study period, and cases with less
severe glaucoma were treated by operative peripheral iridectomy or
Nd:YAG laser iridotomy. To this extent differences in outcome between
acutely affected eyes and fellow eyes treated by operative peripheral




HOW LARGE MUST AN IRiDOTOMY BE?
6.1 SUMMARY
3 cases of acute angle closure glaucoma in eyes with a small, but
patent, Nd:YA6 laser iridotorny are presented, and similar cases in the
literature are reviewed. Theoretically a 15p. diameter iridotomy should
be large enough to prevent angle closure glaucoma due to pupil block.
Mechanisms by which larger iridotornies fail to prevent angle closure
glaucoma, and the role of provocation tests following iridotomy, are
discussed. An iridotomy should be at least 150-200.p in diameter if
acute angle closure glaucoma is to be reliably prevented.
6.2 INTRODUCTION
Various forms of iris surgery have been used to treat angle closure
glaucoma since Von Graefe's original description of the broad iridectomy
in 1857 38 Surgical iridotomy was introduced by Curran in 1920 18>19'20.
Peripheral iridectomy was described by Chandler in 1952 3. Argon laser
iridotomy 1, and more recently Nd:VAG laser iridotomy 2 have already
largely superseded surgical iridectomy. While laser surgery has many
advantages over conventional surgery, it must not be forgotten that laser
iridotomy represents a return to the use of smaller iris openings than
those obtained by surgical peripheral iridectomy 21. Gifford noted in
1921 that very small surgical iridotornies were not as effective in
controlling intraocular pressure as larger iridotomies 20
Reports are now emerging of acute angle closure glaucoma
developing in the presence of a small but patent argon 132-133 or Nd:YAG
80,106 ]aser iridotomy. While cases of acute angle closure glaucoma
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following surgical peripheral iridectomy have generally been attributed
to plateau iris syndrome n?, 204,205^ not a|i cases of acute angle closure
glaucoma following a small laser iridotorny can be placed in this
cateqory 06,132
The mechanism of failure of very small iridotomies may be
obstruction of aqueous flow at very small iridotorny size. Below a
critical surface area significant iris bornbe may occur at normal aqueous
flow rates. When iris bornbe is sufficient to cause iridocorneal contact
throughout a critical extent of the angle, beginning superiorly, acute
angle closure glaucoma occurs 53 ■56 The minimum "safe" area of
iridotomy has not been defined, but an approximate value may be
calculated using a simple mathematical model.
6.3 MATERIALS AND METHODS
6.3.1. Case reports of acute angle closure glaucoma in the
presence of a small patent Nd:VAG laser iridotomy.
We have treated 3 patients who developed acute angle closure
glaucoma despite the presence of a patent Nd.YAG laser iridotomy.
A Zeiss "Visulas" Nd:YAG laser and Zeiss anterior segment YAG
contact lens were used in all treatments. Patients were given
acetazolamide 500 rng orally one hour before treatment, and one drop of
G. Pilocarpine 2% 30 minutes before treatment. A treatment site was
chosen in the superior iris between 10 and 2 o'clock, approximately 2/3
distance from the pupil margin to the base of the iris. An iris crypt was
used, where present. A single 5-10 rnJ pulse was delivered to the
treatment site. If this pulse did not penetrate the iris, further single
pulses were delivered to the same site until penetration was achieved.
Patency was assessed by direct observation of the posterior chamber, or
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anterior lens capsule.
The size of iridotomies was measured by comparison with the
0.2mm spot produced by a Haag-Streit slit lamp focussed on the iris
plane.
6.3.2. Mathematical model of minimum effective
iridotomy area.
A mathematical model of aqueous flow through an iridotomy has
been developed in order to determine the minimum size of iridotomy
needed to prevent iris bombe and acute angle closure glaucoma.
6.3.3. Photometric analysis of the effect of pupil
dilation on iridotomy area.
A photometric technique was devised to analyse changes in
iridotomy area following pupil dilation. 16 eyes of 11 patients treated by
Nd.YAG laser iridotomy were used.
The horizontal corneal diameter was measured using a Haag-Streit
slit lamp measuring eyepiece, which incorporates a graticule with
0.1 mm divisions. The cornea and iris were then photographed using a
Zeiss anterior segment camera.
The pupil was dilated using one drop of Tropicamide 1 % and the eye
was again photographed, using identical camera settings.
Colour transparency photographs were prepared, and projected
onto a white screen. The projected horizontal corneal diameter was
measured in millimetres, and compared with the measurement obtained
using the slit lamp measuring eyepiece. A magnification factor for the
projected image was derived from these measurements for each eye. The
magnification factor was approximately x80 in every case.
The following measurements were then made from the projected
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image, arid converted to unmagnified values using the magnification
factor:
- undilated horizontal pupil diameter
- dilated horizontal pupil diameter
- iridotomy diameter in the radial and circumferential axis, pupil
undilated
- iridotomy diameter in the radial arid circumferential axis, pupil
dilated
- distance from lirnbus to nearest point of iridotomy, pupil
undilated
- distance from lirnbus to nearest point of iridotomy, pupil dilated
The area of the iridotomy before and after pupil dilation was
measured by placing millimetre graph paper on the white screen and
counting the number of squares covered by the image of the iridotomy.
Linear regression analysis was used to detect significant
correlations between changes in iridotomy area on dilating the pupil and
a variety of parameters which could potentially influence this.
6.4 RESULTS
6.4.1 CASE REPORTS.
Case 1. A 75 year old hypermetropic male presented with right
acute angle closure glaucoma of 48 hours' duration. The intraocular
pressure was 78 mm Hg, the anterior chamber was shallow, and the
angle was closed throughout 360 degrees. The left eye had a very narrow,
open angle. Treatment with acetazolamide 500 mg intravenously and G.
Pilocarpine 2% hourly resulted in a fall in intraocular pressure to 12 mm
Hg, with an open angle throughout 360 degrees. Nd:VAG laser iridotomy
was performed three days later. A treatment site 1 mm from the lirnbus
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at 10 o'clock was chosen. The iris was a light grey colour, with no
crypts. Three 9.0 rnJ pulses resulted in a small (200fix 100 u), patent
iridotomy. Minimal iris bleeding occurred at the time of treatment, but
there were no other complications. One week following treatment the
iridotomy was patent, though small. The intraocular pressure was
10 mm Hg. No further eye medication was prescribed.
Two weeks following treatment the patient complained of blurred
vision in the right eye. The intraocular pressure was 68mm Hg, and
gonioscopy revealed 300 degrees of angle closure superiorly. Medical
treatment with topical pilocarpine 2% and timolol 0.5:1. reduced the
intraocular pressure to 13 mm Hg, with an open angle. The iridotomy was
small (SOjjlx 1 OOjjO, but patent. Trabeculectomy with peripheral
iridectomy was performed, leading to an intraocular pressure of 10 mm
Hg, and a visual acuity of 6/5.
Case 2. A 65 year old female presented with left acute angle
closure glaucoma of 24 hours' duration. The intraocular pressure was 58
mm Hg, the anterior chamber was shallow, and the angle was closed
throughout 360 degrees. The right anterior chamber was shallow with
120 degrees of angle closure superiorly, and the intraocular pressure
was 15 mm Hg.
Following initial medical control, left trabeculectomy was
performed.
Further examination of the right eye following treatment with G.
Pilocarpine 2% revealed an open angle throughout 360 degrees. Right
Nd:YAG laser iridotomy was performed. The treatment site was 1 mm
from the limbus, at 10 o'clock. The iris was brown, with no crypts. Four
9.7 rnJ pulses were used to produce a patent iridotomy, and one further
9.7 rnJ pulse was used to enlarge the opening.
One week later the iridotomy was patent, though small. The
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intraocular pressure was 14 mm Hg. At review three weeks later the
right intraocular pressure was found to be 41 mm Hg., and the pupil was
dilated. Gonioscopy was not performed. The patient had been using
cyclopentolate )% drops to the left eye, and may have inadvertently
contaminated the right eye. Following treatment with pilocarpine 2% the
intraocular pressure returned to 16 mm Hg. The iridotomy was patent,
but small - SOjixSOpt (Figure 6.1).
Figure 6.1
How large must an iridotomy be in order to prevent acute angle
closure glaucoma? Case 2. Initial iridotomy size too small.
Acute angle closure glaucoma developed. Iridotomy diameter 50j.i. The
arrow indicates the very small area of full thickness iris opening at the
centre of the treatment site.
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Further laser treatment was performed in order to enlarge the
opening. Five 2.0 mJ Nd:YAG pulses were delivered to the sides of the
existing iridotomy, enlarging the opening to lOOpxIOOp. Following
treatment 6 Betamethasone 0.1 % QID and G Tropicamide ]% once daily
were prescribed. The patient returned four days later complaining of pain
arid reduced vision in the right eye. The intraocular pressure was
50 rnrn Fig, and the pupil was mid-dilated and unreactive. The iridotomy
was now situated very peripherally, with iris strands running forwards
to the cornea, but appeared to be patent. Gonioscopy was riot performed.
The intraocular pressure returned to normal following treatment with
acetazolarnide 500 rng intravenously, and G. pilocarpine 2% hourly. The
iridotomy was patent, but small (1OOpx 1OOp). The angle was open on
gonioscopy. Treatment with G. Pilocarpine 2% QID was prescribed.
A pilocarpine/phenylephrine provocation test as described by
Mapstone 68 performed on the right eye one week later was negative.
Intermittent aching pain above the right eye continued, arid further
Nd:YAG laser enlargement of the iridotomy was performed G weeks later.
Twenty one 1.1 rnJ pulses were delivered using a Wise 103 dioptre
contact lens, resulting in some oozing of blood. A further ten 1.0 mJ
pulses were delivered 30 minutes later. The resulting iridotomy
rn e asu red 200pi x200p..
One week later all symptoms had resolved, and the iridotomy
measured 100px200p. Pilocarpine/phenylephrine testing was again
negative. However provocation using 6. Tropicamide 1% produced a
9 mm Hg rise in HOP, with folds of iris blocking the trabecular meshwork
over 270 degrees on gonioscopy. At follow up three weeks later the
intraocular pressure was 17 mm Hg, with no medication (Figure 6.2).
Subsequent cyclopentolate 1 % provocation testing produced no rise in
intraocular pressure.
Figure 6.2
How large must an iridotomy be in order to prevent acute angle
closure glaucoma? Case 2 . Iridotomy of adequate size.
Following laser enlargement all symptoms resolved and provocation
testing was negative, iridotomy diameter 200ji
Case 3. An 83 year old female presented with intermittent pain in
the left eye. The intraocular pressure was 44 mm Hg, the anterior
chamber was deep, arid Goldman gonioscopy revealed 90 degrees of angle
closure superotemporally. The plane of the iris was flat, with an
anteriorly placed iris insertion. The right eye had a similar angle
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configuration, with normal intraocular pressure. Plateau iris
configuration was diagnosed. The intraocular pressure in the left eye
quickly returned to normal following treatment with acetazolamide 500
rng orally and 6. pilocarpine 2:1 hourly. Goriioscopy revealed 180 degrees
of angle closure superiorly. Nd:YAG laser iridotomy was performed three
days later. The iris was light grey, with no crypts. A treatment site
1mm from the limbus at 2 o'clock was selected. Four 10.9 rnJ pulses
produced a moderately large (200j.lx400jjl), patent iridotomy. There was
minimal iris bleeding at the time of treatment.
Following treatment G. Timolol 0.51 twice daily, 6. Cyclopentolate
11 twice daily, and G. Betamethasone 0.1:1 four hourly were prescribed.
Fourteen days later the patient returned with pain and reduced vision of
24 hours duration in the left eye. The intraocular pressure was
50 mm Fig. Following treatment with G. Pilocarpine 21 and 6. Timolol
0.5:1 the intraocular pressure fell to 7 mm Fig. The iridotomy was patent
and moderately large (200u*400.p.). Indentation goriioscopy revealed
goniosynechiae over 150 degrees superiorly, with plateau iris
configuration. A sector iridectomy was performed. On further follow up
intraocular pressure in the left eye was found to be 28 mm Fig on no
treatment, falling to 21 mm Fig on addition of G. Timolol 0.5:1 twice
daily. Gonioscopy revealed an open angle throughout 360 degrees.
6.4.2 RESULTS - MATHEMATICAL MODEL
A very small iridotomy may be of inadequate physical size to
by-pass pupil block adequately. Given a constant rate of aqueous flow and
complete pupil block, the pressure difference across an iridotomy
increases as the size of the iridotomy decreases, increased posterior
chamber pressure relative to anterior chamber pressure will result in
iris bombe. The degree of bombe is dependent on the rigidity of the iris,
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and the pressure difference across the iris. At a critical level, dependent
on peripheral anterior chamber depth, iris faornbe may become sufficient
to cause iridocorneal contact over a large enough extent of the angle to
precipitate acute angle closure glaucoma 53-56 .
The minimum "safe" area of art iridotorny may be calculated using a
simple mathematical model. Several assumptions are necessary, each of
which must be qualified.
1. Aqueous production is constant. However aqueous production in
fact declines at high intraocular pressure.
2. Pupil block is complete. While pupil block forces in eyes with
acute angle closure glaucoma are substantial, pupil block is likely to be
relative rather than complete during development of an angle closure
glaucoma episode.
3. Ail aqueous passes through the iridotomu. !ri addition to some
aqueous passing through the pupil, some aqueous leaves the eye via
uveoscleral outflow.
4.1ridotomu area is unchanged bu iris bornbe. Iris bornbe, arid
increased flow through a small iridotorny, could conceivably stretch open
an iridotorny, increasing its area.
The limitations of each of these assumptions would tend to result
in reduced iris bornbe for a given iridotorny area. Estimation of minimum
effective iridotorny area based on these assumptions will therefore be
conservative.
In order to calculate the minimum iridotorny area needed to
prevent development of iris bornbe an assessment is first made as to
whether aqueous flow is laminar or turbulent through small iridotornies.
Assuming the iridotorny aperture is 1 Ou, aqueous viscosity equals the
viscosity of water On = 10-3 Newton seconds per square metre).
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aqueous density equals the density of water ((> = 1000 kilograms per
cubic metre)., and aqueous flow, Q, is approximately two microlitres per
minute (3.3x10~11 cubic metres per second), as measured by Bloom et al.
207, then Reynolds number for the system may be calculated.
If the iridotorny size (d) is 10.u diameter, then the aqueous
velocity
v = flow/or2 = 4.2 x10~1rris_1>
Reynolds number for the system
R=pvd/nj, R= 42.
if R is considerably less than 1000, flow is laminar. Aqueous flow
through an iridotorny of diameter lOp, or larger, will be laminar.
Secondly the iridotorny channel may be considered to be a pipe of
length 50p, assuming the peripheral iris thickness is 50p. The pressure
drop (p.d.) along a pipe of length l=50p, diameter d=100p, at flow rate Q
is expressed by the formula :
p.d. = 128^1Q/nd4
= 128x 1 0"3x5x 1 0~5x3.3x 10"11 /3.142x 10"16
= 0.672Nm-2.
= 0.00494 mm Hg, as 1 mm Hg= 136 Mm-2.
An iridotomy of lOOp diameter will have a pressure drop of
0.00494 mm Hg across it, assuming total pupil block.
However, as p.d. is proportional to 1/d4, if the diameter of the
iridotomy were 5Op., p.d. would be .079 mm Hg, under the same
conditions, if the iridotorny were 25p, the p.d.would be 1.27 mm Hg. if
the iridotomy were 12.5p, the p.d. would be 20.2 mm Hg, arid if the
iridotomy were lOp the p.d. would be 49.4 mm Hg. it is not difficult to
conceive that a pressure difference of 10-20 mm Hg across the iris could
result in significant iris bornbe, with iridocorneal contact and angle
closure.
139
Such a pressure difference could develop if the size of the
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FIGURE 6.3
Pressure difference across the iris as a function of iridotomy
area
6.4.3 EFFECT GF PUPIL DILATION ON IRIDOTOMV ARFA
Photographs of 16 eyes of 11 patients taken before and after pupil
dilatation were analysed. The following derived values were then
obtained :
I. Change in iris area by pupil dilation.
The cornea and pupil approximated to a circle in every case. The
area of the iris before and after pupil dilation could be obtained from the
difference between the area of the cornea and the area of the pupil.
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iris area, undilated pupil
= (corneal diameter)2 x ts/4 - (undilated pupil diameter)2 x n/4
Iris area, pupil dilated
- (corneal diameter)2 x jt/4 - (dilated pupil diameter)2 x rf/4
The change in iris area on dilating the pupil was expressed by the
ratio : (iris area, dilated pupil) / (iris area, undilated pupil)
2. Change in iridotomy area by pupil dilation.
The change in the iridotomy area on dilating the pupil was
expressed by the ratio :
(iridotorny area, dilated pupil) i (iridotomy area, undilated pupil)
3. Change in iridotomy shape by pupil dilation.
With the pupil undilated every iridotomy was elliptical, with the
longest axis radial to the lirnbus, and the shortest axis circumferential
to the limbus. A derived "elliptical factor" was calculated from the ratio
(radial axis diameter) / (circumferential axis diameter).
On dilating the pupil the iridotomy shape changed, with the radial
axis becoming shorter and the circumferential axis becoming longer. In
13 eyes the circumferential axis became longer than the radial axis, and
the "ellipse factor" then had a value less than 1. In 3 eyes the iridotomy
became circular.
The change in iridotomy shape on dilating the pupil was expressed
as the ratio :
(ellipse factor, undilated pupil) / (ellipse factor, dilated pupil)
The value of this ratio was termed the "shape change ratio"
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4. Change In position of the iridotomy in relation to the
iimbus.
The difference between the distance of the nearest point of the
iridotomy to the lirnbus before and after dilating the pupil was
calculated, and the value obtained was termed "position change".
Table 6.1 gives the results of photometric analysis of changes in
iridotomy area on dilating the pupil.
Change in iris area, 10CT = no change
Mean area iridotornies, undilated pupil, mm2
Mean area iridotornies, dilated pupil, mm2
Mean change in iridotomy area on dilating
the pupil (100% = no change)
Number of iridotornies which became larger
Number of iridotornies which became smaller
Change in iridotomy area of iridotornies
which became larger (100% = no change)
Change in iridotomy area of iridotomies
which became smaller (100% = no change)
TABLE 6.1
Photometric analysis of changes in iridotomy area on
dilating the pupil
Dilating the pupil reduced the mean area of the iris by 73%. The
iridotomy area became larger in 7 patients and smaller in 9 patients on
dilating the pupil. The mean iridotomy area with the pupil dilated was
99.3% of the mean iridotomy area with the pupil undilated. No mean
change in iridotomy area occurred on dilating the pupil. Eyes in which the
iridotomy became larger, and eyes in which the iridotomy became
smaller were then separated into two groups. The mean change in
iridotomy area among those iridotornies which became larger was 170%,
and the mean change among those which became smaller was 44.3%. No
statistically significant differences were found between these two










pupil undilated; shape change ratio; the distance of the iridotomy from
the limbus with the pupil undilated (unpaired Student t test NS). The
maximum change occurred in two eyes in which the iridotomy area with
the pupil dilated was \9% and 2)% of the iridotomy area with the pupil
undilated. In these eyes the iridotomy was small prior to pupil dilation
(0.031 and 0.033 mm-2). No other factors were present which might have
predicted marked reduction in iridotomy area on pupil dilation.
The iridotomy area following pupil dilation correlated with
iridotomy area prior to pupil dilation (r=0.66, p=0.005), but did not
correlate with the ellipse factor prior to pupil dilation or the distance of
the iridotomy from the limbus prior to pupil dilation. The only factor
which could predict small iridotomy area following pupil dilation was
small iridotomy area prior to pupil dilation.
The change in iridotomy area was independent of change in iris
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Figure 6.4
Change in iridotomy area as a function of change in iris area on
dilating the pupil
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Every iridotomy was elliptical with a longer radial axis prior to
pupil dilation. 13/16 iridotomies became elliptical with a longer
circumferential axis on dilating the pupil, and three iridotomies became
circular. Values for the degree of elliptical shape of iridotornies before
and after dilating the pupil are shown in Table 6.2.
Ellipse factor, pupil undilated (ratio) 243.8+94.0$
(radial / circumferential axis diameter )
Ellipse factor, pupil dilated (ratio) 69.9±20.3$
(radial / circumferential axis diameter )
Shape change ratio 369.9+166.8$
(Ellipse factor, pupil undilated/
Ellipse factor, pupil dilated)
TABLE 6.2
Changes in iridotomy shape on dilating the pupii
The mean change in elliptical shape was by a factor of 369.9$. The
mean change in elliptical shape correlated with the ellipse factor
present prior to pupil dilation ( correlation coefficient r=0.62, t=2.9936,
p=0.01). The shape of iridotomies which were very elliptical prior to
pupil dilation changed more when the pupil was dilated than iridotomies
which were more circular in shape.
The change in iridotomy area on dilating the pupil was independent
of the shape change ratio ( correlation coefficient r=0.123, NS).
Table 6.3 shows the mean distance of iridotomies from the lirnbus
before and after dilating the pupil.
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Distance frorn 1 irnbus, mm., pupil undi 1 ated 1.106+0.511
Distance from limbus, mm, pupil dilated 0.496+0.431
Position change, mm 0.609+0.498
TABLE 6.3
Distance of iridotomies from the limbus before and after
dilating the pupil
There was no significant correlation between the distance of the
iridotorny from the limbus with the pupil undilated and the change in its
area on dilating the pupil (correlation coefficient r-0.17, NS), or the
change in iridotomy position and the change in area on dilating the pupil
(correlation coefficient r=0.244, NS).
6.5 DISCUSSION
Curran observed in 1920 that in some patients with glaucoma the
passage of aqueous through the pupil appeared to be impeded by the iris
"hugging the lens over too great a surface extent"18 Surgical iridotomy
allowed free drainage of fluid from the posterior chamber to the anterior
chamber, with posterior movement of the iris and a reduction in
intraocular pressure. Barkan elaborated the concept of pupil block as the
causative mechanism of iris bornbe, with resulting angle closure40. A
peripheral iridectomy causes "collapse" of iris bornbe, resulting in
widening of the "entrance to" the angle 40 Peripheral anterior chamber
depth, but not central anterior chamber depth, increases following
peripheral iridectomy 53'57-58, due to resolution of iris bornbe.
Failure of surgical peripheral iridectomy, or laser iridotomy, as
evidenced by development of acute angle closure glaucoma, may occur by
one of two mechanisms. A small number of angle closure glaucoma cases
are related to "plateau iris configuration" - an anteriorly placed iris
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root, flat iris plane, and a normal or near normal central anterior-
chamber depth. Pupil dilation results in peripheral iris bunching, with
occlusion of the trabecular meshwork 509.-208 . As pupil block is not
causative, operative peripheral iridectomy or laser iridotorny are
relatively ineffective in preventing further attacks of acute angle
closure glaucoma. One of our patients (case 3) probably had plateau iris
syndrome, and developed acute angle closure glaucoma following
mydriasis despite the presence of a relatively large, patent, iridotorny.
Perhaps the term "angle crowding" angle closure glaucoma would
be a more appropriate term to use for eyes which develop acute angle
closure glaucoma following mydriasis in the presence of a patent
peripheral iridectomy. Two other cases with moderately large peripheral
iridectomies who developed acute angle closure glaucoma while using
mydriatic drops have been reported 117.-204.
Mydriatic or dark room provocation tests following peripheral
iridectomy have been found to be positive in 3-19% of cases 208-211 .
Gonioscopy at the end of a positive provocation test in eyes with a
patent peripheral iridectomy has revealed angle closure in some cases,
due to angle crowding 136>208 However in other eyes the angle has been
open 20S--209^211. Raised intraocular pressure in these eyes may be
explained by the outflow facility lowering effect of anticholinergic
drugs 212 Operative peripheral iridectomy appears to entirely overcome
pupil block. No cases of acute angle closure glaucoma due to iris bombe
have been reported in the presence of a patent surgical iridectomy.
Mydriatic provocation tests following argon laser iridotorny
i21 '2i3, and Nd:YAG laser iridotorny 15, have given similar results to those
performed following operative peripheral iridectomy. However
pilocarpine/phenylephrine tests have been negative in all eyes tested
following argon laser iridotorny 105, or Nd.YAG laser iridotorny 21 •■80 The
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test produces only moderate mydriasis, and increased tone in both the
sphincter and dilator muscles of the iris may prevent angle crowding.
The test induces maximal pupil block 64, and failure to obtain any
positive results suggests that pupil block was fully overcome in all
cases tested.
Acute angle closure glaucoma in the presence of a small, patent
argon laser iridotomy has previously been reported in two patients
132,133 tlandelkorn reported a case of acute angle closure glaucoma
following a 50p diameter argon laser iridotomy 132 Further argon laser
treatment was applied to the site, resulting in satisfactory long term
pressure control. Brainard reported a similar case, in an eye with a 75p.
diameter argon laser iridotomy 133. Further argon laser treatment to
enlarge the iridotomy to 125p resulted in satisfactory long term
intraocular pressure control, suggesting inadequate iridotomy size was
responsible for initial failure.
Acute angle closure glaucoma has also been reported in the
presence of a small, but patent Nd:YA6 laser iridotomy 15-'80■106 Brazier-
reported two cases. One was treated by surgical peripheral iridectomy,
with no further complications. The second was treated with miotics 106
Wishort reported two cases of acute angle closure glaucoma and two
cases of subacute angle closure glaucoma in the presence of patent
Nd:YAG laser iridotomies 15 In three cases the iridotomy was 1OOp
diameter, and in the fourth 15Op. Gray reported two cases of acute angle
closure glaucoma in the presence of a small, patent iridotomy 80 One
developed acute angle closure glaucoma while using G Pilocarpine 41,
and was treated by trabeculectomy. The second was treated by a further
iridotorny. Intraocular pressure subsequently remained normal in both
cases. Two of our cases (cases 1 and 2) developed acute angle closure
glaucoma despite the presence of a small patent iridotomy. Case 1
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responded to trabeculectomy, and case 2 responded to laser enlargement
of the iridotomy.
The occurrence of acute angle closure glaucoma in the presence of
a small, but patent, iridotomy, which responds to surgical peripheral
iridectomy or laser enlargement, suggests the size of the initial
iridotomy was inadequate.
Wishart studied iris bombe using slit lamp photograph assessment
of peripheral anterior chamber depth. In four eyes with very small
iridotornies and progressive narrowing of the angle, repeat laser
iridotomy resulted in deepening of the peripheral anterior chamber 15
This study provides further evidence that very small iridotomies may not
fully relieve iris bombe.
We have calculated that the minimum functional iridotomy
diameter should be approximately 15p., as previously suggested by
Wheeler214. However our clinical experience, and that of others
15,30,106,132,135 shows that iridotornies in the range of 50-150p.
diameter may fail to prevent acute angle closure glaucoma.
Several factors may contribute to the reduction in area of an
iridotomy of theoretically "safe" area below that needed to prevent acute
angle closure glaucoma. Most cases of acute angle closure glaucoma
following Nd:YA6 laser iridotomy have occurred within one month of
treatment. Naveh has observed rapid reduction of Nd:YA6 laser iridotomy
area within an hour of treatment in six eyes 14. In each case a return to
the original iridotomy area occurred within two weeks. Localised iris
oedema around the treatment site may have been responsible.
Reclosure of Nd:YA6 laser iridotomies due to iris pigment
epithelium proliferation is unusual, and tends to occur 1-4 months
following treatment 14>15,22,8°,106 Reclosure resulted in acute angle
closure glaucoma in two eyes reported by Wishart15, and one eye reported
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by Gray 80
Case 2 iri our study developed acute angle closure glaucoma
following mydriasis. Pupil dilation might reduce the area of an
iridotomy, arid folds of iris tissue might functionally block an iridotorny
when the pupil is dilated. Mydriatics might therefore produce acute angle
closure glaucoma in the presence of a patent iridotomy by two
mechanisms - pupil block due to reduction of iridotomy area, and angle
crowding
In a photometric study of iridotomy area following pupil dilation
we observed two eyes in which the iridotomy area became reduced to
20% of undilated area on dilating the pupil. However the factors
responsible for some iridotornies becoming smaller on dilating the pupil,
and some becoming larger, were not identified. Iridotomy area following
pupil dilation correlated with iridotomy area prior to pupil dilation, but
did not correlate with any other measured factor. If the theoretical
minimum effective iridotomy diameter is 15p., iridotomies must be at
least 33.5p in diameter in order to allow for a potential fivefold
reduction in iridotomy area when the pupil is dilated.
In order to answer the question "How large must an iridotorny be in
order to prevent acute angle closure glaucoma?" several factors must be
considered, in forms of angle crowding angle closure glaucoma, such as
plateau iris syndrome, a large iridotomy will not prevent the
development of acute angle closure glaucoma following mydriasis, as
pupil block is not causative.
Theoretical modelling suggests an iridotorny of 10-15.u diameter
will prevent angle closure glaucoma due to pupil block. However an
iridotomy of greater size may fall below this critical level due to early
post treatment oedema, late pigment epithelium proliferation, or pupil
dilation. Wishart reported subacute angle closure glaucoma in an eye
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with a I50.u diameter indotorny 15 All other cases of acute angle
closure glaucoma in the presence of a patent iridotorny have occurred in
eyes with an iridotorny of less than 100ft in diameter. The smallest
potentially safe iridotomy diameter would therefore appear to be 100.U.
However, in order to incorporate a safety margin, we would recommend
that iridotornies should be at least 150-200u in diameter.
Provocation tests have not been helpful in identifying eyes at risk,
as eyes developing acute angle closure glaucoma following Nd:VAG laser
iridotorny have done so before a provocation test had been performed
15,21,80 jt- provocation tests are to be employed, we suggest the use of
G. Tropicarnide \% soon after the iridotorny has been performed, in order
to detect cases at risk of developing acute angle closure glaucoma.
Routine pupil dilation to prevent posterior synechiae formation following
laser iridotorny may be more safely achieved using 6. Phenylephrine 10$,
with measurement of intraocular pressure following dilation. Lowe has
shown that phenylephrine very rarely results in acutely raised
intraocular pressure following peripheral iridectomy204, arid the effect




CHRONIC ANGLE CLOSURE GLAUCOMA AND NARROW ANGLE
GLAUCOMA
CHAPTER 7a
CHRONIC ANGLE CLOSURE GLAUCOMA
7a. 1 SUMMARY
Nd:YAG laser iridotomy was performed in 16 patients with chronic
angle closure glaucoma. Glaucoma control improved in 7 patients, and did
not worsen in any patient. Two patients underwent trabeculectomy
during the follow up period because of failure of Nd:YA6 laser iridotorny
to adequately improve intraocular pressure control. 4/14 (29%) of eyes
lost two or more lines of visual acuity during the follow up period due to
progression of preexisting cataract.
7a.2 INTRODUCTION
Mild degrees of pupil block may result in slowly progressive angle
closure, beginning superiorly 53 Closure may be oppositional or synechial
47,49,51,56,95 an(j f fle response to miotics 47.-54, or the angle appearance on
indentation gonioscopy 88>89, may be used to differentiate these
processes prior to iridectomy. When more than 80% of the angle
circumference is closed, raised intraocular pressure with optic disc
cupping and glaucomatous visual field loss are likely to develop89.
Prior to the advent of laser iridotorny, operative peripheral
iridectomy was the treatment of choice for most cases of chronic angle
closure glaucoma 44,4s,49,52,89,95 However some workers have argued
that cases with extensive goniosynechiae, optic disc cupping or visual
field loss should be treated with primary drainage surgery 49>52'95.
The advent of argon laser iridotomy, and the belief that this was a
non invasive technique 215, led to recommendations that all cases of
chronic angle closure glaucoma should be treated with argon laser
iridotomy 215'139. However laser surgery cannot be regarded as non
invasive 6. While chronic angle closure glaucoma cases have been
included in studies of argon33 and Nd:YAG 137 laser iridotomy techniques,
no study has reported the long term outcome of Nd:YAG laser iridotomy
for chronic angle closure glaucoma.
78.3 MATERIALS AND METHODS
16 patients with a diagnosis of chronic angle closure glaucoma
who underwent Nd:YA6 laser iridotomy between June 1986 and March
1989 were recalled for a detailed follow up examination. The diagnosis
was based on the following features:
- Intraocular pressure greater than 21 mm Hg prior to medical
treatment, with or without pathological optic disc cupping or
glaucomatous visual field loss.
- Part or all of the angle closed on Goldman gonioscopy.
information on the results of examination prior to Nd:YAG laser
iridotomy, and medical and laser glaucoma treatment, were obtained
from the case records. At the follow up examination measurement of
corrected visual acuity , Friedman analyser visual field charting, and
Goldman applanation tonometry were performed. The area of the
iridotomy was measured by comparison with the 0.2 mm spot produced by
a Haag-Streit slit lamp, and the position of the iridotomy was noted.
Goldman gonioscopy was performed by one observer (BWF), followed by
Posner 4 mirror indentation gonioscopy if any part of the angle appeared
to be closed. The pupil was dilated with G. phenylephrine 10% to detect
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posterior synechias, and examine the lens and fundus.
7a.4 RESULTS
16 patients with chronic angle closure glaucoma in one or both
eyes attended for follow up examination. 8 were female, and the mean
age of the group was 66.0±8.4 years. 10 patients had bilateral angle
closure glaucoma, and 6 unilateral angle closure glaucoma. In bilateral
cases one eye was randomly selected for analysis by tossing a coin. The
results of examination at presentation of these eyes is shown in Table
7.1.
Number patients 16
Visual acuity less than 6/12 3
cause - cataract 2
- amblyopia 1
Mean intraocular pressure, mm Hg 35.2+9.5
Cup : disc ratio > 0.7 4
Visual field loss 7
Gonioscopy > 210° angle closure 12
TABLE 7.1
Chronic angle closure glaucoma. Examination at presentation.
Initial medical treatment consisted of 6. Pilocarpine 2% four-
times daily in 14 patients, in 2 patients, with initial intraocular-
pressure greater than 40 rnrn Hg, G. Timolol 0.5:7 twice daily was also
prescribed at the initial visit. Two further patients were found to have
an intraocular pressure greater than 25 mm Hg while using 6. Pilocarpine
2% four times daily, and 6. Timolol 0.5% twice daily was added to their
regimen.
Prior to Nd:YAG laser iridotorny 8 eyes had an intraocular pressure
greater than 21 mm Hg, and the mean intraocular pressure of the group
was 22.9+6.3 mm Hg.
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7a.4.1 Nd:YAG LASER IRIDOTOMY TREATMENT PARAMETERS.
The laser treatment parameters, operative complications and
immediate postoperative complications recorded in the case records are
shown in Table 7.2.
Chronic angle closure glaucoma. Nd:YAG laser iridotomg
treatment parameters and earlg complications.
7a.4.2 FOLLOW UP
The mean follow up period was 21.3+9.7 months. Two of the eyes
analysed had undergone a trabeculectomy operation during the follow up
period because of failure of Nd:YAG laser iridotorny to adequately
improve intraocular pressure control.
7a.4.2.1 GLAUCOMA OUTCOME
7a.4.2.1.1 VISUAL FIELDS AND OPTIC DISCS
Slight progression of visual field loss was noted in 2 eyes, but the
eyes had developed cataract and the visual field changes may have been
secondary to this. The cup : disc ratio did not enlarge by more than 20% in
any eye.
Number patients
Mean number laser pulses
Mean total energy (rnJ)
Primary patency
Iris bleeding
Focal corneal oedema ++








11 patients were being treated with glaucoma medication at the
time of the follow up examination including 2 eges which had undergone
trabeculectomy. After excluding these 2 eyes, 5 eyes needed fewer
medications than prior to laser treatment, 6 the same number of
medications, and 3 needed more medications than prior to laser
treatment. In 3 eyes needing the same number of medications miotics had
been withdrawn, which may be considered advantageous. A total of 8/16
(501) of eyes therefore benefited from laser iridotorny in terms of
rnedication requirement.
7a.4.2.1.3 INTRAOCULAR PRESSURE
14/16 (881) eyes, including the 2 eyes which underwent
trabeculectomy, had an intraocular pressure less than or equal to 21 mm
Hg. The mean intraocular pressure of the group was 18.7+3.2 mm Hg,
which was not significantly less than the mean intraocular pressure on
medication prior to laser iridotomy (22.9±6.3 mm Hg).
After excluding the 2 eyes which underwent trabeculectomy, the
intraocular pressure was within 2 mm Hg of the pretreatment level in 3
eyes, lower in 9 eyes, and higher in 2 eyes.
7a.4.2.1.4 GLAUCOMA CONTROL
Nd:YAG laser iridotomy could be regarded as having improved
glaucoma control if:
1. The same number or fewer medications resulted in reduced
intraocular pressure, or
2. Fewer medications resulted in the same or lowered intraocular-
pressure.
Using these criteria 7/16 (44%) of patients benefited from Nd:YAG
laser iridotorny.
Conversely Nd:¥AG laser iridotorny could be regarded as having
worsened glaucoma control if:
1. The same number or more medications resulted in increased
intraocular pressure, or
2. More medications resulted in the same or increased intraocular-
pressure. Using these criteria no patient had worse glaucoma control
following Nd:YAG laser iridotorny.
7a.4.2.1.5 GONIOSCOPY
After excluding the 2 eyes which underwent trabeculectomy during
the follow up period, 7/14 eyes had partly closed angles on Goldman
goriioscopy at follow up. indentation gonioscopy showed that residual
angle closure was due to goniosynechiae in all but one eye. This eye had
60° of angle closure on Goldman gonioscopy at follow up, but the angle
was entirely open on indentation. The iridotorny area was rather small in
this eye (100pix200p), and it is possible that some degree of residual
iris bornbe was present.
Gonioscopy examinations prior to iridotomy were performed by a
variety of observers, and comparison with the follow up examinations
were therefore not valid.
7a.4.2.2 VISUAL ACUITY OUTCOME
Five eyes lost two or more lines of visual acuity following Nd:YA6
laser iridotorny. In four cases this was due to progression of pre existing
cataract, and in one case due to development of cataract in a previously
clear lens following trabeculectomy.
Three eyes had posterior synechiae, arid in two of these eyes two
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or more lines of visual acuity was lost due to progression of preexisting
cataract.
7a.5 DISCUSSION
The Nd:YA6 laser treatment parameters and complication rates in
chronic angle closure glaucoma eyes were similar to those found when
treating the fellow eye of patients with acute angle closure glaucoma., a;
shown in Table 7.3. (see Tables 4.3 and 7.2 )
Number eyes
Mean number pulses
Mean total energy (m-J)
Primary patency
Iris bleeding
Focal corneal oedema ++
Intraocular pressure rise > 6mm Hg.

















A comparison of Nd:¥AG laser treatment parameters and
complication rates in fellow eyes and chronic angle closure
glaucoma eyes
Slight iris bleeding was probably under-reported in the chronic
angle closure glaucoma group. Post treatment intraocular pressure rise
was probably less frequent in the chronic angle closure glaucoma group
because of the use of topical 0 blockers or oral acetazolarnide prior to
treatment.
7a 5.1 GLAUCOMA OUTCOME
Measurement of glaucoma outcome is complex, as changes in
glaucoma medication following iridotomy alter intraocular pressure
control. We found that 12 of the 14 eyes (86:7) which did not undergo
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trabeculectomy during the follow up period had an intraocular pressure
of less than 21 mm Hg at follow up., compared to 8/16 (50%) eyes prior
to laser iridotomy.This finding is similar to that obtained following
peripheral iridectomy 49>52>89>95, argon laser iridotomy 33 >954 39 and
Nd:YAG laser iridotomy 137 for chronic angle closure glaucoma (see Table
1.14)
The mean intraocular pressure at follow up, 18.7+3.2 mm Hg, was
not significantly lower than that prior to laser iridotomy, 22.9±6.3 mm
Hg. When the intraocular pressure results and medication requirement
results were combined it was evident that 7/14 patients had improved
glaucoma control following Nd:YAG laser iridotomy. After excluding two
patients who underwent trabeculectomy because of failure of Nd:YAG
laser iridotomy to adequately improve glaucoma control, no patient had
worse glaucoma control following Nd.YAG laser iridotomy.
The number of patients in our study was too few to assess
whether patients with visual field loss at presentation responded less
well to iridotomy than patients with a full visual field. Previous studies
have found this to be the case following operative peripheral iridectomy
49,52,89,95
At follow up 7/14 eyes had partly closed angles on Goldman
gonioscopy. Indentation gonioscopy showed that closure was entirely due
to goniosynechiae in 6 of these eyes. In one eye closure was oppositional,
suggesting that part of the closure was due to residual iris bornbe. This
eye had a rather small iridotomy. Wishart described four eyes with
small iridotornies in which repeat laser iridotomy resulted in deepening
of the peripheral anterior chamber 15 Very small iridotornies may fail to
prevent acute angle closure glaucoma 21 >80, and it is conceivable that
very small iridotornies may inadequately overcome iris bombe in chronic
angle closure glaucoma.
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7a.5.2 VISUAL ACUITY OUTCOME
We found loss of two or more lines of visual acuity in 4 of the 14
{29%) eyes which did not undergo trabeculectomy during the follow up
period. This figure is slightly higher than that found for fellow eyes in
our study (2/26 (830, see table 4.4) and for chronic angle closure
glaucoma eyes treated by peripheral iridectomy, argon laser iridotomy,
or Nd:YA6 laser iridotomy in previous studies (7-151, see Table 1.15).
However our numbers were small.
As Nd:YAG laser iridotorny has not been demonstrated to be safer
than operative peripheral iridectomy the indications for Nd:YA6 laser
iridotorny should in general remain the same as those for operative
peripheral iridectomy. However, unlike peripheral iridectomy, Nd:YA6
laser iridotomy does not result in a surgical wound, and therefore does
not make subsequent drainage surgery more difficult. Medical treatment
of chronic angle closure glaucoma is unsatisfactory 48. A reasonable
approach would be to perform Nd:YAG laser iridotomy at the time of
diagnosis in all chronic angle closure glaucoma patients, arid resort to
drainage surgery if additional medical treatment falls to adequately





Nd:YAG laser iridotomy was performed in 22 patients who fulfilled
our diagnostic criteria of narrow angle glaucoma. Glaucoma control
improved in 3 patients and deteriorated in 6 patients following
iridotomy. Two patients underwent trabeculectomy during the follow up
period due to failure of Nd:YAG laser iridotomy to adequately improve
intraocular pressure control. 2/22 (9%) of eyes lost two or more lines of
visual acuity due to progression of preexisting cataract during the
follow up period. One eye developed a dense cataract in a previously clear
lens, having sustained a focal lens opacity at the iridotomy site during
treatment.
7b.2 INTRODUCTION
Several workers have used the term "narrow angle glaucoma" to
describe eyes with the following features i5,2i6-2is
Anterior chamber depth < 2.5 mm
Intraocular pressure > 21 mm Hg
A narrow or slit-like angle
When glaucomatous optic disc cupping and visual field loss are
present the term "narrow angle glaucoma" has been used 15'216>213 and
when these features are absent the term "ocular hypertension with a
narrow angle" has been used 217 However the goriioscopic appearances
which differentiate chronic angle closure glaucoma from narrow angle
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glaucoma are subjective. No clear distinction may be made between
narrow angle glaucoma and open angle glaucoma The existence of narrow
angle glaucoma as a disease entity must therefore be questioned.
The results of laser or surgical treatments of narrow angle
glaucoma have been disappointing 15>216..217 Romano found Nd:YAG laser
iridotorny resulted in a reduction of medication requirement in 33$ of
cases, but increased medication was needed in 6 of the 7 eyes which had
goniosynechiae prior to iridotorny 217. Wishart found Nd:YA6 laser
iridotomy, dye laser iridotomy or argon laser trabeculoplasty combined
with peripheral iridectomy adequately controlled glaucoma in only 24$
of eyes216.
We have examined a group of 22 patients fulfilling the gonioscopic
and intraocular pressure criteria of narrow angle glaucoma or narrow
angle ocular hypertension, treated by Nd:YAG laser iridotorny.
7b.3 MATERIALS AND METHODS
22 patients with a diagnosis of narrow angle glaucoma who
underwent Nd:YAG laser iridotorny between June 1986 and March 1989
were recalled for a detailed follow up examination. The diagnosis was
based on the following criteria:
- Intraocular pressure greater than 21 mm Hg prior to medical
treatment, with or without pathological optic disc cupping or
glaucomatous visual field loss.
- Very narrow but open angle on Goldman gonioscopy. Gonioscopy
prior to Nd:YAG laser iridotorny was performed by a number of
experienced observers, and some degree of subjective variation in
descriptions of angle appearances was likely. Descriptions of optic disc
appearances were also subject to observer variation.
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7b.4 RESULTS
22 patients fulfilled our diagnostic criteria of narrow angle
glaucoma in one or both eyes. 15 of these patients were female and the
mean age of the group was 59.1 ±6.1 years. 9 of the cases were bilateral,
and in these cases one eye was chosen at random for analysis, by tossing
a coin.
Details of the initial glaucoma examination of these eyes is
shown in Table 7.4.
Number patients
Mean intraocular pressure, mm Hg, untreated
visual field loss
cup : disc, ratio > 0.7
TABLE 7.4
Narrow angle glaucoma, initial assessment.
18 patients were initially treated with 6. Pilocarpine 2% four-
times daily, and 2 patients were initially treated with 6. Timolol 0.5:1
twice daily. Two patients with presenting intraocular pressures greater
than 30 mm Hg, and with advanced visual field loss, were treated with
both G Timolol 0.5% twice daily and G Pilocarpine 2% four times daily.
The mean intraocular pressure after initial medical control was
21.5+7.0 mm Hg. 4/22 eyes had an intraocular pressure greater than 21
rnrn Hg. Three eyes developed partly closed angles on gonioscopy while
using miotics.
The mean follow up period of the group was 15.2±6.7 months.








No progression of visual field loss was documented during the
follow up period. One optic disc developed a 30% increase in the cup :
disc ratio during the follow up period.
After excluding the 2 eyes which underwent trabeculectomy, 4 /20
(20%) eyes had an intraocular pressure greater than 21 mm Hg at follow
up. The mean intraocular pressure at follow up was 20.0+3.5 mm Hg,
compared to 21.5+7.0 prior to laser iridotomy (unpaired Student t test
NS).
After excluding the 2 eyes which underwent trabeculectomy, 3/20
(15%) of eyes had lower intraocular pressure with the same number or
fewer medications, or unchanged intraocular pressure with fewer
medications.
In 6/20 (30%) of eyes the intraocular pressure was higher, with
the same or more medications, or the intraocular pressure was
unaltered, with more medications. Measured in this way glaucoma control
improved in 15% of eyes and deteriorated in 30% of eyes following
iridotomy.
7b.4.2 VISUAL ACUITY OUTCOME
3 eyes lost 2 or more lines of visual acuity during the follow up
period. Two of these eyes had preexisting cataract which progressed. The
remaining eye had a clear lens prior to treatment and developed a focal
lens opacity at the laser treatment site due to treatment too close to the
pupil margin . A dense nuclear cataract developed during the follow up
period, reducing visual acuity from 6/9 to perception of light.
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7b.5 DISCUSSION
The mean intraocular pressure with medication following
iridotomy, 20.0+3.5 mm Hg, was not significantly lower than that prior
to iridotomy, 21.5 ±7.0 mm Hg. Glaucoma control was improved in 151 of
eyes and deteriorated in 301 of eyes following Nd:YAG laser iridotomy.
Romano found deterioration of glaucoma control was particularly likely
to occur in patients with goniosynechiae prior to iridotomy 217.
Cataract development was similar to that seen following Nd:YAG
laser iridotomy for chronic angle closure glaucoma. 3/20 (191) eyes lost
2 or more lines of visual acuity due to cataract development. Operative
peripheral iridectomy, argon laser iridotomy and Nd:YA6 laser iridotomy
for chronic angle closure glaucoma have been reported to result in visual
acuity loss of 2 or more lines in 7-151 of eyes, due to cataract
progression (see Table 1.15).
One eye sustained focal lens damage due to treatment close to the
pupil margin . A dense nuclear cataract developed during the following
six months. While focal lens opacity has been described following Nd:YAG
laser iridotomy in humans h-i7,107,122 progression to clinically
significant visual loss has not been reported previously.
The management of narrow angle glaucoma remains difficult, and
Nd:YAG laser iridotomy appears to be of limited value in treatment. Not
only does glaucoma control deteriorate in some patients following
Nd:YA6 laser iridotomy, but should miotics be required there is a high
risk of posterior synechias development119.
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CHAPTER 8
ARGON LASER PRETREATMENT PRIOR TO ND:VAG LASER
IRIDOTOMY
8.1 SUMMARY
Argon laser pretreatment followed by Nd:YA6 laser iridotomy 4-6
weeks later was performed in the right eye of 10 patients. Primary
Nd:¥A6 laser iridotomy was performed in the left eye. Significantly more
Nd:YA6 laser energy was needed to produce an iridotomy in pretreated
eyes (pcO.OOl). A patent Nd:YAG laser iridotomy was not obtained at the
pretreatment site in 2 eyes. After a mean follow up period of 9.4 months
there was no difference in the visual acuity or glaucoma outcome of the
two groups. Pretreated eyes developed a significantly larger pigment
epithelium defect around the iridotomy site, and a greater degree of
pigmentation of the inferior part of the trabecular rneshwork 6 months
following treatment
Argon laser pretreatment followed by Nd:YAG laser iridotomy 4-6
weeks later offers no advantages over primary Nd.YAG laser iridotomy.
8.2 INTRODUCTION
Argon laser iridotomy and more recently Nd YAG laser
iridotomy 2 have already largely superseded operative peripheral
iridectomy 3 in the treatment of angle closure glaucoma. Argon laser
energy is absorbed by pigmented tissue, leading to thermal tissue
destruction35'36. Q-switched Nd:YAG laser pulses create a focus of very
high irradiation at the treatment site, resulting in formation of a
"plasma". Rapid expansion of the plasma produces a shock wave, with
mechanical tearing of adjacent tissues35'36'140'147'148.
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Argon laser iridotorny is associated with a higher incidence of
focal lens opacities and iridotomy reclosure than Nd:YAG laser iridotorny
10,11,13,22,23 iris bleeding occurs more frequently following Nd:YAG
laser iridotorny 10,11,13,22,23 Attempts have been made to combine the
two forms of treatment in order to reduce these complications
37,157,169,219-221
Krasnov used argon laser burns to coagulate the iris stroma prior
to performing Q-switched ruby laser iridotorny two weeks later37.
Zborwski used argon laser burns to coagulate the iris stroma
immediately prior to performing Nd.YAG laser iridotomy 221. Several
workers have commented on the relative ease with which a Nd:YAG laser
iridotorny may be performed at the site of a failed argon laser iridotorny
157,219,220 xhis has also been our experience. However controlled trials
of these techniques have not been undertaken.
Histologically, an argon laser burn results in atrophy of the iris
stroma approximately 2 weeks later32-222. Nd:YAG laser iridotorny might
be more easily performed in an area of stromal atrophy. We have
undertaken a prospective study in which ten patients underwent argon
laser pretreatment in the right eye, followed by Nd:YAG laser iridotorny
4-6 weeks later. Primary Nd:YAG laser iridotomy was performed in the
left eye.
8.3 MATERIALS AND METHODS
The study was approved by the unit ethical committee, and
informed patient consent was obtained prior to entry into the trial. Ten
consecutive patients referred for laser iridotomy were recruited.
Patients with acute angle closure glaucoma were excluded.
Initial assessment included a review of the patients" case records
arid current glaucoma control. Goldman gonioscopy was performed by one
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observer (BWF), followed by Posner 4 mirror indentation gonioscopy if
any part of the angle appeared to be closed. The iris colour, and presence
or absence of iris crypts, was noted.
Argon laser pre treatment was performed in the right eye and
Nd:YAG laser iridotorny in the left eye at the first treatment session.
Nd:YAG laser iridotomy was performed in the pretreated area of the right
eye at the second treatment session.
Acetazolarnide 500 rng was given orally, and and one drop of
6. Pilocarpine 2% topically, 30 minutes before treatment.
8.3.1 ARGON LASER PRETREATtlENT
A Coherent 9900 Argon blue-green laser and Abraham 66 dioptre
iridotorny contact lens were used. A treatment site was chosen in the
superior iris between 10 and 2 o'clock, 2/3 way from the pupil to the iris
base. An iris crypt was used where present. A series of superficial burns
of the iris stroma were made, using 2-5 pulses of 0.5-0.7 mW power, 0.2
second duration, and 200-500ji diameter spot size.
8.3.2 ND:YAG LASER IRIDOTOflY
A Zeiss "Visulas" Nd:YAG laser and Zeiss anterior segment YAG
contact lens were used. A treatment site was chosen in the left eye as
symmetrical as possible to the argon laser pretreatrnent site in the right
eye. An iris crypt was used where present. A single 5-10 mJ pulse was
delivered to the treatment site. If this pulse did not penetrate the iris,
further single pulses were delivered to the same site until penetration
was achieved. Patency was assessed by direct observation of the
posterior chamber, or anterior lens capsule. The iridotorny was
inspected, and the intraocular pressure measured 2 hours following
treatment. Patients were reviewed 24 hours, 1 week, and 1 month
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foliow i ng t rea t rn en t.
Four to six weeks following argon laser pretreatment Nd:YAG laser
iridotomy was performed in the pretreated area of the right eye. The
treatment procedure was identical to that used for primary Nd:VAG laser
iridotomy. The iridotomy was inspected, and the intraocular pressure
measured 2 hours following treatment, and patients were reviewed 24
hours, 1 week, and 1 month following treatment.
8.3.3 FOLLOW UP
Patients were reviewed monthly for three months, and then at
three monthly intervals. Glaucoma medication was withdrawn in a
stepwise fashion in patients with good glaucoma control. Medication was
reintroduced if the intraocular pressure rose above 21 mm Hg.
Six months after treatment Goldman gonioscopy was performed by
one observer (BWF), followed by Posner 4 mirror indentation gonioscopy
if any part of the angle appeared to be closed. Special attention was
given to the degree of pigmentation of the inferior part of the trabecular
rneshwork. The size of the iridotomy was measured by comparison with
the 0.2 mm spot produced by a Haag-Streit slit lamp. The area of the
iridotomy was then calculated using the formula Diameter a x Diameter b
x ti'/4 (see Figure 2.3, page 48). Transillumination of the iris revealed
the extent of pigment epithelium disruption around the iridotomy, and
this area was also measured. Pilocarpine/phenylephrine provocation
testing as described by Mapstone ba and modified by Flarrad 105 was
performed. One drop of G. Phenylephrine IDS arid one drop of
6. Pilocarpine 2% were instilled. The intraocular pressure was measured




Details of the patients' age, sex and diagnosis are given in
table 8.1.
Age, years












Argon laser pretreatment prior to Nd:¥AG laser iridotomy.
Patients age/sex distribution and diagnosis.
"ACG" = Angle Closure Glaucoma.
8.4.1 INITIAL EXAMINATION
Corrected visual acuity was 6/9 or better in 17 eyes. One patient
had nuclear cataracts reducing visual acuity to 6/18 in each eye, and one
patient had a unilateral nuclear cataract reducing visual acuity to 6/60.
Five patients had light brown irises arid five patients had grey irises.
Three patients had prominent iris crypts - two had brown irises and one
had grey irises.
Table 8.2 shows the glaucoma features of each patient
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8.4.2 TREATMENT
All patients had argon laser pretreatment followed by Nd:YAG laser
iridotomy in the right eye. The mean period between argon laser
pretreatment and Nd:YAG laser iridotomy was 36.6±16 days (range 14-62
days). Nine patients underwent Nd:YA6 laser iridotomy in the left eye.
One patient with unilateral chronic angle closure glaucoma affecting the
right eye declined prophylactic treatment in the left eye.
8.4.3 IRIS APPEARANCE FOLLOWING ARGON LASER PRE¬
TREATMENT
The immediate effect of argon laser burns was contracture of the
iris stroma. Following treatment an elevated area of bunched up iris
stroma was seen (Figure 8.1).
Figure 8.1. Argon laser pretreatment site in a grey iris
immediately following treatment. A pale brown elevated, bunched
up area of iris is seen at the treatment site (indicated by arrow).
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The treated area was a light brown colour in grey irises, and dark
brown in brown irises.
One week later the treated area remained elevated, with scattered
pigment in the stroma.
After four to six weeks the treated area was less elevated, but
significant atrophy was not evident. Grey irises appeared to have a dense
granular membrane on the surface of the treated area (Figure 8.2). The
treated area was densely pigmented in brown irises (Figure 8.3).
Figure 8.2. Argon laser pretreatment site in a grey iris 28
days after treatment (the same eye as that shown in Figure 8.1). A
thick granular membrane appears to be present at the treatment site.
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Figure 8.3. Argon laser pretreatment site in a brown iris
42 days following treatment. The treatment site is densely
pigmented.
After four months the stroma in the treated area had become
atrophic. Nd:YAG laser iridotomy had been performed in the argon laser
pretreated area prior to this stage (Figures 8.4, 8.5, 8.6).
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Figure 8.4. Nd.YAG laser iridotomy in an argon laser
pretreatment site 9 months after treatment (same eye as shown
in Figure 8.3). The argon laser treated stroma around the Nd:YA6 laser
iridotomy has become atrophic.
Figure 8.5. Primarg Nd.YAG laser iridotomy 3 months after
treatment.
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Figure 8.6. Nd:YAG laser iridotomy in an argon laser
pretreatment site 3 months after argon laser treatment (fellow
eye of that shown in Figure 8.5). Note stromal atrophy in the argon laser
pretreated area around the Nd.YAG laser iridotomy.
Transillumination of the iris 6 months after treatment revealed
defects in the pigment epithelium at the argon laser pretreated site.
However these changes may have been related to Nd:YAG laser iridotomy
performed in the argon laser pretreated area.
8.4.4 Nd:YAG LASER IRIDOTOMY IN THE ARGON LASER PRE¬
TREATMENT SITE
The iris stroma in the argon laser pretreated area proved difficult
to cut using the Nd:YAG laser.
One patient underwent Nd:YAG laser iridotorny 2 weeks after argon
laser pretreatment. Considerable fragmentation of the surrounding iris
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stroma developed (Figure 8.7). Seven cases underwent Nd.YAG laser
iridotomy 4-6 weeks after argon laser pretreatment. In these cases the
iris stroma appeared to be "tough", and relatively resistant to Nd:YAG
laser photodisruption (Figure 6.8). Two cases underwent Nd:YAG laser
iridotomy 8 weeks following argon laser pretreatment. In these cases
the iris stroma had become atrophic, and penetration of the iris was
easily achieved.
Figure 8.7. Nd:YAG laser iridotomy in an argon laser
pretreatment site 4 months after argon laser treatment. The
Nd:YAG laser iridotomy was performed 2 weeks after argon laser
pretreatment, and considerable fragmentation of the iris stroma
occurred.
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Figure 8.8. Argon laser pretreatment site in a greg iris 56
dags after treatment. A dark grey granular membrane was present on
the surface of the pretreatment site. Nd:¥A6 laser iridotomy at this site
failed. Nd:YA6 laser iridotomy was then performed at a new site
(indicated by arrow).
In every case marked pigment dispersion from the pigment




The number of pulses, arid the total energy used in treatment are
shown in Table 8.3.
Argon laser Nd:VAG after 1°Nd:VAG
pretreatment Argon pre Rx iridotomy
Number of pulses 5.6+4.4 5.4+7.3 2.9±2.0
Total energy (mj) 496+44.1 31.8+29.0 19.4± 13.3
TABLE 8.3
Argon laser pretreatment prior to Nd:YA6 laser iridotomy.
Number of laser pulses, and total energy used in treatment
Nd:VAG laser iridotomy performed following argon laser
pretreatment required significantly more total Nd:YAG laser energy than
primary Nd:YAG laser iridotomy (p<0.001 unpaired student t test). There
was no significant difference in the number of Nd:YAG laser pulses used
in each form of treatment.
A patent iris opening was obtained in all primary Nd:YA6 laser
iridotomies. However Nd:VAG iridotomy at an argon laser pretreated site
failed in three eyes. In two of these eyes a Nd:YAG laser iridotomy was
performed at a fresh site, and in one eye a patent Nd:YAG iridotomy was
obtained at the argon laser pretreated area during a second treatment
session one week later.
In two cases the size of the primary Nd:YA6 laser iridotomy was
thought to be inadequate, and subsequent Nd:YA6 laser enlargement of the
iridotomy was performed.
8.4.6 OPERATIVE COMPLICATIONS
Slight iris bleeding occurred at the time of treatment in 5 primary
Nd:VAG iridotomies and one argon laser pretreated Nd.YAG iridotomy (X2
test NS).
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Post treatment intraocular pressure elevation to above 21 mm Hg
did not occur following primary Nd:YAG laser iridotorny . Intraocular
pressure elevation to 24 mm Hg and 34 mm Hg respectively occurred two
hours after argon laser pretreated Nd:YAG iridotomy in two patients. Both
of these patients had chronic angle closure glaucoma.
Clinically significant iritis or focal corneal oedema did not occur .
FOLLOW UP
The mean duration of follow up was 9.4±3.1 months, with a range
of 5-14 months.
8.4.7 GLAUCOMA OUTCOME
Progression of visual field loss or optic disc cupping did not occur.
Glaucoma control improved in a measurable way in eight patients.
(Table 8.2). In one patient with chronic angle closure glaucoma (patient
7) there was no measurable improvement in glaucoma control. The
patient with open angle glaucoma with narrow angles had slightly worse
glaucoma control following treatment (patient 5). There was no
difference in the outcome of eyes treated with a primary Nd:YAG laser
iridotomy and those treated with argon laser pretreated Nd:YA6 laser
iridotomy.
Goldman gonioscopy revealed open angles in 9 patients. One chronic
angle closure glaucoma patient had angle closure throughout 300 degrees
superiorly in both eyes (patient 9). On indentation small areas of
goniosyriechiae were present superiorly in the right eye, but not in the
left eye.
Pigmentation of the inferior part of the trabecular rneshwork was












Argon laser pretreatment prior to Nd:¥A6 laser iridotomy.
Inferior trabecular meshwork pigmentation 6 months
following treatment
In five patients the inferior part of the trabecular meshwork was
more pigmented in the eye with art argon laser pretreated Nd:YAG laser
iridotomy, and in five patients there was no difference in the degree of
trabecular meshwork pigmentation in the two eyes. This difference was
not statistically significant, using theX2 test with Yate's correction.
Pilocarpine/phenylephrine provocation tests were performed in
both eyes of 8 patients. All tests were negative.
The areas of full thickness iris patency, and of surrounding iris
transillumination defect are shown in Table 8.5.
1° Nd:YAG Argon/YAG
iridotomy area (mm2)










Argon laser pretreatment prior to Nd:YAG laser iridotomy.
Iridotomy area, and the area of the surrounding pigment epithelium
defect. "Argon/YAG" refers to argon laser pretreated Nd:YAG laser iridotomy
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There was no significant difference in the mean iridotorny area of
the two groups using the unpaired Student t test. However the area of
transillumination defect was significantly greater in the argon laser
pretreated Nd:YAG laser iridotorny group (p<0.05).
8.4.8 VISUAL ACUITY OUTCOME
No eye lost more than one line of visual acuity during the follow up
period., arid there was no progression of preexisting lens opacities or
development of new lens opacities. No focal lens opacities were seen.
8.5 DISCUSSION
While claims have been made that combined argon and Nd:YAG laser
iridotomy is more easily performed than primary Nd:YAG laser iridotorny
221, our study is the first controlled study of argon laser pretreated
Nd:YA6 laser iridotorny. We found that Nd:YAG laser iridotorny performed
4-6 weeks after argon laser pretreatment required significantly more
Nd:YAG laser energy than primary Nd:YA6 laser iridotorny. In two cases a
Nd:YAG laser iridotomy was not obtained at the argon laser pretreated
site.
The timing of Nd:YA6 laser iridotorny following argon laser
pretreatrnent appears to be of some importance. In our cases maximal
stromal atrophy did not occur until approximately 4 months after argon
laser pretreatment.
Histological studies of human tissue have shown stromal oedema
around argon laser iridotomy sites 4-24 hours after treatment, with
tissue necrosis arid pigment dispersion 32'222. During the next few days
necrotic cells were seen among surviving collagen trabeculae, but
inflammatory cell infiltration was minimal. Stromal thinning occurred
as early as 1? days following treatment 32, arid this progressed over the
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next 3-4 months. The observation of progressive stromal thinning may
explain why some argon laser iridotornies progressively enlarge over a
period of months 223. The pigment epithelium was relatively spared in
areas of partial thickness iris burns 32 By 5 months - 2 years following
treatment some degree of reparative fibrosis was seen32'222.
Animal studies of argon laser iridotorny produced similar results.
Iridotornies in rabbits and cynornolgus monkeys showed stromal oedema
and necrosis during the first few weeks after treatment., followed by
stromal atrophy 3 months after treatment 584.
The 4-6 week delay period used in our study to allow stromal
atrophy to occur was probably insufficient. After initial resolution of
stromal oedema, atrophy of collagen trabeculae proceeded more slowly. A
delay period of 4 months might have been more satisfactory. However
undue delay in creating a patent iridotomy increases the risk of
goniosynechiae formation, or the occurrence of acute angle closure
glaucoma. We have therefore chosen not to repeat the study using a
longer delay period.
Considerable pigment dispersion occurred at the argon laser
pretreatment site during Nd:YA6 laser iridotorny. Migration and
proliferation of pigment epithelium occurs several weeks following
argon laser iridotomy 184. it is likely that the pigment epithelium was
loosely adherent to the overlying atrophic stroma at pretreated sites.
The shock wave produced by Nd:YA6 laser photodisruption may have
dislodged loosely attached pigment cells.
Histological studies of Nd:YA6 laser iridotornies in humans have
shown minimal disruption of surrounding tissues immediately
following Nd:YAG laser iridotomy a very localised area of stromal
necrosis and blood vessel disruption was seen. Pigment epithelium
disruption occurred over a slightly larger area 1bfc.
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The findings in Dutch-belted pigmented rabbits were similar,
although a wider area of pigment epithelium loss occurred at the time of
treatment169 The iridotornies remained patent, with no inflammatory or
fibrotic reaction 169 Among groups of pigmented and albino rabbits
Nd:YA6 laser iridotorny resulted in localised stromal and pigment
epithelium disruption soon after treatment. Virtually no stromal oedema
or inflammation developed, and there was no subsequent stromal atrophy
or fibrosis 170 However in cyriomolgus monkeys large areas of pigment
epithelium were disrupted by Nd:VAG laser iridotomy, and iridotorny
closure occurred 3-4 weeks later, by migration and proliferation of
pigment cells 11°4&s
We found no significant pigment epithelium loss beyond the
iridotorny site following primary Nd:YA6 laser iridotomy. It would appear
that in humans the pigment epithelium is normally tightly bound to the
overlying stroma, and disruption is very localised during Nd:YA6 laser
iridotomy. The pigment dispersion which occurred at the time of Nd:YA6
laser iridotomy in argon laser pretreated sites was probably due to the
loose attachment of unhealthy pigment epithelium to the overlying
stroma at this site, rather than a primary effect of Nd:YAG laser
photodisruption.
The inferior part of the trabecular rneshwork was more heavily
pigmented in argon laser pretreated eyes than primary Nd:YA6 laser
iridotorny eyes 6 months following treatment. However increased
trabecular rneshwork pigmentation did not appear to affect glaucoma
control. Argon laser iridotomy in the cynomolgus monkey has been found
to cause increased pigmentation of the inferior part of the trabecular
meshwork soon after treatment178. Histologically, the pigment 'was
present both extracellularly, and within giant vacuoles in the
juxtacanalicular endothelial cells of the trabecular rneshwork. One year
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after iridotomy pigmentation was minimal, and no permanent structural
trabecular meshwork damage was detected 17S. It would appear that
pigment released from the iris at the time of iridotomy is efficiently
cleared by bulk aqueous flow, and phagocytosis at the trabecular
meshwork 178 While there has been concern that pigment deposition in an
already compromised glaucomatous trabecular rneshwork might further
reduce outflow facility, Pollack found that outflow facility increased
following argon laser iridotomy in a group of chronic angle closure
glaucoma patients 1S4.
We found that iris bleeding occurred less frequently at the time of
argon laser pretreated Nd:YA6 laser iridotornies than primary Nd:YAG
laser iridotomies. However the difference was not statistically
significant, and iris bleeding produced no demonstrable adverse effects
when it did occur. Previous studies have produced conflicting results.
Zhorskwi found no iris bleeding in 16 eyes treated with argon laser
immediately prior to Nd:YAG laser iridotomy 221. However Robin and
Pollack reported iris bleeding following Nd:YA6 laser iridotomy at failed
argon laser iridotomy sites in 11 of 33 eyes 219, and Drake reported one
case of profuse iris bleeding when a Nd:YAG laser iridotomy was
performed immediately following argon laser pretreatment 224.
Our study has failed to demonstrate any beneficial effect of argon
laser pretreatrnent 4-6 weeks prior to Nd:YAG laser iridotomy. Argon
laser pretreatment resulted in a significant increase in the total amount
of Nd:YAG laser energy required to produce an iridotomy. Considerable
pigment dispersion occurred at the time of argon laser pretreated Nd:YAG
laser iridotomy. Argon laser pretreatment had no effect on visual acuity
or glaucoma outcome, after a mean follow up period of 9.4 months.
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CHAPTER 9
Nd:VAG LASER !R!DOTOMV !N CHINESE PATIENTS:
A COMPARISON OF Nd:YAG AND ARGON LASER IRIDOTOMV IN
CAUCASIAN AND CHINESE EYES
9.1 SUMMARY
A retrospective assessment of clinical experience with argon
laser iridotomy arid Nd:YAG laser iridotomy in Singapore and in Edinburgh
was performed.
The case records of:
16 Chinese patients treated by argon laser iridotomy
11 Caucasian patients treated by argon laser iridotomy
15 Chinese patients treated by Nd:YAG laser iridotomy
14 Caucasian patients treated by Nd:YAG laser iridotomy
were reviewed.
Argon laser iridotomy appeared to be more satisfactory in Chinese
patients than in Caucasian patients. Conversely Nd:YAG laser iridotomy
appeared to be more satisfactory in Caucasian patients than in Chinese
patients. Quantification of the laser energy used in these treatments was
riot, possible due to differences in iridotomy technique in Singapore and
in Edinburgh. However qualitative differences in tissue responses to
argon and O-switched Nd:YAG laser energy which appeared to be
dependent on racial differences in iris structure were observed. Further-
controlled studies of iridotomy techniques in Chinese patients are
warranted.
9.2 INTRODUCTION
Light energy has been used to produce iridotomies in two ways -
thermal damage due to tissue absorption of light energy, and mechanical
disruption due to the rapid expansion of plasmas produced by very short
duration laser pulses 35,36,140,147,148 Thermal destruction has been
produced using xenon arc light 26, ruby laser27'28'185, argon laser 1, dye
laser 15'34'218, krypton laser 225 and free running Nd:YA6 laser energy
189,191 Thermal absorption is dependent on tissue pigmentation35'36.
Laser energy within the visible spectrum, such as argon blue-green, is
absorbed by melanin. The more heavily pigmented a tissue, the greater
the energy uptake. Irises in pigmented races may therefore be expected
to absorb laser energy readily, whereas lightly pigmented irises in
Caucasians may absorb laser energy less well. Several workers have
commented that lightly pigmented irises are particularly difficult to
treat using the argon laser 12,23,30,105,121,141-144
Very short duration laser pulses focussed over a small area
produce a very high irradiation, resulting in the stripping of electrons
from atoms and "plasma" formation. Rapid expansion of the plasma
results in a mechanical shock wave, producing mechanical disruption of
adjacent tissue35'36'140'147'148. Photodisruption has been produced using
the Q-switched ruby laser37'188, and Nd.YAG laser2. Photodisruption is
independent of tissue absorption and therefore of tissue
pigmentation 35'36 The effects of photodisruptive energy are dependent
on the mechanical properties of the tissue being treated rather than its
colour The relatively delicate irises found of Caucasians may be readily
penetrated using photodisruption 10,11,13,22,23,224 However clinical
experience in Singapore has indicated that the thicker, tougher irises of
Chinese patients may be more difficult to penetrate using
photodisruptive laser energy.
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in order to evaluate the relative merits of thermal iridotomy and
photodisruptive iridotomy in Chinese and Caucasian eyes a retrospective
assessment of clinical experience with argon laser iridotomy and 0-
switched Nd:YAG laser iridotomy in Singapore and in Edinburgh was
performed.
9.3 MATERIALS AND METHODS
In November 1987 the case records of the 56 patients most
recently treated by Nd:YAG laser iridotomy or argon laser iridotomy in
Edinburgh arid in Singapore were reviewed. A relatively small number of
cases was available as a Nd:YAG laser had only recently been purchased
in Edinburgh and in Singapore. In addition few cases of argon laser
iridotomy had been performed in Edinburgh, iridotomies performed in
eyes with acute angle closure glaucoma were excluded. In patients who
had had bilateral iridotomies only one eye., chosen by tossing a coin, was
used for statistical analysis.
The following information was obtained from the records of each
patient :
Patient data : race, age, sex, diagnosis arid indication for
iridotomy, iris colour.
Treatment parameters : type of laser used, power setting, spot
size, pulse duration, number of pulses used, qualitative assessment of
iris tissue reaction to laser energy.
Treatment result: production of a patent iridotomy at the first or
subsequent treatment sessions, and the occurrence or absence of late
iridotorny closure.
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9.3.1 ARGON LASER TREATMENT
All argon laser treatments were performed using a Coherent 900
blue-green argon laser, and Abraham 66 dioptre iridotomy contact lens. A
series of burns were used to "chip" through the iris until penetration was
achieved. Further enlarging burns were applied as necessary until an
iridotomy of 200 - 300p. diameter was obtained.
All treatments in Singapore were performed by one surgeon
(ASML). A "short" duration (0.05 or 0.1 second), small diameter (50.u)
burn technique was used. One iridotomy was produced in each eye.
Argon laser iridotomies were performed by a variety of operators
in Edinburgh. A "long" duration (> 0.1 second), large diameter (50-200u)
burn technique was used. Two iridotomies were produced in each eye, in
order to reduce the risk of acute angle closure glaucoma if one iridotomy
reclosed.
The total energy, in Joules, used in a treatment was calculated by
multiplying the power setting, in watts, for each pulse by the time
duration, in seconds, of that pulse, and summing these values. When
more than one spot size or time duration were used in a treatment, the
most frequently used spot size arid time duration were recorded.
The argon laser in Edinburgh was calibrated and found to be 84%
efficient at the 1 watt setting. It was not possible to arrange calibration
of the argon laser used in Singapore.
9.3.2 Nd:¥AG LASER TREATMENT
A Zeiss Visulas Nd:VAG laser and Zeiss anterior segment contact
lens were used to treat patients in Edinburgh. A Coherent 7970 Nd:VAG
laser and Abraham Nd:YAG iridotomy contact lens were used to treat
patients in Singapore. Both laser systems produced a pulse duration of 7
nanoseconds, and a spot diameter of 30pirn. All treatments in Singapore
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were performed by one surgeon (ASML), and all treatments in Edinburgh
were performed by one surgeon (BWF). The lasers were self calibrating
and had recently undergone factory testing.
Single 5 -7 rnJ pulses were delivered to the treatment site until
penetration was achieved. An iris crypt was used where available.
Further pulses were used to enlarge the iridotomy to 200 - 30Op.
diameter when necessary. One iridotomy was produced in each eye. The
total energy used in treatment was obtained by summing the energy value
of each pulse.
9.4 RESULTS
The number of patients in each group and the age and sex
distribution are given in Table 9.1. The groups were similar in
composition.



















Argon and Nd:YAG laser iridotomy in Chinese and
Caucasian eyes: Patient groups
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Argon laser Nd:YA6 Laser
Chinese Caucasian Chinese Caucasian
Number patients 16 II 15 14
Fellow eye
or narrow angle 13 5 4 14
Chronic AC6 5 8 0 0
Other 0 1 3 0
TABLE 9.2
Argon and Nd:¥AG laser iridotomy in Chinese and Caucasian
eyes: Indications for laser iridotomy in each group.
"Other" refers to patients with iris bornbe due to extensive posterior
synechias formation.
All Nd:YAG laser iridotornies performed in Caucasians were in the
fellow eye of acute angle closure glaucoma patients.
The distribution of iris colour for each group is shown in Table 9.
Argon laser Nd:YA6 laser
Chinese Caucasian Chinese Caucasian
Number patients 16 11 15 14
Dark brown 16 0 15 0
Light brown 0 5 0 5
Grey 0 6 0 9
TABLE 9.3
Argon and Nd:YAG laser iridotomy in Chinese and
Caucasian eyes : iris colour
Chinese irises are heavily pigmented, and are thicker than
Caucasian irises.
9.4.1 ARGON LASER 1R1DGTOMV TREATMENT RESULTS.
The argon laser treatment parameters used are shown in Table 9.4.
Chinese Caucasian
Number patients 16 1 1
Spot size < 50u 16(100%) 6 (55%)
Burn duration < 0.05s 1 1 (69%) 0
>0.1 s 5 (31 %) 11(100%)
More than one site attempted o 8 (73%)
Mean max power used, watts 1.3+ 0.2 1.5+0.9
TABLE 9.4
Argon laser iridotomy in Chinese and Caucasian eyes:
treatment parameters
A smaller spot size and shorter duration burn technique was used
in Chinese eyes. In 8 of the 11 Caucasian eyes treated, more than one
treatment site was used. The unit's policy during this period was to
perform 2 argon laser iridotomies in each eye, as the reported incidence
of argon laser iridotomy reclosure was high 22A-,3°
The failure rate for producing a patent iridotomy at the first and





patency at 1st session 3(19%)
Failure to produce
patency at subsequent sessions 2 (12.5:1)
Reclosure 0
TABLE 9.5
Argon laser iridotomy in Chinese and Caucasian eyes :







Among Caucasians patency was obtained at the first treatment
session in only 6 of 11 eyes, compared to 13 of 15 Chinese eyes. In
Caucasians long duration, large diameter burns resulted in superficial
iris damage. Laser absorption was probably reduced due to light iris
pigmentation. Iris penetration was difficult to achieve in these
circumstances.
In Chinese eyes each short duration, small diameter burn produced
a well defined "punched out" area of iris damage. Repeated burns easily
penetrated the iris, and subsequent burns were then used to enlarge the
iris opening. Significant iris charring did not occur in any eye. Pigment
dispersion occurred at the moment of full thickness iris penetration, but
was otherwise minimal.
There were no cases of iridotorny reclosure during the follow up
period of the study.
The number of laser pulses and total laser energy used in the
treatment of each group are shown in Table 9.6.
Chinese Caucasian
Number pulses 64.6±45.3 178.5± 174.2
(range) (11-160) (5-540)
Total energy, Joules 5.4+4.5 55.7±88.3
(Range) (1.65-18.9) (3.1-272.2)
TABLE 9.6
Argon laser iridotomy in Chinese and Caucasian eyes:
Number of laser pulses and total energy used
The number of argon laser pulses used in treatment was fewer in
Chinese eyes than in Caucasian eyes (unpaired Student t test p<0.02). The
total argon laser energy used in treatment was less in Chinese eyes than
in Caucasian eyes (unpaired Student t test p<0.05). However different
techniques were used in the two groups. Two iridotornies were performed
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in 9 of the 1 1 Caucasian patients, increasing the total laser energy used.
The long duration, large diameter burns used in Caucasians were probably
less efficient in penetrating the iris than the short duration small
diameter burns used in Chinese patients. Quantitative comparison of
argon laser iridotomy in Chinese and Caucasian patients was therefore
not valid.
9.4.2 Nd:YAG LASER IRIDOTOMY TREATMENT RESULTS
The treatment parameters used for Nd:YAG laser iridotorny were
identical in Chinese arid Caucasian eyes : 3Op spot diameter, 7 ns pulse
duration, 5 -7 rnJ energy per pulse. Only one site was treated in each eye.
The failure rate for producing a patent iridotomy at the first and
at subsequent treatment sessions, arid the reclosure rate, are shown in
Table 9.7.
Chinese Caucasian
Number patients 15 14
Failure to produce
patency at 1st session 2(133>) 0
Failure to subsequently
produce patency - 0
Reclosure 0 0
TABLE 9.7
Nd:YAG laser indotomy in Chinese and Caucasian eyes:
patency and reclosure rates
Among Caucasians patency was obtained at. the first treatment
session in every eye. The iris was readily penetrated, especially if
treatment was applied in an iris crypt. The iris tissue appeared to be
very delicate, arid was easily "cut" by Nd:YAG laser pulses. In contrast
patency was not obtained at the initial treatment session in two Chinese
eyes, and these were subsequently treated using the argon laser. Chinese
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irises were difficult to penetrate. The stroma was thick and heavily
pigmented. Initial laser pulses caused profuse pigment dispersion from
the stroma which impaired subsequent visualisation of the iris, and may
have interfered with the delivery of laser energy to the iris plane. While
the Chinese cases included in this study were treated by ASML, the
subsequent clinical experience of 6WF in treating Chinese patients has
been similar.
There were no cases of iridotomy reclosure during the follow up
period of the study.
The number of laser pulses and total laser energy used in the
treatment of each group are shown in Table 9.8.
Chinese Caucasian
Number pulses i5.4±28.7 3.4+2.4
(range) (1-104) (1 -9)
Total energy, Joules 0.0588+0.0537 0.0293±0.0219
(Range) 0.015-0.196 0.0049-0.0729
TABLE 9.8
Nd:¥A6 laser iridotomy in Chinese and Caucasian eyes:
Number of laser pulses and total energy used
The number of Nd:YAG laser pulses used in treatment was not
significantly different in Chinese and Caucasian eyes. The total Nd:YAG
laser energy used in treatment was greater in Chinese eyes than in
Caucasian eyes, but the difference was not statistically significant
(unpaired Student t test p=0.069).
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9.5 DISCUSSION
Several reports describe special difficulties in performing argon
laser iridotomies in blue irises I2,23ji05,12t,i32,i4i-i44,2i3_ Variations in
technique have been suggested to overcome these difficulties, such as
the use of a thermally induced bubble on the surface of the iris to focus
laser energy 141, the use of green filtered argon laser light143, and the
use of an initial "contraction" burn 142
Our study suggests that argon laser iridotorny may be more
difficult to perform in Caucasian eyes than Chinese eyes, although
variation in iridotorny technique made quantitative analysis unreliable.
Laser treatment parameters have been found to be critical when
performing argon laser iridotomies in heavily pigmented irises. Initial
experience using relatively long duration (0.1 seconds) laser burns
seemed to indicate that these irises were particularly difficult to treat
213 However several workers then found that high power, short duration
(0.02-0.05 seconds) laser burns easily penetrated heavily pigmented
irises 12,105,112,132,226 jn Singapore the transition from a "long burn" to a
"short burn" technique led to a marked reduction in the total laser energy
needed in treatment 227
0 switched Nd:VA6 laser iridotorny is independent of iris
pigmentation, but is dependent on the mechanical properties of the iris.
Nd:YAG laser iridotomies have been found to be more easily produced in
lightly pigmented irises than in heavily pigmented irises 11 ■224 Reported
Nd:YAG laser energy levels used in Saudi Arabia 137, Israel 14, Alaska 111
and China 228 have in general been higher than those used in North
America 10'11 >22>2Z.
We observed that Nd.YAG laser iridotorny appeared to be more
difficult to perform in Chinese eyes than in Caucasian eyes, although no
statistically significant difference in the mean total laser energy used
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in treatment was found. While potency was easily achieved at the first
treatment session in every Caucasian, patency was not achieved in two
Chinese patients.
Racial differences in the structure of the iris are significant, and
the findings of studies carried out in one race do not necessarily apply to
other races. The iris in Chinese eyes is more heavily pigmented and
thicker than in Caucasian eyes, and appears to be more difficult to cut
using the Q-switched Nd:YAG laser. While comparative studies of
Q-switched Nd:VA6 laser iridotomy and argon laser iridotomy in
Caucasians have favoured Nd:YAG laser iridotomy iQ.d 3,22,23^ controlled




What is the place of Nd:YAG laser iridotomy in the management
of angle closure glaucoma? Does Nd:YAG laser iridotomy compare
favourably with operative peripheral iridectomy., a well established,
safe and effective form of treatment 25•■43'44'86 ?
10.1 IS Nd:YAG LASER IRIDOTOMY AS EFFECTIVE AS
OPERATIVE PERIPHERAL IRIDECTOMY ?
10.1.1 ACUTE ANGLE CLOSURE GLAUCOMA
We have observed two patients who developed a recurrence of
acute angle closure glaucoma despite the presence of a small patent
iridotomy. Subsequent trabeculectomy or peripheral iridectomy
prevented further attacks. Similar cases have been reported previously
15,80,106 jn every case the diameter of the iridotomy has been less
than 150j_i. Theoretically an iridotomy of diameter 15u ought to
prevent iris bornbe 21 -'214. However dilating the pupil may reduce the
area of an iridotomy by a factor of 5 (see page 143). in clinical
practice a diameter of 150-200u has been found to be necessary to
prevent acute angle closure glaucoma 21. Provocation tests have not
proved to be helpful in detecting eyes at risk of acute angle closure
glaucoma following iridotomy 15'21 '30.
In a non-randomised study of Nd:YAG laser iridotomy for acute
angle closure glaucoma we found 89:1 of eyes remained normotensive
without medication on follow up. However, selection of cases was
biased towards milder forms of glaucoma. Gray has reported that 508
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of eyes remained normotensive without medication following Nd:YA6
laser iridotomy for acute angle closure glaucoma a0. Previous studies
have shown that approximately 70:1 of eyes remain normotensive
without medication following peripheral iridectomy for acute angle
closure glaucoma 25,43,46.86,87 y,/e are currently performing a
prospective randomised comparison of Nd:YAG laser iridotomy arid
operative peripheral iridectomy in a consecutive series of 250 cases
presenting with acute angle closure glaucoma.
10.1.2 FELLOW EVES
Operative peripheral iridectomy is a very effective means of
preventing acute angle closure glaucoma in fellow eyes 25,42,46,86,87
We have observed acute angle closure glaucoma in a fellow eye despite
the presence of a small patent Nd:YAG laser iridotomy 21. To our
knowledge acute angle closure glaucoma in a fellow eye with a patent
Nd:YA6 laser iridotomy has not been described previously. Following
enlargement of the iridotomy a pilocarpine/phenylephrine provocation
test and a cyclopentolate ]% provocation test were negative, and the
eye has remained normotensive during a follow up period of 8 months.
Again, it would appear that ari iridotomy must have a diameter of at
least 150-200pi in order to prevent iris bornbe and subsequent acute
angle closure glaucoma.
In a randomised prospective comparison of Nd:YAG laser
iridotomy and operative peripheral iridectomy in the fellow eyes of 52
patients we found no difference in intraocular pressure control
between the two groups after a mean follow up period of 11.8 months.
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to. 1.3 CHRONIC ANGLE CLOSURE GLAUCOMA
Is Nd:YAG laser iridotorny as effective as operative peripheral
iridectomy in the treatment of chronic angle closure glaucoma? We
found that 83$ of eyes with chronic angle closure glaucoma had
normal intraocular pressure, with topical medication if necessary,
following Nd.YAG laser iridotomy. This compared with figures of
76-100$ reported following operative peripheral iridectomy
49,52,89,95 63-92$ foil owing argon laser iridotorny 33-'95-'139 and 90$
following Nd:YAG laser iridotomy 537 (see Table 1.14). We found that
improved intraocular pressure control and gonioscopic widening of the
angle failed to occur in two eyes with a very small iridotomy. Our
observations confirm those of Wishart, who found that repeat
iridotomy resulted in a widening of the angle in four eyes with a small
iridotomy 15
Nd:YAG laser iridotorny appears to be as effective as operative
peripheral iridectomy in the treatment of chronic angle closure
g 1 aucorna, provided the iridotorny is at least 150-200p. in diarneter.
However the number of patients in our study was small and a
controlled comparison of Nd.VAG laser iridotorny and operative
peripheral iridectomy has not been undertaken.
10.2 is Nd.VAG LASER IRIDOTOMY AS SAFE AS
OPERATIVE PERIPHERAL IRIDECTOMY?
10.2 1 LONG TERM VISUAL ACUITY OUTCOME
We found that 4/26 (15$) of fellow eyes treated with Nd:YAG
laser iridotomy lost two or more lines of visual acuity due to cataract
development during a mean follow up period of 11.8 months, compared
to 0/26 (0$) of eyes treated by operative peripheral iridectomy. These
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findings suggest that Nd:YA6 laser iridotomy does not result in a lower
incidence of visual acuity loss due to cataract development than
operative peripheral iridectomy. Previous studies have reported a
3-10% incidence of visual acuity loss due to cataract development
following Nd:YAG laser iridotomy in fellow eyes 11 ■137J compared to a
1-33% incidence following peripheral iridectomy (see Table 1.11).
Acute angle closure glaucoma eyes developed cataract more
frequently than fellow eyes. We found 1/19 (5%) of eyes treated by
Nd:YAG laser iridotomy, 3/15 (20%) of eyes treated by operative
peripheral iridectomy, and 6/20 (30%) of eyes treated by
trabeculectomy lost two or more lines of visual acuity due to cataract
development or progression. The number of patients in our study was
too small to reliably assess whether Nd:YAG laser iridotomy results in
a lower incidence of cataract development than operative peripheral
iridectomy. A larger randomised comparison of Nd:YAG laser iridotomy
arid operative peripheral iridectomy in the treatment of acute angle
closure glaucoma is now in progress. Our finding of a high rate of
cataract development following drainage surgery confirm the results
of previous studies 45 (see Table 1.10).
10.2.2 OPERATIVE AND EARLY POSTOPERATIVE
COMPLICATIONS
10.2.2.1 CORNEA
Corneal endothelium damage following Md:VAG laser iridotomy is
thought to he caused by high velocity particles projected from the
treatment site by plasma rapid expansion 7 Our findings support this
hypothesis. In 42% of fellow eyes treated by Nd:YAG laser iridotomy
focal granularity of the corneal endothelium was evident by slit lamp
examination 24 hours following treatment. In a further 151 of eyes
these changes were more pronounced, and accompanied by overlying
corneal oedema. The mean total laser energy used in treatment was
higher in patients who developed corneal changes (30.95+21.6 rnJ),
compared to those who did not (16.2+19.7 rnJ), although the difference
was not statistically significant.
We did not find a significant decrease in central corneal
endothelial cell density following Nd:YAG laser iridotorny or operative
peripheral iridectomy. Other studies have also failed to demonstrate
central corneal endothelial cell density reduction following Nd:YAG
laser iridotomy 8,io,iis c,r operative peripheral iridectomy 8,82,197 |n
contrast one study found a small, but significant, decrease in central
corneal endothelial cell density following argon laser iridotomy 10.
While bullous keratopathy has been reported following argon
laser iridotomy 24, this has not occurred following Nd:YAG laser
iridotomy. Focal corneal endothelium changes following Nd:YAG laser
iridotorny do not appear to be of long term significance.
10.2.2.2 HYPHAEMA
'We found 581 of fellow eyes developed slight iris bleeding
during Nd:YAG laser iridotomy, compared to 271 of eyes during
operative peripheral iridectomy CX2 test with Yate's correction
p<0.05). Other workers have reported an incidence of 15-901 iris
bleeding following Nd:YAG laser iridotomy (see Table 1.5) Iris bleeding
was transitory and produced no detectable adverse effects.
10.2.2.3 EARLY POST TREATMENT iNTRAOCULAR
PRESSURE ELEVATION
A transient elevation of intraocular pressure occur red in fellow
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eyes during the first three hours after treatment in 21% of cases
treated by NdYAG laser iridotorny and 8$ of cases treated by operative
peripheral iridectomy. The mean intraocular pressure of the laser-
treated group was significantly higher than that of the surgical group
one hour and three hours following treatment. Early post treatment
intraocular pressure elevation has been reported in 20-40$ of eyes
following argon laser iridotomy or Nd:YAG laser iridotomy (see Table
1.6)
It has been postulated that raised aqueous prostaglandin levels
following iridotomy may mediate raised intraocular pressure 176
However, indornethacin does not prevent post iridotomy intraocular
pressure elevation in rabbits 177 It is more likely that particulate
debris and plasma proteins released at the time of iridotomy result in
transient mechanical blockage of trabecular rneshwork outflow !77'17S.
The absence of intraocular pressure elevation following operative
peripheral iridectomy may be due to the relative absence of
particulate debris in the aqueous following the procedure, iris tissue
is physically removed from the eye during operative peripheral
iridectomy, but not during Nd.YAG laser iridotomy.
Our findings, and those of others (see Table 1.6) indicate that
raised intraocular pressure commonly occurs following Nd:YAG laser
iridotomy unless preventive treatment is given. Pretreatment with
pilocarpine 5", timolol 200, or apraclonidine 201 lowers the incidence
of post laser intraocular pressure elevation.
10.2.2.4 FOCAL LENS OPACITIES
While focal lens opacities have been reported following Nd.YAG
laser iridotomy i4-i?,io?,i22^ these opacities have not progressed, and
have not resulted in reduced visual acuity.
202
We have observed nuclear cataract development with loss of
visual acuity in two eyes with focal lens opacities at the Nd:YAG laser
iridotorny site. The first was a fellow eye in which visual acuity fell
from 6/9 to 6/12 due to nuclear cataract development. The second was
an eye treated by Nd.YAG laser iridotorny following a diagnosis of
"narrow angle glaucoma". The treatment site was placed too close to
the pupil and a focal lens opacity developed. Visual acuity fell from
6/9 to perception of light during a 10 month follow up period, due to
the development of a very dense nuclear cataract. It is likely that
cataract development in this case was caused by the Nd:YAG laser
i ri dotorny procedure.
We also found focal "lens opacities at operative peripheral
iridectomy sites. However these opacities did not progress and did not
result in reduced visual acuity.
10.2.2.5 IRITIS
We found iritis in 42$ of fellow eyes following operative
peripheral iridectomy, and 23$ of fellow eyes following Nd:YAG laser
iridotorny (X2 test with Yate's correction, no significant difference,
(see Table 4.3, page 81). Other workers have reported a 3-12$
incidence of iritis following Nd:YAG laser iridotomy, and a 7$
incidence following operative peripheral iridectomy (see Table 1.8).
Definitions of significant iritis vary. While iritis tends to be of mild
severity following Nd:YAG laser iridotorny and operative peripheral
iridectomy, and of little significance per se, its presence may
contribute to posterior synechiae development.
10.2.2.6 POSTERIOR SVNECHiAE
We found posterior synechiae in 3/26 (12$) of fellow eyes
following either Nd.YAG loser iridotomy or operative peripheral
iridectomy (see page 87,88). The prevalence of posterior synechiae
was higher among acute angle closure glaucoma eyes: 42% of eyes
treated by Nd:YAG laser iridotomy, 27% of eyes treated by operative
peripheral iridectomy, and 40% of eyes treated by trabeculectomy (see
page 116).
Previous studies have reported a similar prevalence of posterior
synechias following peripheral iridectomy for acute angle closure
glaucoma 87'119, and have also found a higher prevalence of posterior
synechias among acute angle closure glaucoma eyes than fellow eyes
57 We found a higher prevalence of posterior synechiae following
Nd:YAG laser iridotomy than has been reported previously 23. However,
in our study pupil dilation was carried out in order to detect posterior
synechiae. Previous studies in which this was not done may have
under-reported the true prevalence of posterior synechiae 23
10.3 WHAT IS THE OPTIMAL METHOD OF PRODUCING A
Nd:YAG LASER IRIDOTOMY ?
We have found that argon laser pre treatment of the iris stroma
does not facilitate Nd:YAG laser iridotomy (see chapter 8).
Significantly more Nd:YA6 laser energy was needed to produce an
iridotomy in an argon laser pre treated site than in a previously
untreated iris (see Table 8.2). Pigment dispersion from the pigment
epithelium layer of the iris was more marked following Nd:YAG laser
iridotomy in an argon laser pre treated site, than following primary
Nd:YAG laser iridotomy (see page 177).
We have found that an iridotomy must be at least 150-200.U in
diameter in order to reliably prevent the development of acute angle
closure glaucoma (see chapter 6).
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The production of larger iridotomies requires more laser energy
than the production of small iridotomies. We have found that high laser-
energy levels are more likely to produce focal corneal endothelium
damage than low levels in both acute angle closure glaucoma eyes (see
page 110), arid fellow eyes (see page 86). Our initial experience with
the "linear incision" technique devised by Wise using a 103 dioptre
contact lens 12 indicates that multiple low energy laser pulses may
cause less endothelial damage than a small number of higher energy
pulses. The production of an iridotorny of defined size is also more
readily achieved using the "linear incision" technique. ,4 randomised
comparison of this treatment with operative peripheral iridectomy is
currently in progress.
Without preventive treatment approximately 30;T of fellow eyes
develop transient intraocular pressure elevation following Nd:YAG
laser iridotomy (see page 85). Pretreatmerit with acetazolamide (see
page 93), Pilocarpine 199, Timolol 20°, or apraclonidine201, greatly
reduces the incidence of this complication.
We found the incidence of iritis arid posterior synechiae was
similar following Nd:YAG laser iridotomy and operative peripheral
iridectomy in fellow eyes (see Tables 4.3 and 4.4). Topical steroid
treatment should therefore be used following Nd:YAG laser iridotorny.
A mydriatic may be used providing an iridotomy of adequate size has
been produced. 6. Phenylephrine 101 has been found to carry minimal
risk of provoking acute angle closure glaucoma when used following
operative peripheral iridectomy 19S, and might therefore be
appropriate following Nd:VAG laser iridotomy.
Racial differences in the structure of the iris influence the ease
with which Nd:VAG laser iridotorny may be performed. We found that
higher mean energy levels were used to produce Nd:YAG laser
iridotornies in Chinese eyes than in Caucasian eyes, although the
difference was not statistically significant (see Table 9.6). While
Nd:YA6 laser iridotomy has been shown to be more satisfactory than
argon laser iridotomy in Caucasians 10,is,22,23^ this may not be the
case in other races.
Nd:YAG laser iridotomy technique continues to improve. Our
studies suggest that Nd:YAG laser iridotomy is as safe as operative
peripheral iridectomy, and as effective provided a large enough iris
opening is produced. However, Nd:YAG laser iridotomy has not been
demonstrated to be safer than operative peripheral iridectomy and
must be regarded as an invasive technique 6, only undertaken when a
well defined benefit from treatment may be anticipated.
PROJECTS CURRENTLY IN PROGRESS
The following related projects are currently in progress.
1. A randomised prospective comparison of Nd:YAG laser
iridotomy and operative peripheral iridectomy in the treatment of
acute angle closure glaucoma.
A randomised prospective study comparing the long term visual
acuity and glaucoma outcome of Nd:YAG laser iridotomy and operative
peripheral iridectomy in acute angle closure glaucoma and fellow eyes
began in July 1989. "Linear incision" low energy laser treatment is
being used, with a Wise 103 dioptre contact lens. To date, 93 patients
have been entered into the study. We plan to recruit a total of 200
patients and follow them for 5 years. We anticipate that this study
will further define the long term visual acuity and glaucoma outcome
following Nd:VAG laser iridotomy.
2. Corneal thickness and endothelial cell density
A study is in progress in which a group of 20 patients
presenting with acute angle closure glaucoma have hourly intraocular
pressure and corneal thickness measurements made during the period
of initial medical control of the acute attack . Frequent measurements
continue until the rate of change of corneal thickness has become low,
and then 12 hourly, followed by daily readings are obtained.
We plan to enrol 20 patients into the study, and correlate the
rate of resolution of corneal oedema with factors such as the duration
of the acute attack of angle closure glaucoma, patient age arid central
endothelial cell density.
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DEVELOPMENTS IN THE LITERATURE
Several groups of workers are studying Nd:YA6 laser iridotorny
techniques and three recently published papers are of special interest
in the context of our research.
Panek et al. have studied changes in the endothelial cell density
of both the central cornea and the cornea overlying the Nd:YAG laser
iridotomy treatment site of 18 patients 230. While there was no
significant change in central endothelial cell density, a small, but
significant decrease (3.81 decrease, p=0.04) of endothelial cell
density overlying the iridotorny site was found 1-8 weeks after
t re a t rnent. Th e se f i nd i ngs a re cons i s t e ri t w i t h o u r own s t ud i e s (Table
4.5} and those of other workers S40,H5 |S|d;VAG laser iridotomy may
result in some focal corneal endothelial cell damage overlying the
treatment site, but does not cause a significant decrease in central
corneal endothelial cell density.
Prum et al. have made videographic studies of argon and Nd:VAG
laser iridotomy techniques in cadaver eyes 231. Argon laser burns-
caused mounding up of the iris pigment layer prior to iris penetration,
an effect which was not seen during Nd:YAG laser iridotomy 231. This
observation is consistent with the iris pigment epithelium effects we
have observed following argon laser pretreatment of the iris (see
Tables 8.4 and 8.5). Argon laser burns appear to loosen the adherence
of the iris pigment epithelium to the overlying iris stroma.
flcGalliard and Wishart have reported the results of Nd:YAG laser
iridotomy for chronic angle closure glaucoma in 73 eyes of 43 patients
232. 691 of eyes with peripheral anterior synechiae had reduced
intraocular pressure following iridotomy. There was no reduction of
intraocular pressure in eyes without peripheral anterior synechiae.
This study confirms our preliminary finding of a beneficial effect of
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Nd:VA6 laser iridotomy in some patients with chronic angle closure
glaucoma (see chapter 7).
Several components of our research work have been reported
recently. Background animal work in rabbits has confirmed that the
Q-switched Nd:YA6 laser produces only very localised effects on the
retina arid vitreous 233 Data contained in chapters four234, five 21,
six 235, and eight236 of this thesis has been published. A further paper
discussing the effect of pupil dilation on iridotomy area is in press.
209
REFERENCES
1. Abraham RK, Miller GL: Outpatient argon laser iridectomy for
angle closure glaucoma: a two year study.
Trans Arn Acad Ophthalmol Otolaryng 1975,79:529-538.
2. Frankhauser F, Roussel P, Steffen J, Van Der Zypheri E,
Chrenkova A: Clinical studies on the efficiency of high power
laser radiation upon some structures of the anterior segment of
the eye. First experience of the treatment of some pathological
conditions of the anterior segment of the human eye by means of a
Q-switched laser system.
!nt Ophthalmol 1981,3:129-139.
3. Chandler PA: Narrow Angle Glaucoma
A.M.A. Arch Ophthalmol 1952,47:695-716
4. Rivera AH, Brown RH, Anderson DR.
Laser Iridotomy vs Surgical Iridectomy - Have the indications
Changed?
Arch Ophthalmology 1985,103:1350-1354
5. Rich W.The economics of Nd-YAG laser treatment.
Dev Ophthalmol 1987,14: 93-96
6. Spaeth GL. Laser Treatment is Invasive Surgery
Ophthalmic Surgery 1988,19(7):463-464
7. Kerr-Muir MG, Sherrard ES.
Damage to the corneal endothelium during Nd/VAG photodisruption.
Brit J Ophthalmol 1985,69:77-85
8. Wishart PK, Sherrard ES, Nagasubramanian S, Kerr Muir MG,
Hitchings RA. Corneal endothelial changes following short pulsed
laser iridotomy and surgical iridectomy.
Trans Ophthalmol Soc UK 1986,105:541 -548
9. Canning CR, Capon MR, Sherrard ES, Kerr-Muir MG, Pearson R,
Cooling R:
Neodyrniurn: YAG laser iridotomies short-term comparison with
capsulotornies and long-term follow-up.
Graefes Arch Clin Exp Ophthalmol 1988,226:49-54
210
10. Robin AL, Pollack IP A comparison of neodyrniurn: YAG and
argon laser iridotornies.
Ophthalmology 1984,91:1011-1016
11. Schwartz LW, Moster MR., Spaeth GL, Wilson RP, Poryzees E.
Neodymium-YAG laser iridotornies associated with closed or
occludable angles.
Am J Ophthalmol 1986,102:41 -44
12. Wise JB. Low-energy linear-incision neodyrnium: YAG laser
iridotorny versus linear-incision argon laser iridotomy. A
prospective clinical investigation.
Ophthalmology 1987,94:1531 -1537
13. Del Priore LV, Robin AL, Pollack IP: Neodymium: YAG and argon
laser iridotomy. Long-term follow-up in a prospective, randomized
clinical trial.
Ophthal mol ogy 1988,95:1207-1211.
14. Naveh N, Zborwski-Gutrnan L, Blurnerithal M. Neodymium-YAG
laser iridotomy in angle closure glaucoma: preliminary study.
Brit J Ophthalmol 1987,71:257-261,
15. Wishart PK, Hi tellings RA. Neodyrniurn YAG and dye laser
iridotorny-a comparative study.
Trans Ophthalmol Soc UK 1986,105:521 -540
16. Montgomery DM!, Dutton GN. Correspondence: Intralenticular
haemorrhage complicating pulsed laser iridotomy.
Brit J Ophthalmol 1987,71:484
17. Berger CM, Lee DA , Christensen RE: Anterior lens capsule
perforation and zonular rupture after Nd.YAG laser iridotomy
Am J Ophthalmol 1989,107:674-675
18. Curran EJ: A New Operation for Glaucoma Involving A New
Principle In The Aetiology And Treatment of Chronic Primary
Glaucoma.
Archives Ophthalmol 1920,49:131-155
19. Curran EJ: Peripheral Iridotomy in Acute Arid Chronic Glaucoma:
some results after 10 years duration. Anatomical classification of
glaucoma.
Transactions Ophthalmol Soc UK 1931,51:520-538
211
20. Sifford H: Peripheral Iridotorny (Curran) in The Treatment Of
Glaucoma.
Am J Ophthalmol 1921,4:889-894
21. Fleck BW, Fairley E, McGlynn C : A prospective comparison of
Nd:¥AG laser iridotorny and surgical peripheral iridectomy in the
treatment of acute closed-angle. In Khoo CV et al eds. Proceedings
of the XXVI internation Congress of Ophthalmology, Amsterdam:
Elsevier Science Publishers B.V.I991:852-858.
22. McAllister JA, Schwartz LW, Moster M, Spaeth GL: Laser-
peripheral iridectomy comparing Q-switched neodyrniurn VAG with
argon.
Traris Ophthalmol Soc UK 1985,104: 67-69
23. Moster MR, Schwartz LW, Spaeth GL, Wilson RP,
McAllister JA, Poryzees EM. Laser iridectomy. A controlled study
comparing argon and neodymiumWAG.
Ophthalmology 1986,93:20-24
24. Schwartz AL, Martin NF, Weber PA.
Corneal Decompensation after Argon Laser Iridectomy.
Arch Ophthalmol. 1988,106:1572-1574.
25.Playfair TJ, Watson PG. Management of Acute Primary
Angle-Closure Glaucoma : A long term follow-up of the results of
peripheral iridectomy used as an initial procedure.
Brit J Ophthalmol 1979,63:17-22
26. Meyer-Schwickerath C Erfahrungen rnit der Lichtkoagulation
der Netzhaut und der Iris
Doc Ophthalmol 1956,10:119-131
27. Zweng HC, Flocks M, Kapney MS et al.
Experimental laser photocoagulation.
A rn J 0ph t ha 1 rn o1. 1964,58:353-362.
28. Perkins ES. Laser iridotomy for secondary glaucoma.
Trans Ophthalmol Soc UK 1971,91:777-780.
29. Abraham RK, Munnerly C: Laser iridotomy- improved
methodology with a new iridotomy lens.
Ophthalmology 1979,86(Suppl): 126.
212
30. Podos SM, Kels BD, Pitch R et ol.
Continuous wave argon laser iridectomy in angle-closure
glaucoma.
Am J Ophthalmol. 1979,88: 836-842.
31. Pollack IP, Patz A. Argon laser iridotomy: an experimental and
clinical study.
Ophthalmic Surg 1976,7(0:22-30.
32. Schwartz LW, Rodrigues MM, Spaeth 6L et al. Argon laser
iridotomy in the treatment of patients with primary angle-closure
glaucoma or pupillary block glaucoma: A clinicopathologic study.
Ophthalmology 1978,85:294-309.
33. Quigley HA. Long term follow up of laser iridotomy.
Ophthalmology 1981,88:218-224.
34. Bass MS, Geary CV, Perkins ES, Wheeler CB. Single treatment
laser iridotomy
Brit J Ophthalmol 1979,63:29-30
35. Marshall J Lasers in ophthalmology: The basic principles.
Eye 1988,2:S98-S1 12
36. Peyrnan OA, Raichand M, Zeirner RC.
Ocular effects of various laser wavelengths.
Survey of Ophthalmology 1984,28:391-404
37.Krasnov MM: Q-switched laser iridectomy ang Q-switched laser
goniopuncture.
Adv Ophthalmol 1977,34:192-196.
38.Von Graefe A. Uher die Iridectomie bei Glaucoma und Liber den
glaucomatosen Process.
Albrecht von Graefe Arch Ophthalmol 1857,3:456-555.
39. Barkari 0: Glaucoma : Classification, causes and surgical
control (Results of gonioscopic research). Am J Ophthalmol
1938,21:1099
40. Barkan 0 : Iridectomy in narrow angle glaucoma.
Am .J Ophthalmol 1954 ;504-519.
41. Pfluger E Operazioni moderne del glaucoma.
Arch d'ophtal. 1893-94,1:321.
42. Lowe RF: Acute Angle Closure Glaucoma The Second Eye: An
Analysis Of 200 Cases.
Brit J Qphthalrnol 1962,46:641 -650
43. Lowe RF: Primary Angle Closure Glaucoma - A Review 5 years
after bilateral surgery.
Brit J Ophthalmol 1973,57:457-463
44. Murphy MB, Spaeth GL. Iridectomy in primary angle-closure
glaucoma. Classification and differential diagnosis of glaucoma
associated with narrowness of the angle.
Arch Ophthalmol 1974,92:114-122.
45. Sugar HS. Cataract formation and refractive changes after
surgery for angle closure glaucoma.
Am J Ophthalmol 1970,69:747-749
46. Williams DJ, Gills JP Jr, Hall GA.
Results of 233 peripheral iridectomies for narrow-angle glaucoma.
Am J Ophthalmol. 1968,65: 548.
47. Foulds WS, Phillips CJ: Some observations on chronic
closed-angle glaucorna.
Brit .J Ophthalmol 1957,41:208-213
48. Lowe RF: Primary creeping angle-closure glaucoma.
Brit J Ophthalmol 1964,48:544-550
49. Playfair TJ, Watson PG. Management of chronic or intermittent
primary angle-closure glaucoma. A long term follow up of the
results of peripheral iridectomy used as an initial procedure.
Brit J Ophthalmol 1979,63:23.
50. Pollack IP Chronic angle-closure glaucoma. Diagnosis and
treatment in patients with angles that appear open.
Arch Ophthalmol 1971,85:676-689
51 Forbes M, Becker B. Iridectomy in advanced angle-closure
glaucoma.
Am J Ophthalmol. 1964,57:57.
214
52. Gelber EC, Anderson DR. Surgical decisions in chronic angle
closure glaucoma.
Arch Ophthalrnol. 1976,94:1461.
53. Phillips CI Closed-angle glaucoma: Significance of sectoral
variations in angle depth.
Brit J Ophthalmol 1956,40:136-143
54. Bhargava SK, Leighton DA, Philips CI: Early angle-closure
glaucoma. Distribution of iridotrabecular contact and response to
pilocarpine.
Arch Ophthalmol 1973,89:369-372
5-5. Mapstone R. One Gonioscopic Fallacy
Brit J Ophthalmol 1979,63:221 -224
56. Phillips CI. Sectoral Distribution of Goniosynechiae
Brit J Ophthalmol 1956,40:129-135
57. Lee DA, Brubaker RF, ilstrup DM. Anterior chamber dimensions
in patients with narrow angles and angle-closure glaucoma.
Arch Ophthalmology 1984,102:46-50
58. Jacobs IH, Krohn DL. Central anterior chamber depth after laser
iridectomy.
Am J Ophthalmol 1980,89: 865-867.
59. Lowe RF. Primary angle closure glaucoma: inheritance and
environment.
Brit J Ophthalmol 1972,56:13-20.
60. Fontana ST, Brubaker RF.
Volume and depth of the anterior chamber in the normal ageing eye.
Arch Ophthalmol 1980,98:1803-1808
61. Phillips CI: Aetiology of angle-closure glaucoma.
Brit J Ophthalmol 1972,56:248-254
62. Johnson SB, Coakes RL, Brubaker RF. A simple photograrnrnetric
method of measuring anterior chamber volume.
Am J Ophthalmol 1978,85:469-474
215
63. Markov,'Hz SN, Morin JD. The ratio of lens thickness to axial
length for biometric standardization in angle-closure glaucoma.
Am J Ophthalmol 1985,99:400-402
64. Mapstone R. Mechanics of pupil block.
Brit J Ophthalmol 1968,52:19-25
65. Mapstone R. Forces determining pupil size.
Exptl Eye Res 1970,10:47-52
66. Mapstone R. Closed angle glaucoma. Experimental results.
Brit J Ophthalmol 1974,58:41-45
67. Mapstone R. Precipitation of angle closure.
Brit J Ophthalmol 1974,58:46-54
68. Mapstone R. Provocative tests in closed-angle glaucoma.
Brit .J Ophthalmol 1976,60:115-119
69. Mapstone R. Normal response to pilocarpine and phenylephrine.
Brit. J Ophthalmol 1977,61:510-511
70. Mapstone R. Dilating dangerous pupils.
Brit J Ophthalmol 1977 ~61:517-524
71. Mapstone R. Outflow changes in positive provocative tests.
Brit J Ophthalrnol 1977,61:634-636
72. Mapstone R. The Fellow Eye.
Brit. .J Ophthalrnol 1981,65:410-413
73. Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. Brit
J Ophthalmol 1985,69:93-95
74. Mapstone R, Clark CV.
Diurnal variation in the dimensions of the anterior chamber.
Arch Ophthalmol 1985,103:1485-1487
75. Leighton DA, Phillips CI, Tsukahara S. Profile of presenting
states of eyes in angle closure glaucoma.
Brit J Ophthalmol 1971,55:577-584
216
76. Bigar F, Witmer R. Corneal endothelial changes in primary
acute angle-closure glaucoma.
Ophthalmology; 1982,89 ;596-599
77. Patel BCK, Tullo AB. Corneal sensation in acute-angle closure
glaucoma.
Acta Ophthalmologica 1988,66:44-46
78. Rutkowski PC, Thompson HS. Mydriasis and increased
intraocular pressure. Iris fluorescein studies.
Arch Ophthalmol 1972,87:25-29
79. Airaksinen PJ, Saari KM, Tiainen TJ, Jaanio ET. Management of
acute closed angle glaucoma with miotics and timolol.
Brit J Ophthalmol 1979,63:822-825.
80. Gray RH, Hoare Nairn J, Ayliffe WHR.
Efficacy of Nd-VAG Laser iridotomies in acute angle-closure
glaucoma.
Brit J Ophthalmol 1989,73:182-185
81. Setala K. Corneal endothelial cell density after an attack of
acute glaucoma.
Acta Ophthalmol 1979,57:1004.
82. Markowitz SN, Moriri JD. The endothelium in primary
angle-closure glaucoma.
Am J Ophthalmol. 1984,98:103-104.
83. Olsen T. The endothelial cell damage in acute glaucoma. On the
corneal thickness response to intraocular pressure.
Acta Ophthalmol 1980,58:257.
84. Winstanley J. iris atrophy in primary glaucoma.
Trans Ophthalmol Soc UK 1961,81:23-35
85. Lowe RF. Primary angle closure glaucoma : damage to cornea
arid lens. Brit J Ophthalmol 1965;49:460-465.
86. Krupin T, Mitchell KB, Johnson MF, Becker B. The long term
effects of iridectomy for primary acute angle-closure glaucoma.
Am J Ophthalmol 1978,86:506-509
87 Floman N, Berson D, Landau L. Peripheral iridectomy in closed
angle glaucoma - late complications.
Bri t J Ophthal rnol 1977,61:101-104
88. Forbes M. Indentation gonioscopy and efficacy of iridectomy in
angle-closure glaucorna.
Trans Arn Ophthalmol Soc. 1974,72:488.
89. Horie T, Kitazawa V, Nose H. Visual field changes in primary
angle closure glaucoma.
Jap J Ophthalmol 1975., 19:108-115.
90. Campbell DOA. Comparison of diagnostic techniques in
angl e-cl osure gl aucorna.
Am J Ophthalmol 1979,88:197-204.
91. Maps tone R. Outflow changes in normal eyes after closed-angle
glaucoma.
Brit J Ophthalmol 1977,61:637-640
92. Hillman JS. Acute closed-angle glaucoma: an investigation into
the effect of delay in treatment.
Brit J Ophthalmol 1979,63:817-821.
93. McNaught El, Rerirne A, McClure E, Chisholm !A.
Pattern of visual damage after acute angle-closure glaucoma.
Trans Ophthalmol Soc UK 1974,94:406-415.
94. Mitchell KW, Wood CM, Howe JW et al. The visual evoked
potential in acute primary angle closure glaucoma.
Brit J Ophthalmol 1989,73:448-456.
95. Go FJ, Varnarnoto T, Kitazawa V. Argon laser iridotorny and
surgical iridectomy in the treatment of primary angle-closure
glaucoma. Jpn J Ophthalmol 1984,28:36-46.
96. Loh RCK. The problem of glaucoma in Singapore.
Singapore Med J. 1968,9:76-80.
97. Lirn ASM. The pattern of ocular disease in Singapore.
Transactions of the Australian College of Ophthalmologists 1971,
3:122-125.
218
98. Arkell SM , Lightmsn Da , Sornmer A., Taylor HR, Korshin
OMJielsch M.
The prevalence of glaucoma among Eskimos of Northwest Alaska
Arch Ophthalmol 1987,105:482-485
99. Alsbirk PH. Early detection of primary angle-closure
glaucoma. Limbal and axial chamber depth screening in a high risk
population (Greenland Eskimos).
Acta Ophthalmol 1988,66: 556-564
100. Alper MG, Laubach JL. Primary angle-closure glaucoma in the
American negro.
Arch Ophthalmol 1968,79:663-668.
101. Luke S. Complications of peripheral iridectomy.
Can J Ophthalmol 1969,4 :346-351.
102. Robin AL, Pollack IP. Argon Laser peripheral iridotomies in
the treatment of primary angle closure glaucoma; long-term
follow-up.
Arch Ophthalmol. 1982,100:919.
103. Yarnanoto T, Shirato S, Kitazawa Y.
Argon laser iridotomy in angle-closure glaucoma: a comparison of
two methods.
Jpn J Ophthalmol 1982,26:387-396.
104. Klapper P.M. 0-switched neodymium:YAG laser iridotomy.
Ophthalmol ugy 1984,91:1017-1021
105. Harrad RA, Stannard KP, Shilling JS. Argon Laser iridotomy.
Brit J Ophthalmol. 1985,69:368-372.
106. Brazier DJ. Neodymium-YAG laser iridotomy.
J R Soc Med 1989,79:658-660
107. Haut J, Gaven I, Moulin F, Larricart P, Marre JM, Van
Effenterre 6.
Study of the first hundred phakic eyes treated by peripheral
iridotomy using the Nd:YA6 laser.
Int Ophthalmol 1986,9:227-235
219
108. Wise JB. Large iridotomies by the linear incision technique
using the neodymiurn:VA6 laser at tow energy levels. A study using
cynomolgus monkeys.
Ophthalmology 1987,94:82-86
109. Wand M, Clark JA, Hill DA. Nd: NJA6 laser iridectomies: 100
consecutive cases.
Ophthalmic Surg 1988,19:399-402
110. Pollack IP, Robin AL, Dragon DM, Green WR, Quigley HA,
Murray TG, Hotchkiss ML. Use of the neodymium:¥AG laser to
create iridotomies in monkeys and humans.
Trans Arn Ophthalmol Soc 1984,82:307-328
111. Robin AL, Arkell S, Gilbert SM, Goossens AA, Werner RP,
Korshin OM.
Q-switched neodymiurn-VAG laser iridotomy. A field trial
with a portable laser system.
Arch Ophthalmol 1986,104:526-530
112. Mishima S, Kitazawa ¥, Shirato S. Laser therapy for
glaucoma.
Aust NZ J Ophthalmol 1985,13:225-235
113. Korey M, Gieser D, Kass MA, Waltrnan SR, Gordon M, Becker B.
Central corneal endothelial cell density and central corneal
thicknes in ocular hypertension and primary open angle glaucoma.
Arn J Ophthalmol 1982,94;610-616
114. Smith J, Whitted P. Corneal endothelial changes after argon
laser iridotomy.
Am J Ophthalmol. 1984,98:153-156.
115. Schrerns W, Belcher CD Hi, Tomlinsori CP. Changes in the
human central corneal endothelium after neodymiumWAG laser
surgery.
Ophthalmic Laser Ther 1986,1:143-152
116. Gilbert CM, Robin AL, Pollack IP.
Hyphaerna complicating neodymiurnWAG iridotomy.
Ophthal rnol ogy 1984,91:1 123.
220
117. Douglas WHG, Strachan IM.
Surgical safety of prophylactic peripheral iridectomy.
Brit J Ophthalmol. 1967,51:459-462.
118. Nodes BL, Bentivegna JF, Weyer NJ. Hyphema complicating
laser iridotorny.
Arch Ophthalmol. 1982,100:924-925.
119. Phillips Ci, Clark CV, Levy AM. Posterior synechias after
glaucoma operations: aggravation by shallow anterior chamber and
pilocarpine.
Brit J Ophthalmol 1987,71:428-432.
120. Phillips CI, Snow JT. Peripheral iridectomy in angle closure
glaucoma - a common complication
Brit J Ophthalmol 1967,51:733-738
121. Vassur V, Melarned S, Cohen S, Ben-Sira 1. Laser Iridotomy in
closed angle glaucoma.
Arch Ophthalmol. 1979,97:1920-1921.
122. Welch DB, Apple DJ, Mendelsohn AD, Reidy JJ, Chalkley
TH,Wilensky JT. Lens injury following iridotomy with a
Q-switched neodymium-YA6 laser.
Arch Ophthal mol 1986,104:123-125
123. Bongard B, Pederson JE. Retinal burns from experimental laser
iridotomy.
Ophthalmic Surgery 1985,16:42-44.
124. Mainster MA, Sliney DH, Belcher CD, Buzney SM. Laser
photodisruptors; damage mechanisms, instrument design and
safety.
Ophthalmology 1983,90:973-991.
125. Puliafito CA, Steinert RF. Laser surgery of the lens;
experimental studies. Ophthalmology 1983,90:1007-1012.
126. Krauss JM, Puliafito CA, Miglior S, Steinert RF, Cheng HM.
Vitreous Changes After Neodyrniurn-YAG Laser Photodisruption.
Arch Ophthalmology 1986,104:592-597
127. Berger BB. Foveal photocoagulation from laser iridotomy.
Ophthalmol ogy 1984,91:1029-1033
221
128. Karmon G, Savir H. Retinal damage after argon laser
iridotomy.
Am J Ophthalmol 1986,101:554-560
129. Karjalainen K, Laatikainen L, Raitta C. Bilateral
nonrhegmatogenous retinal detachment following neodyrniurn-YAG
laser iridotomies (letter).
Arch Ophthalmol 1986,104:1134
130. Wilson P. Trabeculectomy : Long term follow up.
Brit J Ophthalmol 1977,61:535-538
131. Watson PG, Grierson 1. The place of trabeculectomy in the
treatment of glaucoma.
Ophthalmology 1981,88:175-196
132. Maridelkorn R, Mendelsohn A, Olander K et al.
Short exposure times in argon laser iridotomy.
Ophthalmic Surg 1981,12:805-809.
133. Brainard JO, Landers JH, Shock JP. Recurrent angle closure
glaucoma following a patent 75-micron laser iridotomy: a case
report.
Ophthalmic Surg 1982,13:1030-1032.
134. Mackie EG, Rubinstein K. Iridencleisis in congestive giucorna.
Brit J Ophthalmol. 1954,38:641-652.
135. Ghoshal TK, Blaxter PL.
Results of peripheral iridectomy in closed-angle glaucoma.
Brit J Ophthalmol. 1969,53:110-115.
136. Godel V, Stein R, Feiler-Ofrey V.
Angle-closure glaucoma following peripheral iridectomy and
mydriasis.
Am J Ophthalmol, 1968,65:555-560
137. Torney KF, Traverse CE, Shammas IV. Neodyrniurn-YAG laser
iridotomy in the treatment and prevention of angle closure
glaucoma. A review of 373 eyes.
Arch Ophthalmol 1987,105:476-481
222
138. Phillips CI. Timolol in operated closed angle glaucoma.
Brit J Ophthalmol 1980,64:240 -246
139. Gieser DK, Wilensky JT.
Laser iridectomy in the management of chronic angle-closure
glaucoma.
Am J Ophthalmol 1984,98:446-450
140. Loertscher H, Rol P. Basic physics of Neodymium:VAG laser.
Int Ophthalmol Clin 1985,25:1-14.
141 Hoskins HD, Migliazzo CV. Laser Iridectomy - a technique for
blue irises.
Ophthalmic Surg 1984,15:488-490.
142. Stetz D, Smith H, Pitch P.
A simplified Technique for Laser Iridectomy in Blue irides.
Am J Ophthalmol 1983,96:249-251
143. Mi nning CA.
The use of green only argon laser for iridotomy in blue eyed
patients.
Am J Ophthalmol. 1983,96:114-115.
144. Beckman H, Sugar HS. Laser iridectomy therapy of glaucoma.
Arch Ophthalmol 1973,90:453-455.
145. Wheeler CB. Laser Iridectomy.
Phy Med Biol 1977,6:1115-1135 ~
146. Krasnov MM. Q-switched ("cool") lasers in ophthalmology.
Int. Ophthalmol Clin 1976,16 : 29-44.
147. Vogel A, Hentschel W, Holzfuss J, Lauterborn W. Cavitation
bubble dynamics and acoustic transient generation in ocular
surgery with pulsed neodymiurn:VAG lasers.
Ophthalmology 1986,93:1259-1269.
148. Capon MRC, Mellerio J. Nd:VA6 lasers: plasma characteristics
and damage mechanisms.
Lasers Ophthalmol 1986,1:95-106.
149. Wilmanns I, Stodtmeister R, Pillunat LE. Nd:YA6 laser shock
waves In artificial eyes.
Ophthalmologica 1S88,19u 210-215
150. Vernon SA, Cheng H. Freeze frame analysis on high speed
cinematography of Nd/VAG laser explosions in ocular tissues.
Brit J Ophthalmol 1986,70:321-325
151. Aron-Rosa D.Aron JJ, Grieseman M. Use of the Neodymium
laser to open the posterior capsule after lens implant surgery. Am
intra-ocular Implant Soc J 1980, 6: 352.
152. Greenridge KC.
Md.VAG caosulotorny - energy requirements and visual outcome.
Cataract 1984:31-33
153. Stark WJ, Worthen DM, Holloday JT, et al. Neodymium : VAG
lasers. An FDA Report.
Ophthalmology 1985,92:209-212.
154. Brown RH , Lynch MG, Tearse JE, Nunn RD. Neodymiurn-YAG
vitreous surgery for phakic and pseudophakic malignant glaucoma.
Arch Ophthalmol 1988,104:1464-1466
155. Epstein DL, Steinert RF, Puliafito CA. Neodymium-YAG laser-
therapy to the anterior hyaloid in aphakic malignant
(ciliovitreal block) glaucoma.
Am J Ophthalmol 1984,98:137-143
156. Weinberger D, Lusky M, Debbi S, Ben Sira I.
Pseudophakic and aphakic pupillary block.
Ann Ophthalmol 1988,20:403-405
157. Rockwood EJ, Meyers SM, Meisler DM, Zakov ZN, Langstori RH.
Treatment of selected cases of pupillary block with YAG
laser iridotomies (letter).
Ophthalmic Surg 1984,15:968
158. Shrader CE, Belcher CD, Thomas JV, Simmons R.J, Murphy EB.
Pupillary and iridovitreal block in pseudophakic eyes.
Ophthalmology 1984,91:831 -837
159. Klapper RM.
The role of neodymiurn:YAG laser in microsurgery of the glaucomas.
Int Ophthalmol Clin 1985,25:101-117
160. Dutton GN, Allan D, Cameron SA. Pulsed Neodymium-YAG laser
trabeculotomy: energy requirements and replicability.
Brit J Ophthalmol 1989,73:177-181
161. Schrerns W, Tomlirison CP, Belcher CD. Visual field
improvement after neodymiurn:VAG laser puncture of miotic cysts.
Ophthalmic Surgery 1987,18 :342-343
162. Vega LP, Sabates R.
N e o d ym i um: VAG 1 a s er t re a t rnen t of pe rs istent pup i 11 a ry rn e rnb rane.
Ophthalmic Surgery 1987,18:452-454
163. Frarikhauser F, Lortscher H, Van Der Zypen E.
Clinical studies on high and low power laser radiation upon some
structures of the anterior and posterior segments of the eye.
Experiences in the treatment of some pathological conditions of
the anterior and posterior segments of the human eye by means of
a Nd:YAG laser, driven at various power levels,
int Ophthalmol 1982,5:15-32.
164. Fleck BW, Dhillon BJ, Khanna V, McConnell, Chawla HB. Nd:VAG
Laser Augmented Pneumatic Retinopexy. Ophthal.
Surg. 1988,19:855-858.
165. Fleck BW, Chew PTK, Lirn ASM, Tock EDC.
Nd:VAG laser disruption of rabbit lens nucleus.
Lasers and Light in Ophthalmology 1990,3:227-232.
166. Goldberg MF, Tso MO, Mirolovich T. Histopathological
characteristics of neodyrniurn-YAG laser iridotorny in the human
eye.
Brit J Ophthalmol 1987,71 -.623-625.
167. Rodrigues MM, Spaeth GL, Moster M, Thomas G, Hackett J.
Histo p a t ho 1 o gy o f ne ody rn i um: YAG 1 aser i r i de c t orn y i n hu rn a ri s.
Ophthalmology 1985,92:1696-1700
225
168. Dragon DM, Robin AL, Pollack IP, Quigley HA, Green WR,
Murray TG, Hotchkiss ML, D'Anna S.
Neodymium:YAG laser iridotomy in the cynomolgus monkey.
Invest Ophthalmol Vis Sci 1985,26:789-796
169. Latina MA, Puliafito CA, Steinert RR, Epstein DL.
Experimental iridotomy with the Q-switched neodymium-YAG
laser.
Arch Ophthalmol 1984,102:1211-1213
170. Seedor JA, Greenidge KC, Dunn MW. Neodymium:YAG laser
iridectomy and acute cataract formation in the rabbit.
Ophthalmic Surg 1986,17:478-482
171. Krauss JM, Puliafito CA, Steinert RF. Laser interactions with
the cornea.
Survey of Ophthalmology 1986,31:37-53
172. Venkatesh S, Guthrie S, Cruikshank FR, Bailey RT, Foulds WS,
Lee WR.
Thermal lens measurements In the cornea.
Brit J Ophthalmol 1985,69:92-95
173. Schubert HD. Endothelial repair following Nd:YAG laser injury.
Invest Ophthalmol and Vis Sci 1984,25:971-976
174. Khodadoust AA, Arkfeld DF, Capri oil J, Sears M.
Ocular effect of Neodymium-Vag laser.
Am J Ophthalmol 1984,98:144-152
175. Meyer KT, Petitt TH, Straasma BR.
Cornea Endothelial Damage With NeodyrniurmVAG Laser.
Ophthal rnol ogy 1984,91:1022-1029
176. Gailitis R, Peyrnan GA, Pulido J, Mitchell MD, Weinreb RM.
Prostaglandin release following Nd:YAG iridotomy in rabbits.
Ophthalmic Surg 1986,17:467-469
177. Liu SJ, Hunter DM, Oei T, Lin T, Lam KW. Study of
prostaglandins and intraocular pressure in rabbits after~Nd:YAG
laser anterior segment procedures.
Ophthalmic Surg 1988,19:112-115
226
178. Robin AL, Pollack IP, Quigley HA, D'Anna S, Addicks EM.
Histological studies of angle structures after laser iridotorny in
primates.
Arch Ophthalmol 1982,100:1665-1670
179. Higginbotham EJ, Ogura V. Lens clarity after argon and
neodymium-YAG laser iridotorny in the rabbit.
Arch Ophthalmol 1987,105:540-541
180. Jampol LM, Goldberg MF. Jednock N. Retinal damage from a
Q-switched YAG laser. Am J Ophthalmol. 1983,96:326-329.
181. Frankhauser F, Rol P. Microsurgery with the neodymium:YAG
laser: an overview.
Int Ophthalmol Clin 1985,25:55-64
182. Schirmer KE. Argon laser surgery of the iris, optimised by
contact lenses.
Arch Ophthalmology 1983,101:1130-1132
183. Wise JB, Munnerlyn CR, Erickson PJ.
A high-efficiency laser iridotorny-sphincterotomy lens.
Am J Ophthalmol' 1986,101:546-553
184. Pollack IP. Use of argon laser energy to produce iridotomies.
Trans Am Ophthalmol Soc 1979,77:674-706.
185. Perkins ES, Brown NAP. Iridotomy with a ruby laser.
Brit J Ophthalmol 1973,57:487-498
186. Bonney CH, Gaasterland DE. Low-energy, Q-switched ruby
laser iridotomies in Macaca mulatta.
Invest Ophthalmol Vis Sci. 1979,18:278-287.
187. Pollack IP, Robin AL.
Iridotomies in cynomolgus monkeys using a Q-switched ruby laser.
Trans Am Ophthalmol Soc 1980,78:88-106.
188. Robin AL, Pollack IP. The Q-switched ruby laser in glaucoma.
Ophthalmology 1984,91:366-371.
189. Peyrnan GA, Larson B. Effects of the CW YAG laser on the
human iris and retina.
Ophthalmol ogy 1984,91:1034-1039
227
190. Rol P, Kwasniewska S, van der Zypen E, Fankhauser F.
Transsclera) indotomy using a neodymium: YAG laser operated
both with standard equipment and an optical fiber system - a
preliminary report: Part l-Optical system and biomicroscopy
results.
Ophthalmic Surg 1987,18:176-182
191. Van der Zypen E, Fankhauser F, Kwasniewska S.
Transscleral iridotomy using a neodymium: YAG laser operated
both with standard equipment and an optical fiber system - a
preliminary report: Part Sf-Light and electron microscopic
findings.
Ophthalmic Surg 1987,18:337-341
192. Peyman 6A, Katoh N. Effects of an erbium: YAG laser on ocular
structures.
int Ophthalmol 1987,10:245-252
193. Yates F: J Royal Statistical Soc 1934, 1:217
194. Swinscow TDV. Statistics at square one. Chapter 8. The X2
tests. Page 49. British Medical Association Publications 1983.
195. Foubister G, Hughes SPF: Fractures of the femoral neck: a
retrospective and prospective study. J R Coll Surg Edinb 1989,
34:249-252.
196. Code! V, Regenbogen L. Cataractogenic factors in patients
with primary angle-closure glaucoma after peripheral iridectomy.
Am J Ophthalmol 1977..S3:180-184.
197. Korey M, Gieser D, Kass MA, Waltrnan SR, Gordon M, Becker B
Central corneal endothelial cell density and central corneal
thickness in ocular hypertension and primary open angle glaucoma.
Am J Ophthalmol 1982,94:610-616.
198. Lowe RF. Angle-closure, pupil dilatation and pupil block.
Brit J Ophthalmol 1966,50:385-389
199. Schrems W, Eichelbronner 0, Krieglstein GK. The immediate




200. Stilma JS, Boen Tan IN. Timolol and intra-ocular pressure
elevation following neodymium: VA6 laser surgery.
Doc Ophthalmol 1986,61:233-239
201. Kitazawa Y, Taniguchi T, Sugiyarna K. Use of apraclonadine to
reduce acute intraocular pressure rise following Q-switched
Nd:YA6 laser iridotorny.
Ophthalmic Surgery 1989,20:49-52
202. Mishirna S. Clinical investigations on the corneal endothelium.
Ophthalmology 1982,89:525-530
203. Waring 60, Bourne WM, Edelhauser HF, Kenyon KR. The corneal
endothelium.
Ophthalmology 1982,89:531 -591
204. Lowe RF. Primary angle-closure glaucoma : postoperative
acute glaucoma after phenylephedrine eyedrops.
Am J Ophthalmol 1968;65:552-554
205. Wand M, Grant WM, Simmons RJ, Hutchinson BT. Plateau iris
syndrome. Trans Am Acad Ophthalmol Otolaryngol.
1977,83:122-130.
206. Sugar HS. Postoperative cataract in successfully filtering
glaucomatous eyes.
Am J Ophthalmol 1970,69.740
207. Bloom JN, Levene RZ, Thomas 6, Kirnura R. Fluorophotometry
and the rate of aqueous flow in man.
Arch Ophthalmol 1976,94:435-443.
208. Lowe RF. Primary angle closure glaucoma - investigations
after surgery for pupil block.
Arn .J Ophthalmol 1964,57:931 -938
209. Harris LS, Gal in MA. Cycloplegic provocative testing.
Arch Ophthalmol 1969,81:356-358
210. Hung PT, Chou LH. Provocation and mechanism of
angle-closure glaucoma after iridectomy.
Arch Ophthalmol 1979,97:1862-1864.
99q
211. Friedman Z, Neumann E. Comparison of prone position, dark
room, and mydriatic tests for angle closure glaucoma before and
after peripheral iridectomy.
Am J Ophthalmol 1972,74: 24-27
212. Harris LS. Cycloplegic-induced intraocular pressure
elevations.
Arch Ophthalmol 1968,79:242-246.
213. Karmon G, Vender T, Savir H. Evaluation of laser iridectomy
in angle-closure glaucoma: provocative tests.
Brit J Ophthalmol 1982,66:471-473
214. Wheeler CB. Laser iridectomy.
Phys Med Biol 1977,22 :1115-1135.
215. Pitch P. The treatment of chronic angle-closure glaucoma.
Ann Ophthal rnol. 1981,13:21.
216. Wishart PK, Nagasubrarnanian S, Hitchings PA.
Argon laser trabeculoplasty in narrow angle glaucoma.
Eye 1987,1:567-576
217. Romano JH, Hi tchings PA, Pooinasawrny D. Role of Nd:¥A6
peripheral iridectomy in the management of ocular hypertension
with a narrow angle.
Ophthalmic Surg 1988,19:814-816
218. Hi tchings PA. Combined dye and argon laser treatment for
na rrow ang 1 e g 1 au co rna.
Trans Ophthalmol Soc 1984,104:52-54
219. Robin AL, Pollack IP. Q-switched neodyrmum-VAG laser
iridotomy in patients in whom the argon laser fails.
Arch Ophthalmol 1986,104:531 -535,
220. Naveh-Floman N, Blumenthal M. A modified technique for
serial use of argon arid neodyrniurn:VAG lasers in laser iridotomy.
Am J Ophthalmol 1985,100:485-486.
221. Zborwski-Gutrnan L, Rosner M, Blumenthal M, Naveh N.
Sequential Use of Argon and ND:YA6 Lasers to produce an
iridotomy- a pilot study.
Metabolic, Pediatric and Systemic Ophthalmology. 1988,11:58-60.
230
222. Rodrigues MM, St reel en B, Spaeth GL, Schwartz LW. Argon
laser iridotorny on primary angle-closure or pupillary block
glaucoma.
Arch Ophthalmol 1978,96:2222-2231
223. Sachs SW, Schwartz B. Enlargement of laser iridotomies over
time.
Brit J Ophthalmol 1984,68:570-573
224. Drake MV. NeodyrniurmYAG laser indotorny.
Surv Ophthalmol 1987,32:171-177
225 Yassur Y, David R, Rosenblatt I, Marrnour U. Iridotorny with red
krypton laser.
Brit J Ophthalmol 1986,70:295-297
226. Ritch R, Palrnberg P. Argon laser iridectomy in densley
pigmented irides.
Am J Ophthalmol 1982,93 :800-801.
227. Chiang C, Lirn ASM, Ang BC, Min 6, Fleck BW. Laser iridotorny
as an alternative to surgical iridectomy. Proceedings of the 21st
Annual Combined Surgical Meeting, Singapore Academy of Medicine,
November 1987.
228. Ye T, Ge J, Zhuan W. A preliminary study of short-term
efficacy of Nd:YA6 laser peripheral iridotomy in patients with
primary angle closure glaucoma. Eye Science (China). 1987,3:1.
229. Lirn ASM. Peripheral Iridectomy- surgical: Argon: YAG.
1989. PG Publishing, Singapore.
230. Panek Vv'C, Lee DA, Christensen RE. The effects of Nd:YAG laser
iridotorny on the corneal endothelium. Am J Ophthalmol 1991, 111:
505-507.
231. Prurn BE, Shields SR, Shiel ds MB, Hickingbotharn D, Chand 1 er
DB. In vitro videographic comparison of argon and Nd:YAG laser
iridotomy. Am J Ophthalmol 1991, 111 : 589-594.
232. McGalliard JN, Wishart PK. The effect of Nd:YAG iridotomy on
intraocular pressure in hypertensive eyes with shallow anterior
chamber. Eye 1990, 4 :823-829.
231
233. Fleck BW, Chew PTK, Lim ASM, lock EDC.
Effects of pulsed Nd.YAG laser on the surface of rabbit retina.
Ophthalmic Surgery 1991 ;22:168-171.
234. Fleck BW, Dhillon B, Khanna V, Fairley E, McGlynn C.
A randomised, prospective comparison of Nd:YAG laser iridotorny
and operative peripheral iridectomy in fellow eyes.
Eye 1991;5:315-321.
235. Fleck BW. How large must an iridotomy be?
Br J Ophthalmol 1990;74:583-588.
236. Fleck BW, Wright E, McGlynn C.
Argon laser pretreatment 4-6 weeks before Nd:YAG laser
iridotorny. Ophthalrnic Surgery 1991,22:644-649.
COMMUNICATIONS FROM THESE STUDIES
PAPERS PUBLISHED
1. Fleck BW, Dhillon B, Khanna V, Fairley E, McGlynn C.
A randomised, prospective comparison of Nd:YAG laser iridotomy
and operative peripheral iridectomy in fellow eyes.
Eye 1991;5:315-321.
2. Fleck BW, Fairley E, McGlynn C : A prospective comparison of
Nd:YAG laser iridotorny and surgical peripheral iridectomy in the
treatment of acute closed-angle. In Khoo CY et al eds. Proceedings
of the XXVI Intemation Congress of Ophthalmology, Amsterdam:
Elsevier Science Publishers B.V.I991:852-858.
3. Fleck BW. How large must an iridotomy be?
Brit J Ophthalmol 1990;74:583-588.
4. Fleck BW, Wright E, McGlynn C.
Argon laser pretreatment 4-6 weeks before Nd:YAG laser
i ri dotorny. 0phthal rni c Surgery 1991;22:644-649.
5. Fleck BW, Wright E, Fairley E. The effect of pupil dilation on
Nd:YAG iridotomy area. Brit J Ophthalmol 1992 (in press).
VERBAL COMMUNICATIONS
1. Prospective randomised controlled trial of Neodyrnium-YAG
laser iridotomy and surgical peripheral iridectomy in the
treatment of acute angle closure glaucoma. A preliminary report.
Fleck BW, Dhillon BJ, Khanna V, McConnell JMS. 5th Annual
Conference of the British Medical Laser association. January 1987.
2. Laser Iridotomy as an alternative to Surgical iridectomy.
Chiang C, Lirn ASM, Any BC, Min 6, Fleck BW. 21st Annual Combined
Surgical Meeting, Singapore Academy of Medicine. November 1987.
3. A Comparison of Argon with Nd YAG Laser iridotomy in S.E. Asian
and Caucasian Eyes. Fleck BW, Wong PK, Cheong P, Chiang C, Dhillon
B, Khanna V, Lirn ASM. 7th Singapore - Malaysia Joint Meeting in
Ophthalmology. March 1988.
4. Dhillon B, Fleck BW, Mackintosh 6. Khanna V. Nd: YA6 Iridolomy
in Primary Chronic Narrow Angle Glaucoma. Scottish
Ophthalmology Club. Edinburgh, March 1988.
5. Fleck BW. A Prospective Randomised of Nd YAG Laser Iridotorny
and Surgical Iridectomy in the treatment of the Fellow Eye of
Patients with acute closed angle glaucoma. College of
Ophthalmologists Inaugural Meeting, London 1989.
6. Fleck BW, Fairley E, McGlynn C. A prospective comparison of
Nd:YA6 laser iridotomy and surgical peripheral iridectomy in the
treatment of acute angle closure glaucoma. XXVI International
Congress of Ophthalmology. Singapore, March 1990.
234
Eye (1991) 5, 315-321
A Randomised, Prospective Comparison of ND:YAG
Laer Iridotomy and Operative Peripheral Iridectomy
in Fellow Eyes
B. W. FLECK, B. DHILLON, V. KHANNA, E. FAIRLEY, C. MCGLYNN
Edinburgh
Summary
A prospective, randomised comparison of Nd:YAG laser iridotomy and operative
peripheral iridectomy in the fellow eye of 52 patients presenting with acute angle
closure glaucoma has been undertaken. Nd:YAG laser iridotomy resulted in a sig¬
nificantly higher incidence of iris bleeding at the time of treatment (p<0.05), higher
intraocular pressure one hour (p<0.02) and three hours (p<0.02) following treat¬
ment, and a higher incidence of focal corneal oedema 24 hours following treatment
(p<0.001). One laser treated patient developed acute angle closure glaucoma two
weeks following treatment despite the presence of a small patent iridotomy.
After a mean follow-up period of 11.8 months there was no significant difference
between the two groups in visual acuity, or intraocular pressure. It is concluded that
Nd:YAG laser iridotomy is a satisfactory alternative to operative peripheral iridec¬
tomy in the prophylactic treatment of fellow eyes.
Argon1 and Nd:YAG2 laser iridotomy have
already largely superseded operative periph¬
eral iridectomy3 in the treatment of angle
closure glaucoma.4 Laser surgery is more con¬
venient and less costly than conventional sur¬
gery.5 Rare but serious operative
complications such as endophthalmitis, flat
anterior chamber and malignant glaucoma,
are completely eliminated. However laser
surgery should not be regarded as non
invasive.6
Several studies have compared argon laser
and Nd:YAG laser iridotomy. Nd:YAG laser
iridotomy requires less laser energy, produces
fewer short term complications, and has a
much lower rate of delayed iridotomy closure
than argon laser iridotomy.7"12 Nd:YAG laser
iridotomy hs not been compared with oper¬
ative peripheral iridectomy in a prospective
study. Peripheral iridectomy is a remarkably
'safe' operation, with few short or long term
complications.13 We are currently performing
a long term prospective randomised compari¬
son of these treatments in a variety of forms of
angle closure glaucoma, and our initial results
in the treatment of the fellow eye following
acute angle closure glaucoma are presented in
this paper.
Material and Method
Ethical approval of the study was obtained
from the Regional Surgical Specialties Ethical
Committee. Consecutive patients with acute
angle closure glaucoma in one eye were
accepted into the trial if the referring opthal-
mologist believed the patient to be suitable
for either Nd:YAG laser iridotomy or oper¬
ative peripheral iridectomy in the fellow eye.
If the fellow eye had an intraocular pressure
greater than 21 mmHg or a cup:disc ratio
greater than 0.6 the patient was excluded
from the study. Informed patient consent to
Correspondence to: Dr B. W. Fleck, Princess Alexandra Eye Pavilion, Chalmers Street, Edinburgh EH3 9HA.
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inclusion in the trial was obtained before
randomisation.
Initial examination included assessment of
corrected visual acuity, intraocular pressure,
Goldman gonioscopy, slit lamp examination
of the lens, and fundal examination. Specular
microscopy was performed using a Keeler-
Konan Pocklington specular microscope.
Several central fields were photographed and
stored for later analysis.
Forty-eight hours prior to surgical or laser
treatment all systemic and topical introcular
pressure lowering agents, other than G Pil¬
ocarpine 2%, were discontinued. One drop of
G Pilocarpine 2% was instilled one hour
before treatment.
Surgery
Operative peripheral iridectomy was performed
under general anaesthetic, or subconjunctival local
anaesthetic. Retrobulbar local anaesthetic was not
used, in order to avoid possible intraocular pres¬
sure changes induced by this procedure during the
early postoperative period.
Laser treatment
A Zeiss 'Visulas' Nd:YAG laser and Zeiss anterior
segment YAG contact lens were used. A treatment
site was chosen in the superior iris, between 10 and
2 o'clock, approximately 2/3 distance from the
pupil margin to the base of the iris. An iris crypt was
used, when present. A single 5-10 mj pulse was
delivered to the treatment site. If this pulse did not
penetrate the iris, further single pulses were
delivered to the same site until penetration was
achieved. A gush of aqueous fluid from the pos¬
terior chamber could be seen at the moment of pen¬
etration. Patency was assessed by direct
observation of the posterior chamber, or anterior
lens capsule.
Post treatment assessment
Goldman applanation tonometry was performed
one, two, three, six and 24 hours following treat¬
ment. A Perkins hand held applanation tonometer
was used to measure the early post operative intra¬
ocular pressure in some surgical patients who had
had a general anaesthetic. Systemic and topical
intraocular pressure lowering agents were withheld
unless the pressure rose above 40 mm Hg.
Twenty four hours after treatment the cornea
was examined and focal endothelial damage scored
as 0 (no change present), + (focal granularity), or
+ + (focal full thickness corneal oedema). Iritis was
judged to be present if there were more than five
white cells per field using a 3 mm long slit beam.
The presence of dispersed pigment particles in the
aqueous was not judged to be indicative of iritis.
Intraocular pressure was measured, the iridotomy
or iridectomy inspected for patency, and the lens
examined. No topical treatment was given unless
significant iritis was present, in which case G Beta¬
methasone 0.1% four times daily for one week was
prescribed. Mydriatics were not used.
Follow up
Patients were assessed one week, one month, six
months, and 12 months following treatment. The
pupil was dilated using G. Phenylephrine 10% one
month following treatment in order to detect pos¬
terior synechiae, and to examine the lens and fun¬
dus. Six months following treatment specular
microscopy, gonioscopy and pilocarpine/phenyl¬
ephrine provocation testing were performed.
Goldman gonioscopy was performed on all
patients, followed by Zeiss 4 mirror indentation
gonioscopy if any part of the angle appeared to be
closed. Pilocarpine/phenylephrine provocation
testing as described by Mapstone14 and modified by
Harrad15 was used. One drop of G Phenylephrine
10% and one drop of G Pilocarpine 2% were
instilled. The intraocular pressure was measured
one hour later. An intraocular pressure rise of
more than 8 mm Hg was regarded as a positive
result.14
Specular microscopy analysis
Patients were coded by number, and endothelial
cell counts were performed by an observer unaware
of the coding system. Using standardised print
magnification and a transparent grid, three repre¬
sentative fields of 0.05 mnr were chosen for each
patient, and the cells within these fields were
counted. The mean value for the three areas was
then calculated.
Statistical analysis
Where appropriate the unpaired Student t test or
the chi squared test were used to test the signifi¬
cance of differences between the two groups.
Results
Twenty six patients in each group have now
completed at least six months of follow-up.
Thirteen patients from the surgical group and
sixteen patients from the laser treated group
have completed one year of follow-up. The
current mean follow-up time for the surgical
group is 11.7 ± 8.7 months, and that of the
laser treated group 16.1 ± 11.0 months (t test
NS). Two patients in the laser treated group
have died, in each case approximately nine
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Age (years) 67.5 ± 13.1 68.3 ± 12.6 NS
Age range 41-88 40-88
Right:Left 10:6 11:15
Figures are presented as mean ± one standard
deviation.
P = statistical p value, NS = Not statistically
significant.
months following treatment. No patients have
been lost to follow-up.
Details of initial assessment of the two
groups are given in Tables I and II.
A patent laser iridotomy was obtained at
the initial treatment session in 25 patients.
Treatment sessions on three consecutive days
were needed to obtain a patent iridotomy in
one patient. A patent iridectomy was pro¬
duced in all surgical patients. A mean of
3.1 ± 2.6 pulses (range 1-10) with a mean
total energy of 25.8 ±21.4 mJ (range 4.9-
72.9) was used in laser treatment. One pulse
was sufficient to create an adequate iridotomy
in 11 patients, and less than 10 mJ total energy
was used in 10 patients. Slight iris bleeding
occurred at the time of treatment in 15 laser
patients and seven surgical patients (X2 test
p<0.05). There were no other operative
complications.
Immediate post treatment assessment
The mean intraocular pressure before treat¬
ment and one, two, three and six hours fol¬
lowing treatment are shown in Fig. 1.
Complete data was available in nine surgically
treated patiens and 15 laser treated patients.
The groups were significantly different at one
hour and three hours using the unpaired stu¬
dent t test, p<0.02. Two surgically treated
Table II Initial Examination
Visual acuity worse than 6/9 due to cataract
Intraocular pressure, mm Hg
Gonioscopy (Goldman) angle partly closed
Iris colour Brown:Grey
P = statistical p value, NS = Not statistically significant.
patients (8%) developed an intraocular pres¬
sure rise to between 20 and 25 mm Hg within
three hours of surgery. Seven laser treated
patients (27%) developed an intraocular pres¬
sure rise to greater than 20 mm Hg within
three hours of treatment, and in three of these
patients the intraocular pressure rose to
above 40 mm Hg.
Of the 15 laser treated patients with com¬
plete intraocular pressure data, the peak pres¬
sure occurred one hour following treatment in
seven, at two hours in four, and at three hours
in four. In all but two cases the intraocular
pressure had returned to normal six hours fol¬
lowing treatment.
The results of examination 24 hours fol¬
lowing treatment are shown in Table III.
Focal corneal oedema was most marked 24
hours following laser treatment, and had fully
resolved after one week in all cases. The total
laser energy used to treat the 15 patients who
subsequently developed focal corneal
oedema was 30.95 ±21.6 mJ, compared to
18.2 ± 19.7 mJ for those who did not. This
difference was not statistically significant. The
total laser energy used to treat the six patients
who subsequently developed iritis was
39.75 ±16.2 mJ, compared to 20.7 ± 18.2 mJ
for those who did not. Again this difference
was not statistically significant.
Six surgical patients were found to have
minimal focal lens opacities at the iridectomy
site due to mild operative trauma to the
anterior lens capsule. These opacities were
not progressive and did not lead to visual loss
during the follow-up period. Two laser treated
patients developed focal lens opacities under¬
lying the treatment site. In one case a faint
haze was present deep to the anterior capsule,
with no subsequent progression or loss of
vision. The second case developed polychro¬
matic crystals in the anterior lens cortex
underlying the treatment site, with sub-
Surgery Laser P
3 4 NS
15.0 ±3.6 15.5 ±3.4 NS
6 6 NS
10:16 10:16 NS




Time post treatment (hrs)
Fig. 1. Early post treatment intraocular pressure.
sequent development of nuclear cataract and loss of
one line of visual acuity, from 6/9 to 6/12.
One month follow-up
One laser treated patient developed acute
angle closure glaucoma three weeks following
treatment. The patient had been using cyclo-
pentolate 1% drops to the other eye, and may
have inadvertently contaminated the affected
eye. Following treatmentwith pilocarpine 2%
the intraocular pressure returned to normal.
The iridotomy was small (50 p x 50 p) but
patent. Nd:YAG laser enlargement of the iri¬
dotomy was performed, resulting in no
further symptoms. A subsequent pilocarpine/
phenylephrine provocation test was negative.
One patient was found to have developed
iridotomy closure two weeks following treat¬
ment and further laser treatment to re-open
the iridotomy was performed.
Posterior synechiae developed in three sur¬
gical patients, and three laser treated
patients. Two of the surgical patients and one
of the laser treated patients had had iritis at
the 24 hours post treatment examination. The
adhesions were of minimal extent in all cases,
did not progress, and were not associated with
subsequent cataract development or visual
loss during the follow-up period of the study.
Six month follow-up
Table IV summarises the findings in the two
groups of six months following treatment.
When compared with pre-treatment
measurements visual acuity was unchanged,
or changed by only one line in all surgical
patients. However in the laser treated group
visual acuity deteriorated by two or more lines
in two patients. These patients had developed
nuclear cataract—one in a previously clear
lens, and one in a lens with pre-existing
nuclear cataract.
The mean intraocular pressure was
14.5 ± 2.7 and 15.0 ± 3.2 mm Hg in the sur¬
gical and laser groups respectively. One laser
treated patient had an intraocular pressure of
25 mm Hg. All other patients had an intra¬
ocular pressure of less than or equal to 21 mm
Hg, and no patient required topical
medication.
All iridotomies and iridectomies were
patent. Gonioscopy revealed an open angle in
all surgical patients, with focal goniosyne-
chiae adjacent to the iridectomy in two
patients. Two laser treated patients had partly
closed angles on Goldman gonioscopy, but
the angles were open on indentation. One of
these two patients had focal areas of goniosy-
nechiae adjacent to the iridotomy site.
No patient developed more than a 10%
change in the cup:disc ratio, and no patient
developed pathological optic disc cupping.
Pilocarpine/phenylephrine provocation
tests were performed on 14 surgical patients
and 23 laser patients. All tests were negative.
Satisfactory pre-treatment and six months
post treatment specular micrographs were
obtained in seven surgical patients and nine
laser treated patients (see Table V). The two
groups did not significantly differ in mean
endothelial cell count either before or six
months following treatment. There was no
significant percentage change in endothelial
cell count following treatment in either group,
and no difference between the two groups.
Table III Examination 24 hours following treatment.
Surgery Laser P
Focal corneal





mm Hg 11.1 ±3.1 12.2 ± 4.0 NS
Iritis 11 6 NS
Patent 26 26 NS
Focal lens opacities 6 2 NS
P = statistical p value, NS = Not statistically
significant.
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Tabic IV Examination 6 months following treatment
Surgery Laser P
Visual acuity loss of two or more lines 0 2 NS
Posteria synechiae 3 3 NS
Intraocular pressure, mm Hg 14.5 ±2.7 15.0 ±3.2 NS
Gonioscopy-angle partly closed 0 2 NS
Provocation test positive 0 0 NS
P = statistical p value, NS = Not statistically significant.
Final follow-up
At the final follow-up examination an addi¬
tional two laser treated patients with initially
clear lenses were found to have developed
nuclear cataract sufficient to cause two or
more lines of visual acuity loss. Visual acuity
loss ofmore than one line did not occur in any
surgical patient (x2 NS). The intraocular pres¬
sure at the final follow-up examination was
14.9 ± 2.4 mm Hg in the surgical group, and
14.3 ± 2.4 mm Hg in the laser treated group.
No patient had an intraocular pressure
greater than 21 mm Hg, but one laser treated
patient was using topical (3 blocker medication
to maintain normal intraocular pressure.
Discussion
One laser treated patient developed acute
angle closure glaucoma despite the presence
of a small patent iridotomy. This case, and
three other similar cases, have been discussed
in another paper.16 Lowe found that conser¬
vative treatment of the fellow eye resulted in a
50% incidence of subsequent acute angle
closure glaucoma.17 However, acute angle
closure glaucoma following prophylactic sur¬
gical peripheral iridectomy is extremely
rare.13'17'18 Small argon19'20 or Nd:YAG21"23
laser iridotomies may, however, fail to pre¬
vent acute angle closure glaucoma.
One case developed closure of a previously
patent iridotomy, two weeks following treat¬
ment. This patient had not developed signifi¬
cant iritis following treatment. ND:YAG
Table V Corneal endothelium cell density
Surgery Laser P
Pre-trcatment cell density, mm 2 2470.3 ± 522.7 2531.7 ± 649.1 NS
Post-treatment cell density, mm"2 2442.0 ±557.1 2188.0 ± 560.7 NS
Percentage change -3.6 ±3.95 -7.2 ± 10.6 NS
P = statistical p value, NS = Not statistically significant.
laser iriditomy closure is uncommon8'11,21"24
Late iridotomy closure, or partial closure, is
much more common following argon laser iri¬
dotomy and has been reported to occur in
approximately 20% of cases.10"12'15
Short term complications
Short term complications following Nd:YAG
laser iridotomy include iris bleeding, intra¬
ocular pressure rise, focal corneal oedema,
iritis and focal lens opacity.
Fifty-eight per cent of our laser treated
patients developed iris bleeding at the time of
treatment, a significantly higher incidence
than that found during operative surgery.
Other workers have reported an incidence of
20-60% microhyphaema following Nd:YAG
laser iridotomy.7"12'22'24 Macrohyphaema did
not occur in our series, bleeding was tran¬
sitory and did not appear to result in any
adverse effect.
Our finding of transitory, but very marked,
intraocular pressure elevation in some
patients during the first three hours following
Nd:YAG laser iridotomy confirms the find¬
ings of previous studies7"9,11,12'23'24 Timolol25
and apraclonidine26 have been found to mini¬
mise the development of post-treatment
intraocular pressure elevation, and it is now
our practice to give acetazolamide 500 mg
orally one hour before performing Nd:YAG
laser iridotomy.
Focal corneal endothelium changes over¬
lying the treatment site occurred in 58% of
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our laser treated patients. Other workers
have reported that 4-30% of eyes developed
focal endothelial changes following Nd:YAG
laser iridotomy.7'8'10'11'22'24 Punctate areas of
endothelial loss overlying treatment sites
have been attributed to damage caused by the
dispersion of high velocity particulate
debris.27'28
Reduced endothelial cell density following
argon laser iridotomy has been described by
some workers,7 but others have found no
change.29 We found no significant change in
endothelial cell density following Nd:YAG
laser iridotomy, confirming previous stud¬
ies.7'3" No significant change in endothelial
cell density following operative peripheral iri¬
dectomy was found in our study, again con¬
firming the results of other workers.30'31
The incidence of iritis and posterior syn-
echiae was similar following laser iridotomy
and operative iridectomy. Focal lens opacities
were found underlying the laser treatment site
in two patients. Focal opacities induced by
NdrYAG laser photodisruption are rare,21'24'32
in contrast to a much higher incidence fol¬
lowing argon laser iridotomy.1'7'1011'12 We
found six cases of small focal lens opacities at
the site of operative peripheral iridectomy.
Focal opacities, whether caused by argon
laser iridotomy, Nd:YAG laser iridotomy or
operative peripheral iridectomy have pre¬
viously been found to be non-progressive and
do not lead to visual loss. However one of our
laser treated patients lost one line of visual
acuity due to nuclear cataract following the
development of a focal opacity at the time of
treatment.
Long term glaucoma outcome
There was no significant difference in the
mean intraocular pressure of the two groups
six months following treatment, or at the time
of most recent follow-up. Optic disc appear¬
ance remained unchanged in all eyes, and
gonioscopic appearances six months follow¬
ing treatment were similar in the two groups.
Two laser treated eyes had areas of angle
closure which could be opened on indenta¬
tion. Wishart has reported progressive angle
narrowing in four eyes following Nd:YAG
laser iridotomy, with widening of the angle on
performing a further laser iridotomy.21 It is
possible that small iridotomies do not fully
overcome iris bombe.
Long term visual outcome
While four laser treated patients lost two or
more lines of visual acuity due to cataract
development during the follow-up period,
and no surgical patients lost vision, this differ¬
ence was not statistically significant. Del
Priore reported progression of cataract fol¬
lowing Nd:YAG laser iridotomy in two of
forty three patients.10 On long term follow-up
approximately 10-15% of fellow eyes sub¬
jected to peripheral iridectomy develop catar¬
act sufficient to reduce visual acuity by two or
more lines.18'33 These figures compare with an
incidence of 8% among fellow eyes treated
conservatively.34
Conclusion
While the follow-up period of our study was
only 11.8 months, our findings suggest that
the short term complications of NdrYAG
laser iridotomy do not adversely affect the
long term outcome. Short term complications
may be minimised by appropriate iridotomy
technique. Oral acetazolamide or a topical
beta-blocker given prior to treatment will
reduce the incidence of post treatment intra¬
ocular pressure elevation.25 The use of low
energy laser pulses in conjunction with a Wise
103 dioptre contact lens should minimise
endothelial trauma.9 The production of a
large iridotomy will minimise the risk of sub¬
sequent acute angle closure glaucoma.16
Nd:YAG laser iridotomy and operative
peripheral iridectomy appear to have a similar
long term outcome. We are currently under¬
taking a five year prospective comparison of
Nd:YAG laser iridotomy and operative per¬
ipheral iridectomy in 200 patients in order to
test further this hypothesis. Bearing in mind
the convenience of laser treatment, and the
lack of possible anaesthetic complications,
Nd:YAG laser iridotomy must remain the
treatment of choice in angle closure
glaucoma.
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A RANDOMISED, PROSPECTIVE COMPARISON OF ND:YAG LI AND OPI IN FE 321
Congress of the College of Ophthalmologists,
London, March 1989.
Key words: Angle Closure Glaucoma, Nd:YAG laser
iridotomy, perihcral iridectomy, specular microscopy.
References
1 Abraham RK, Miller GL: Outpatient argon laser iri¬
dectomy for angle closure glaucoma: a two year
study. Trans Am Acad Ophthalmol Otolaryng
1975;79:OP529-38.
2Frankhauser F, Roussel P, Steffen J, Van Der
Zyphen E, Chrenkova A: Clinical studies on the
efficiency of high power laser radiation upon
some structures of the anterior segment of the
eye. First experience of the treatment of some
pathological conditions of the anterior segment of
the human eye by means of a Q-switched laser
system. Int Ophthalmol 1981;3:129-39.
I Chandler PA: Narrow Angle Glaucoma. Arch Oph¬
thalmol 1952;47:695-716.
4 Rivera AFI, Brown RH, Anderson DR: Laser irido¬
tomy vs surgical iridectomy—have the indications
changed? Arch Ophthalmol 1985;103:1350-4.
5 Rich W: The economics of Nd-YAG laser treatment.
Dev Ophthalmol 1987;14:93-6.
6 Spaeth GL: Laser treatment is invasive surgery.
Ophthalmic Surg 1988;19:463^1.
7 Robin AL and Pollack IP: A comparison of neo-
dymium: YAG and argon laser iridotomies. Oph¬
thalmology 1984;91:1011-16.
8 Schwartz LW, Moster MR, Spaeth GL, Wilson RP,
Poryzees E: Neodymium: YAG laser iridotomies
associated with closed or occludable angles. Am J
Ophthalmol 1986;102:41—4.
'Wise JB: Low-energy linear-incision neodymium:
YAG laser iridotomy versus linear-incision argon
laser iridotomy. A prospective clinical investiga¬
tion. Ophthalmology 1987;94:1531-7.
10 Del Priore LV, Robin AL, Pollack IP: Neodymium:
YAG and argon laser iridotomy. Long-term fol¬
low-up in a prospective, randomized clinical trial.
Ophthalmology 1988;95:1207-11.
II McAllister JA, Schwartz LW, Moster M, Spaeth GL:
Laser peripheral iridectomy comparing
Q-switched neodymium YAG with argon. Trans
Ophthalmol Soc UK 1984;104:67-9.
12 Moster MR, Schwartz LW, Spaeth GL, Wilson RP,
' McAllister JA, Poryzees EM: Laser iridectomy.
A controlled study comparing argon and neo¬
dymium: YAG. Ophthalmology 1986;93:20-4.
"Playfair TJ and Watson PG: Management of acute
• primary angle-closure glaucoma: a long term fol¬
low-up of the results of peripheral iridectomy
used as an initial procedure. Br J Ophthalmol
1979,63:17-22.
14
Mapstone R: Provocative tests in closed-angle glau¬
coma. Br J Ophthalmol 1976;60:115-9.
15 Harrad RA, Stannard KP, Shilling, JS: Argon Laser
iridotomy. Br J Ophthalmol 1985:69:368-72.
16 Fleck BW: How large must an iridotomy be? Br J
Ophthalmol 1990;74:583-8.
"Lowe RF: Acute angle closure glaucoma. The
second eye an analysis of 200 cases. Br J Ophthal¬
mol 1962;46:641-50.
18 Lowe RF: Primary angle-closure glaucoma. A
review 5 years after bilateral surgery. Br J Oph¬
thalmol 1973;57:457-63.
19 Mandelkorn R, Mendelsohn A, Olander K, Zim¬
merman TJ: Short exposure times in argon laser
iridotomy. Ophthalmic Surg 1981;12:805-9.
20Brainard JO, Landers JH, Shock JP: Recurrent
angle closure glaucoma following a patent 75-
micron laser iridotomy: a case report. Ophthalmic
Surg 1982;13:1030-2.
21 Wishart PK and Hitchings RA: Neodymium: YAG
and dye laser iridotomy—a comparitive study.
Trans Ohthalmol Soc UK 1986;105:521^10.
22 Gray RH, Hoare Nairn J, Ayliffe WHR: Efficacy of
Nd: YAG laser iridotomies in acute angle-closure
glaucoma. Br J Ophthalmol 1989;73:182-5.
23 Brazier DJ: Neodymium: YAG laser iridotomy. J
Roy Soc Med 1989:79:658-60.
24Naveh N, Zborowsky-Gutman L, Blumenthal M:
Neodymium: YAG laser iridotomy in angle
closure glaucoma: preliminary study. Br J Oph-
thalmol 1987;71:257-61.
25 Stilma JS, Boen Tan TN: Timolol and intra-ocular
pressure elevation following neodymium: YAG
laser surgery. Doc Ophthalmol 1986;61:233-9.
26 Kitazawa Y, Taniguchi T, Sugiyama K: Use of apra-
clonadine to reduce acute intraocular pressure
rise following Q-Switched Nd:YAG laser irido¬
tomy. Ophthalmic Surg 1989;20:49-52.
27 Kerr-Muir MG and Sherrard ES: Damage to the cor¬
neal endothelium during Nd:YAG photodisrup-
tion. Br J Ophthalmol 1985;69:77-85.
28 Canning CR, Capon MR, Sherrard ES, Kerr Muir
MG, Pearson R, Cooling R: Neodymium:YAG
laser iridotomies: short-term comparison with
capsulotomies and long-term follow-up. Graefes
Arch Clin Exp Ophthalmol 1988;226:49-54.
29 Smith J and Whitted P: Corneal endothelial changes
after argon laser iridotomy. Am J Ophthalmol
1984;98:153-6.
30 Wishart PK, Sherrard ES, Nagasubramanian S, Kerr
Muir MG, Hitchings RA: Corneal endothelial
changes following short pulsed laser iridotomy
and surgical iridectomy. Trans Ophthalmol Soc
UK 1986;105:541-8.
31 Markowitz SN and Morin JD: The endothelium in
primary angle-closure glaucoma. Am J Ophthal¬
mol 1984;98:103-4.
32 Montgomery DMI and Dutton GN: Correspon¬
dence: Intralenticular haemorrhage complicating
pulsed laser iridotomy. Br J Ophthalmol
1987;71:484.
33 Krupin T, Mitchell MB, Johnson MF, Becker B: The
long term effects of iridectomy for primary acute
angle-closure glaucoma. Am J Ophthalmol
1978;86:506-9.
34 Godel V, Regenbogen L: Cataractogenic factors in
patients with primary angle-closure glaucoma
after peripheral iridectomy. Am J Ophthalmol
1977;83:180-4.
© 1991 Elsevier Science Publishers B.V. All rights reserved.
New frontiers in ophthalmology. C.Y. Khoo et al., editors.
A prospective comparison ofNd:YAG laser iridotomy and surgical
peripheral iridectomy in the treatment of acute closed-angle
glaucoma
B.W. Fleck, A. Fairley and C. McGlynn
Eye Pavilion, Chalmers street, Edinburgh EH3 9HA, Scotland, U.K.
Abstract
A group of 41 patients presenting with acute closed-angle glaucoma was treated
with Nd:YAG laser iridotomy (26 patients) or surgical peripheral iridectomy (15
patients). Prospective assessment was carried out, with a mean follow-up period of
14.8 months (range 3-36 months).
At the end of the follow-up period 88% of laser treated patients and 86% of
surgical patients had normal intraocular pressure with no medical therapy. Two
laser treated patients and three surgical patients lost more than two lines of visual
acuity due to nuclear cataract formation.
Three laser treated patients developed a further attack of closed-angle glaucoma.
Two of these patients had an iridotomy less than 100 microns in diameter. The
third patient had an angle configuration suggestive of plateau iris syndrome.
It is concluded that Nd:YAG laser iridotomy is a satisfactory alternative to
surgical peripheral iridectomy in the treatment of acute closed-angle glaucoma,
provided the diameter of the iridotomy is greater than 100 microns.
Introduction
Peripheral iridectomy for closed-angle glaucoma (CAG) was introduced by Pfliiger
in 1893 [1]. Xenon arc white light [2], ruby laser [3], argon laser [4] and dye laser
[5] thermal energy have been used as an alternative means of creating an irido¬
tomy. More recently pulsed Nd:YAG laser photodisruption has been found to be
more satisfactory then argon laser thermal energy in creating a permanent iris
opening [6],
While large series of cases have been reported describing the use of Nd:YAG
laser iridotomy in various forms of closed-angle glaucoma [7,8], relatively little
attention has been given to the special problems involved in treating acutely
affected eyes [9]. These eyes are often hyperaemic, with some degree of corneal
and iris oedema. They exhibit marked pupil block effects.
We have compared the safety and effectiveness of Nd:YAG laser iridotomy and
surgical peripheral iridectomy in acute closed-angle glaucoma by undertaking a
prospective study of 41 patients.
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Materials and Methods
Forty-one patients presenting with acute or subacute closed-angle glaucoma during
a 33-month-period were recruited into an open, prospective study. Twenty-six
patients underwent Nd:YAG laser iridotomy and 15 surgical peripheral iri¬
dectomy.
Laser treatment
All patients were given acetazolamide 500 mg orally 1 h before treatment. One
drop of G. Pilocarpine 2% was instilled 30 min before treatment. A Zeiss Visulas
Nd:YAG laser and Zeiss anterior segment YAG contact lens were used in all
treatments.
A treatment site was chosen in the superior iris, between 10 and 2 o'clock,
approximately two-thirds from the pupil margin to the limbus. An iris crypt was
used, when present. A single 5—10 mJ pulse was delivered to the treatment site. If
this pulse did not penetrate the iris, further single pulses were delivered to the same
site until penetration was achieved. A gush of aqueous fluid from the posterior
chamber occurred at the moment of penetration. Patency was assessed by direct
visualisation of the posterior chamber or anterior lens capsule.
Surgical treatment
Peripheral iridectomy was carried out using a limbal incision in 10 patients, and a
corneal incision in five patients. The iris was grasped with grooved forceps, and an
iridectomy was performed with scissors. Limbal incisions were closed with one 8/0
"Vicryl" suture. Corneal incisions were not sutured.
Follow-up
At the 6-month visit indentation gonioscopy, and a modification of the pilocarpine/
phenylephrine provocation test described by Mapstone [10] were performed. The
intraocular pressure was measured, one drop of G. Pilocarpine 2% and one drop of
G. Phenylephrine 10% were instilled and the intraocular pressure was remeasured
1 h later. An intraocular pressure rise of more than 8 mmHg, with angle closure on
gonioscopy, was regarded as a positive result.
At the final follow-up visit the size of the iridotomy was estimated by com¬
parison with the 200 (0. spot produced by a Haig Streit slit lamp. Most iridotomies
were elliptical, and the surface area of iris patency was calculated using the
formula rc/4 x Diameter 1 X Diameter 2. The pupil was dilated using G. Phenyl¬
ephrine 10% in order to detect posterior synechiae and allow examination of the
lens and fundus.
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Table 1. Patient groups
Surgery Laser
Number of patients 15 26
Age 63.6+11.1 71.7 ± 10.5
Male:female 6:9 6:20
Iris colour grey/brown 6:9 11:15
Follow-up (months) 12.9 ± 16.6 16.6 ± 10.7
Follow-up range (months) 3-35 3-36
Figures express mean ± one standard deviation.
Results
The two patient groups were very similar, as can be seen in Tables 1 and 2.
Laser treatment
Primary failure to achieve patency occurred in one patient. The mean number of
pulses required to create a patent iridotomy was 4.2 ± 5. Seven patients required
only one pulse. There was no significant difference in the number of pulses
required to perforate brown and grey irides (4.8 ±5.1 vs. 3.9 ± 5.0).
The mean power required to create a patent iridotomy was 32.3 ± 35.4 mJ (range
5-136 mJ). Brown irides did not differ from grey irides (37.6 ± 40.7 vs. 29.0 ±
32.5). In eight patients less than 10 mJ energy was needed to create a patent
iridotomy.
Three patients had residual corneal oedema at the time of laser treatment.
However the mean number of pulses (1.3) and total power (7.1 mJ) required to
create an iridotomy in these patients was not significantly different from that of the
group as a whole.
Slight oozing of blood at the treatment site occurred in 13 patients. Focal corneal
oedema overlying the treatment site was evident in five patients 24 h following
treatment. Focal lens opacities at the treatment site were not evident in any
patient.
Table 2. Examination at presentation
Surgery Laser
Duration acute attack (h) 33.5 ±41.5 32.9 ± 17.1
Intraocular pressure at presentation 46.1 ± 15.1 46.3 ± 19.2
Corneal oedema present (patients) 9 (60%) 18 (69%)
Figures express mean ± one standard deviation;
Figures in brackets represent percentage of the group.
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Surgical treatment
The posterior pigment layer of the iris remained intact following surgery in one
patient, and was subsequently opened using the Nd:YAG laser. No other operative
complications occurred.
Recurrent acute closed-angle glaucoma
Three laser treated patients developed a recurrent attack of acute closed-angle
glaucoma despite the presence of a patent iridotomy.
Case 1 developed recurrent acute closed-angle glaucoma 1 month following laser
treatment despite a patent, though small (100 x 50 p.), iridotomy.
Case 2 had a deep anterior chamber with an angle configuration suggestive of
plateau iris syndrome. She developed recurrent acute closed-angle glaucoma 14
days after initial laser iridotomy, while using G. Betamethasone QID and G.
Cyclopentolate 1% BD. The iridotomy was patent and of moderate size (200 x
400 p).
Case 3 developed recurrent acute closed-angle glaucoma 1 day following laser
iridotomy. The iridotomy was patent but small (50 x 50 p).
Visual outcome
Thirteen laser treated patients (50% of the group), and 10 surgically treated
patients (67% of the group) had a visual acuity of 6/12 or better at their final
follow-up examination. Factors responsible for reduced vision are shown in Table 3.
Two laser patients and two surgical patients lost more than two lines of visual
acuity due to the development of nuclear cataract in lenses which were clear prior
to treatment. The visual acuity of a further surgical patient fell below the 6/12 level
due to progression of pre-existing early nuclear cataract.
Glaucomatous visual loss occurred in one patient who was lost to follow-up for
several months following laser treatment.
Table 3. Causes of reduced vision at final follow-up visit
Surgery Laser
Cataract development/progression 3 2
Pre-existing cataract 0 6
central retinal vein occlusion 0 2
age-related macular degeneration 2 2
amblyopia 0 1
Uncontrolled glaucoma 0 1
OJU
Glaucoma outcome
Five laser treated patients and two surgical patients needed topical medication to
maintain normal intraocular pressure at the time of their final follow-up visit.
However three of the five laser treated patients had an initial diagnosis of subacute
closed-angle glaucoma and may have had a more chronic form of the disease, with
pre-existing trabecular meshwork damage. Two had pathological cupping of the
optic disc at presentation. If patients with an initial diagnosis of subacute closed-
angle glaucoma are excluded, 88% of the laser treated patients and 86% of
surgically treated patients had normal intraocular pressure without medication at
their final follow-up visit.
The mean intraocular pressure at follow-up was 16.9 ± 7.4 mmHg in the laser
treated group and 16.0 ± 3.7 mmHg in the surgical group.
Gonioscopy
Indentation gonioscopy was performed at the 6 month follow-up visit. Four laser
treated patients had partly closed angles, and two of these needed topical medica¬
tion to maintain normal intraocular pressure. A further two laser treated patients
had small areas of goniosynechiae. Three surgical patients were found to have a
partly closed angle on indentation, and one of these needed medication to maintain
normal intraocular pressure. Six laser treated patients showed marked pigmenta¬
tion of the trabecular meshwork inferiorly, a finding not seen in surgical patients.
The mean total power used in treating these patients was 52.3 ± 48.7 mJ, compared
with 32.3 ± 35.4 mJ for the whole group. This difference is not statistically
significant. Three of the patients had brown irides and three had grey irides. One of
the six patients needed topical medication to maintain normal intraocular pressure
at the time of their final follow-up visit.
Provocation tests
Pilocarpine/phenylephrine provocation tests were performed in all patients at the 6
month follow-up visit. All tests were negative. However, three laser treated
patients had sustained a recurrent attack of acute closed-angle glaucoma prior to
this visit, as described above.
Iridotomy size
The mean surface area of iris patency following laser iridotomy was 0.087 ± 0.124
mm2. The mean surface area of the surgical iridectomies was 1.22 ± 0.95 mm2.
This difference is statistically highly significant (unpaired Student r-test, p < 0.001).
Three patients had an iridotomy size less than 100 p x 100 p (0.00785 mm2). Two
of these patients developed recurrent closed-angle glaucoma.
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Posterior synechiae
Eleven laser-treated patients (42% of the group) and four surgically-treated pa¬
tients (27% of the group), had posterior synechiae at the time of their final
follow-up visit. Only 31% of laser-treated patients received a mydriatic following
treatment, compared with 67% of surgical patients, due to concern about the
possibility of provoking a further attack of acute closed-angle glaucoma. Of the
five patients who lost more than two lines of visual acuity due to cataract, three had
posterior synechiae (two laser-treated and one surgically-treated patients).
Discussion
The safety and effectiveness of any treatment for acute closed-angle glaucoma may
be assessed by measuring the incidence of recurrent attacks, the long-term visual
outcome and long-term glaucoma control. Recurrent attacks of acute CAG are rare
following peripheral iridectomy and have generally been attributed to plateau iris
syndrome [11]. One of our patients probably had plateau iris syndrome and
developed recurrent acute CAG despite the presence of a relatively large, patent
iridotomy. The mechanism of failure of very small iridotomies may be different.
Below a critical surface area significant iris bombe may occur at certain aqueous
flow rates. Recurrent acute CAG has been described following argon laser irido¬
tomy [12] and NdrYAG laser iridotomy [9] when the iridotomy was very small.
The minimum "safe" size of iridotomy has not been defined. Our study suggests
that iridotomies must have a size of at least 100 x 100 u in order to prevent
recurrent acute CAG.
Visual loss due to cataract development occurred in two laser treated patients
and three surgical patients. Floman found two or more lines of visual acuity loss
due to cataract in 38% of eyes 1—3 years following surgical peripheral iridectomy
for acute CAG [13]. Very little information has been published on cataract
development following Nd:YAG laser iridotomy for acute CAG. Our findings
suggest there is no significant difference in the rate of cataract development
following surgical peripheral iridectomy or Nd:YAG laser iridotomy for acute
CAG. Focal lens opacities underlying the treatment site are unusual following
Nd:YAG laser iridotomy [6] and were not seen in any of our patients.
Posterior synechiae (PS) may contribute to cataract development following
peripheral iridectomy [13]. Floman found loss of two ormore lines of visual acuity
due to cataract development in 56% of eyes with PS compared to 27% of eyes
without PS [13]. PS occurred more commonly in our laser treated group, possibly
due to our reluctance to use posttreatment mydriatics.
After excluding subacute closed-angle glaucoma patients, 88% of laser treated
patients and 86% of surgically treated patients had normal intraocular pressure
without medication at their final follow-up visit. Playfair found 72% of patients
had normal intraocular pressure without medication 6 months to 12 years following
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surgical peripheral iridectomy [14]. Our figures may be skewed towards milder
forms of disease. The study was open and several patients with prolonged attacks
of acute closed-angle glaucoma who responded poorly to initial medical treatment
underwent primary trabeculectomy during the study period. However, within the
study group we found no difference between the effect of surgical peripheral
iridectomy or Nd:YAG laser iridotomy on long-term intraocular pressure control.
Six laser treated patients had marked pigmentation of the inferior trabecular
meshwork 6 months following treatment, but this had no effect on intraocular
pressure control. A similar number of patients in each group were found to have
areas of closed-angle on indentation gonioscopy 6 months following treatment.
We have found that visual outcome and glaucoma control are similar following
surgical peripheral iridectomy or Nd:YAG laser iridotomy for acute closed-angle
glaucoma. The risk of recurrent acute closed-angle glaucoma is high if a laser
iridotomy is smaller than 100 x 100 u in size. We are currently undertaking a large
long-term randomised comparison of Nd:YAG laser iridotomy and surgical periph¬
eral iridectomy in the treatment of acute closed-angle glaucoma.
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Four cases of acute angle closure glaucoma in
eyes with a small but patent Nd-YAG laser
iridotomy are presented, and similar cases in
the literature are reviewed. Theoretically a 15
pm diameter iridotomy should be large enough
to prevent angle closure glaucoma due to pupil
block. Mechanisms by which larger irido-
tomies fail to prevent angle closure glaucoma,
and the role of provocation tests following
iridotomy, are discussed. An iridotomy should
be at least 150-200 pm in diameter if acute
angle closure glaucoma is to be reliably
prevented.
Various forms of iris surgery have been used to
treat angle closure glaucoma since von Graefe's
original description of the broad iridectomy in
1857.' Surgical iridotomy was introduced by
Curran in 1920." Peripheral iridectomy was
described by Chandler in 1952.5 Argon laser
iridotomy,6 and more recently Nd-YAG laser
iridotomy,' have already largely superseded
surgical iridectomy. While laser surgery has
many advantages over conventional surgery, it
must not be forgotten that laser iridotomy
represents a return to the use of smaller iris
openings than those obtained by surgical
peripheral iridectomy.8 Gifford noted in 1921
that very small surgical iridotomies were not as
effective in controlling intraocular pressure as
larger iridotomies.'
Reports are now emerging of acute angle
closure glaucoma developing in the presence of a
small but patent argon"" or Nd-YAG"'2 laser
iridotomy. While cases of acute angle closure
glaucoma following surgical peripheral iridec¬
tomy have generally been attributed to plateau
iris syndrome,'3"15 not all cases of acute angle
closure glaucoma following a small laser irido¬
tomy can be placed in this category.'12 We have
treated four patients who developed acute angle
closure glaucoma despite the presence of a patent
Nd-YAG laser iridotomy.
The mechanism of failure of very small
iridotomies may be related to obstruction of
aqueous flow at very small iridotomy size. Below
a critical surface area significant iris bombe may
occur at normal aqueous flow rates. When iris
bombe is sufficient to cause iridocorneal contact
throughout a critical extent of the angle,
beginning superiorly, acute angle closure
glaucoma results."12 The minimum 'safe' size of
iridotomy has not been defined, but an approxi¬
mate value may be calculated from a simple
mathematical model.
Material and methods
We are undertaking a prospective randomised
comparison of Nd-YAG lasei iiidotomy and
surgical peripheral iridectomy in the treatment
of acute angle closure glaucoma. The cases
presented belong to the laser treated group in
this study.
A Zeiss Visulas Nd-YAG laser and Zeiss
anterior segment YAG contact lens were used in
all treatments. Patients were given acetazolamide
500 mg orally one hour before treatment, and
one pilocarpine eyedrop 2% 30 minutes before
treatment.
A treatment site was chosen in the superior iris
between 10 and 2 o'clock, approximately two-
thirds of the distance from the pupil margin to
the base of the iris. An iris crypt was used, when
present. A single 5-10 mj pulse was delivered to
the treatment site. If this pulse did not penetrate
the iris, further single pulses were delivered to
the same site until penetration was achieved. A
gush of aqueous fluid from the posterior chamber
could be seen at the moment of penetration.
Patency was assessed by direct observation of the
posterior chamber or anterior lens capsule.
The size of iridotomies was measured by
comparison with the 0-2 mm spot produced by




A 75-year-old hypermetropic man presented
with right acute angle closure glaucoma of 48
hours' duration. The intraocular pressure was 78
mmHg, the anterior chamber was shallow, and
the angle was closed throughout 360°. The left
eye had a very narrow, open angle. Treatment
with acetazolamide 500 mg intravenously and
pilocarpine eyedrops 2% hourly resulted in a fall
in intraocular pressure to 12 mmHg, with an
open angle throughout 360°. Nd-YAG laser irido¬
tomy was performed three days later. A treatment
site 1 mm from the limbus at 10 o'clock was
chosen. The iris was a light grey colour, with no
crypts. Three 9 0 mj pulses resulted in a small
(200x100 pm) patent iridotomy. Minimal iris
bleeding occurred at the time of treatment, but
there were no other complications. One week
after treatment the iridotomy was patent, though
small. The intraocular pressure was 10 mmHg.
No further eye medication was prescribed.
Two weeks after treatment the patient com¬
plained of blurred vision in the right eye. The
intraocular pressure was 68 mmHg, and gonio-
scopy revealed 300° of angle closure superiorly.
Medical treatment with topical pilocarpine 2%
and timolol 0-5% reduced the intraocular
pressure to 13 mmHg, with an open angle. The
iridotomy was small (50x 100 pm) but patent.
Trabeculectomy with peripheral iridectomy was
performed, leading to an intraocular pressure of
10 mmHg, and 6/5 visual acuity.
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Figure I Case 2. Initial iridolomy size too small. Acute angle closure glaucoma developed.
Iridolomy diameter 50 |im. The arrow indicates the very small area offull thickness opening at
the centre of the treatment site.
CASE 2
A 65-year-old woman presented with left acute
angle closure glaucoma of 24 hours' duration.
The intraocular pressure was 58 mmHg, the
anterior chamber was shallow, and the angle was
closed throughout 360". The right anterior
chamber was shallow, with 120" of angle closure
superiorly, and the intraocular pressure was 15
mmHg.
After initial medical control left trabeculec¬
tomy was performed.
Further examination of the right eye after
treatment with pilocarpine eyedrops 2% revealed
an open angle throughout 360". Right Nd-YAG
laser iridotomy was performed. The treatment
site was 1 mm from the limbus, at 10 o'clock.
The iris was brown, with no crypts. Four 9-7 mj
pulses were used to produce a patent iridotomy,
and a further single 9 7 mj pulse was used to
enlarge the opening.
One week later the iridotomy was patent,
though small. The intraocular pressure was 14
mmHg. At review three weeks later the right
intraocular pressure was found to be 41 mmHg,
and the pupil was dilated. Gonioscopy was not
performed. The patient had been using cyclo-
pentolate 1% drops to the left eye, and may have
inadvertently contaminated the right eye. After
treatment with pilocarpine eyedrops 2% the
intraocular pressure returned to 16 mmHg. The
iridotomy was patent, but small - 50x50 |im
(Fig 1). Further laser treatment was given to
enlarge the opening. Five 2 0 mj Nd-YAG
pulses were delivered to the sides of the existing
iridotomy, enlarging the opening to 100x100
pm. After this treatment, eyedrops of Beta¬
methasone 01% four times a day and tropicamide
1% once daily were prescribed. The patient
returned four days later complaining of pain and
reduced vision in the right eye. The intraocular
pressure Was 50 mmHg, and the pupil was mid-
dilated and unreactive. The iridotomy was now
situated very peripherally, with iris strands
running forwards to the cornea, but appeared to
be patent. Gonioscopy was not performed. The
intraocular pressure returned to normal after
treatment with acetazolamide 500 mg intra¬
venously, and pilocarpine eyedrops 2% hourly.
The iridotomy was patent,.but small (100X 100
pm). The angle was open on gonioscopy. Treat¬
ment with pilocarpine eyedrops 2% four times a
day was prescribed.
A pilocarpine/phenylephrine provocation test
as described by Mapstone" was performed on
the right eye one week later and was negative.
Intermittent aching pain above the right eye
continued, and further Nd-YAG laser enlarge¬
ment of the iridotomy was performed six weeks
later. Twenty-one I T mj pulses were delivered
by means of a Wise 103-dioptre contact lens,
resulting in some oozing of blood. A further 10
TO mj pulses were delivered 30 minutes later.
The resulting iridotomy measured 200x200 pnt.
One week later all symptoms had resolved,
and the iridotomy measured 100x200 pm.
Pilocarpine/phenylephrine testing was again
negative. However, provocation with Tropic-
amide eyedrops 1% produced a rise of 9 mmHg
in IOP, with folds of iris blocking the trabecular
meshwork over 270° on gonioscopy. At follow-
up three weeks later the intraocular pressure was
17 mmHg, with no medication (Fig 2).
Figure 2 Case 2. Following laser enlargement all symptoms resolved and provocation testing
was negative. /ridotnmy diameter 200 |im.
CASE 3
An 83-year-old' woman presented with inter¬
mittent pain in the left eye. The intraocular
pressure was 44 mmHg, the anterior chamber
was deep, and Goldmann gonioscopy revealed
90° of angle closure superotemporally. The plane
of the iris was flat, with an anteriorly placed iris
insertion. The right eye had a similar angle
configuration, with normal intraocular pressure.
Plateau iris configuration was diagnosed. Intra¬
ocular pressure in the left eye quickly returned to
normal after treatment with acetazolamide 500
mg orally and pilocarpine eyedrops 2% hourly.
Gonioscopy revealed 180° of angle closure
superiorly. Nd-YAG laser iridotomy was per¬
formed three days later. The iris was light grey,
with no crypts. A treatment site 1 mm from the
limbus at 2 o'clock was selected. Four 10-9 mj
pulses produced-a moderately large (200x400
|im) patent iridotomy. There was minimal iris
bleeding at the time of treatment.
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After this treatment, eyedrops of Timolol
0-5% twice daily, cyclopentolate 1% twice daily,
and betamethasone 01% four hourly were
prescribed. Fourteen days later the patient
returned with pain and reduced vision of 24
hours' duration in the left eye. The intraocular
pressure was 50 mmHg. After treatment with
Pilocarpine eyedrops 2% and timolol eyedrops
0-5% the intraocular pressure fell to 7 mmHg.
The iridotomy was patent and moderately large
(200x400 |tm). Identation gonioscopy revealed
goniosynechiae over 150° superiorly,with plateau
iris configuration. A sector iridectomy was
performed. On further follow-up the intraocular
pressure in the left eye was found to be 28 mmHg
on no treatment, falling to 21 mmHg on addition
of timolol eyedrops 0-5% twice daily. Gonioscopy
revealed an open angle throughout 360°.
case 4
A 71-year-old hypermetropic woman presented
with left acute angle closure glaucoma of eight
hours' duration. The intraocular pressure was
46 mmHg and the anterior chamber was shallow.
The right eye had a normal intraocular pressure
and a shallow anterior chamber. After medical
treatment with acetazolamide 500 mg intra¬
venously and pilocarpine eyedrops 2% hourly
the left intraocular pressure fell to 9 mmHg
within two hours. Goldmann gonioscopy
revealed 150° of angle closure superiorly. The
right eye also had a very narrow angle, with 150°
of angle closure superiorly.
Nd-YAG laser iridotomy was attempted in the
left eye the next day. The iris was brown, with no
crypts. Three 9 9 mj pulses were delivered to
two sites, with no penetration. Three days later
four 10-2 mj pulses were delivered, two to each
of the previous treatment sites. The final pulse
produced a very small, patent iridotomy at 2
o'clock, in the mid iris position. A single
enlarging pulse of 9 2 m] was delivered to this
site on the following day. A very small (50 pm)
iridotomy resulted. The patient was discharged
home with betamethasone eyedrops 01% twice
daily and cyclopentolate eyedrops 1% once daily
to the left eye.
She returned six days later complaining of
severe pain in the left eye. The intraocular
pressure was 45 mmHg, and the anterior
chamber was very shallow. The iridotomy was
patent but very small. The intraocular pressure



















Figure 3 Pressure difference across the iris as a function of
iridotomy size.
acetazolamide 500 mg intravenously and pilo¬
carpine eyedrops 2% hourly. A surgical peri¬
pheral iridectomy was performed the next day.
Postoperatively the patient was treated with
betamethasone eyedrops 01% four times daily
and tropicamide eyedrops 1% once daily. Two
days later she complained of pain over the left
eye. The pupil was dilated, and the peripheral
iridectomy was patent. The intraocular pressure
was 41 mmHg. Gonioscopy was not tolerated.
The intraocular pressure fell to 10 mmHg after
treatment with acetazolamide 250 mg orally
twice daily, pilocarpine eyedrops 2% four times
daily, and timolol eyedrops 0-5% twice daily.
Long term treatment with pilocarpine eyedrops
2% four hourly and timolol eyedrops 0 5% twice
daily has been necessary to maintain normal
intraocular pressure in the left eye.
mathematical model
A very small iridotomy may be of inadequate
physical size to by-pass pupil block adequately.
Given a constant rate of aqueous flow, the
pressure difference across an iridotomy increases
as the size of the iridotomy decreases. Increased
posterior chamber pressure relative to anterior
chamber pressure will result in iris bombe. The
degree of bombe is dependent on the rigidity of
the iris and the pressure difference across the
iris. At a critical level, dependent on peripheral
anterior chamber depth, iris bombe may become
sufficient to cause iridocorneal contact over a
large enough extent of the angle to precipitate
acute angle closure glaucoma.16" "20
The minimum 'safe' size of an iridotomy may
be calculated from a simple mathematical model.
Firstly, an assessment is made as to whether
aqueous flow is laminar or turbulent through an
iridotomy aperture of 10 gm. On the assumption
that aqueous viscosity equals the viscosity of
water (i]=10J Newton seconds per square
metre), aqueous density equals the density of
water (q= 1000 kilograms per cubic metre), and
aqueous flow, Q, is approximately 2 [d per
minute (3-3x10"" cubic metres per second), as
measured by Bloom et al," then Reynolds'
number for the system may be calculated.
If the iridotomy size (d) is 10 |tm diameter,
the aqueous velocity
v=flow/7tr2=4-2x 10 ' ms '.
Reynolds' number for the system
R=pvd/q, R=42.
If R is considerably less than 1000, flow is
laminar. Aqueous flow through an iridotomy of
diameter 10 |im or larger will be laminar.
Secondly, the iridotomy channel may be
considered to be a pipe of length 50 |im on the
assumption that the peripheral iris thickness is
50 (im. The pressure drop (pd) along a pipe of
length 1=50 pm, diameter d=100 |tm, at flow
rate Q is expressed by the formula:
pd= 128qlQ/jtd4
= 128x10 'x5x 10-5x3-3x10 "/3T42x
10"
= 0-672 Nm 2
= 0 00494 mmHg, as 1 mmllg= 136 Nm \
An iridotomy of 100 |tm diameter will have a
pressure drop of 0 00494 mmHg across it on the
assumption of total pupil block.
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However, as pd is proportional to 1/d', if the
diameter of the iridotomy were 50 pm pd would
be 0 079 mmHg, under the same conditions. If
the iridotomy were 25 pm, the pd would be 1-27
mmHg. If the iridotomy were 12-5 |tm, the pd
would be 20-2 mmHg, and if the iridotomy were
10 |tm the pd would be 49 4 mmHg. It is not
difficult to conceive that a pressure difference of
10-20 mmHg across the iris could result in
significant iris bombe, with iridocorneal contact
and angle closure. Such a pressure difference
could develop if the size of the iridotomy was
between 10 and 15 pm in diameter (Fig 3).
Discussion
Curran observed in 1920 that in some patients
with glaucoma the passage of aqueous through
the pupil appeared to be impeded by the iris
'hugging the lens over too great a surface
extent'.' Surgical iridotomy allowed free drain¬
age of fluid from the posterior chamber to the
anterior chamber, with posterior movement of
the iris and a reduction in intraocular pressure.
Barkan elaborated the concept of pupil block as
the causative mechanism of iris bombe, with
resulting angle closure." A peripheral
iridectomy causes 'collapse' of iris bombe,
resulting in widening of the 'entrance' to the
angle." Peripheral anterior chamber depth, but
not central anterior chamber depth, increases
following peripheral iridectomy""" owing to
resolution of iris bombe.
Failure of surgical peripheral iridectomy, or
laser iridotomy, as evidenced by development of
acute angle closure glaucoma, may occur by one
of two mechanisms. A small number of cases of
angle closure glaucoma are related to 'plateau iris
configuration' - an anteriorly placed iris root, fiat
iris plane, and a normal or near normal anterior
chamber depth. Pupil dilatation results in peri¬
pheral iris bunching, with occlusion of the
trabecular meshwork."" As pupil block is not
causative, surgical peripheral iridectomy or laser
iridotomy are relatively ineffective in preventing
further attacks of acute angle closure glaucoma.
One ofour patients (case 3) probably had plateau
iris syndrome, and developed acute angle closure
glaucoma following mydriasis despite the
presence of a relatively large, patent iridotomy.
Case 4 developed acute angle closure glaucoma
following mydriasis despite the presence of a
small patent iridolomy and subsequently a larger
surgical iridectomy. The mechanism of acute
intraocular pressure rise may have been iris
crowding in the angle. Plateau iris configuration
was not present. Perhaps the term 'angle crowd¬
ing' angle closure glaucoma would be a more
appropriate term to use for eyes which develop
acute angle closure glaucoma following
mydriasis in the presence of a patent peripheral
iridectomy. The cases of two other patients with
moderately large peripheral iridectomies who
developed acute angle closure glaucoma while
using mydriatic drops have been reported." "
Mydriatic or dark room provocation tests
following peripheral iridectomy have been found
to be positive in 3-19% of cases." " Gonioscopy
at the end of a positive test in eyes with patent
peripheral iridectomies has revealed angle
closure in some cases, due to angle crowding."-"
However, in other eyes the angle has been
open.""" Raised intraocular pressure in these
eyes may be explained by the outflow facility
lowering effect of anticholinergic drugs."1
Surgical peripheral iridectomy appears entirely
to overcome pupil block. No cases of acute angle
closure glaucoma due to iris bombe have been
reported in the presence of a patent surgical
iridectomy.
Mydriatic provocation tests following argon
laser iridotomy"" and Nd-YAG laser
iridotomy" have given similar results to those
performed following surgical peripheral
iridectomy. However, pilocarpine/pheny¬
lephrine tests have been negative in all eyes
tested following argon laser iridotomy" or Nd-
YAG laser iridotomy."" The test produces only
moderate mydriasis, and increased tone in both
the sphincter and dilator muscles of the iris may
prevent angle crowding. The test induces maxi¬
mal pupil block," and failure to obtain any
positive results suggests that pupil block was
fully overcome in all cases tested.
Acute angle closure glaucoma in the presence
of a small, patent argon laser iridotomy has
previously been reported in two patients.1""
Mandelkorn el al reported a case of acute angle
closure glaucoma following a 50 |im diameter
argon laser iridotomy.' Further argon laser treat¬
ment was applied to the site, resulting in satis¬
factory long term pressure control. Brainard
reported a similar case, in an eye with a 75 pm
diameter argon laser iridotomy.'" Further argon
laser treatment to enlarge the iridotomy to
125 pm resulted in satisfactory long term intra¬
ocular pressure control, suggesting inadequate
iridotomy size was responsible for initial failure.
Acute angle closure glaucoma has also been
reported in the presence of a small, but patent
Nd-YAG laser iridotomy.""" Brazier reported
two cases. One was treated by surgical peripheral
iridectomy, with no further complications. The
second was treated with miotics." Wishart and
Hitchings reported two cases of acute angle
closure glaucoma and two cases of subacute
angle closure glaucoma in the presence of patent
Nd-YAG laser iridotomies." In three cases the
iridotomy was 100 pm diameter and in the
fourth 150 pm. Gray et al reported two cases of
acute angle closure glaucoma in the presence of a
small, patent iridotomy." One developed acute
angle closure glaucoma while using pilocarpine
eye drops 4%, and was treated by trabeculec¬
tomy. The second was treated by a further
iridolomy. Intraocular pressure subsequently
remained normal in both cases. Two of our cases
(cases 1 and 2) behaved in a very similar way to
the two cases reported by Gray el al. Case 1
responded to trabeculectomy, and case 2 res¬
ponded to laser enlgargement of the iridotomy.
The occurrence of acute angle closure glaucoma
in the presence of a small, but patent, iridotomy
which responds to surgical peripheral iridectomy
or laser enlargement, suggests the size of the
initial iridotomy was inadequate.
Wishart studied iris bombc using slit-lamp
photographic assessment of peripheral anterior
chamber depth. In four eyes with very small
iridotomies and progressive narrowing of the
now targe must an indoiomy be? 587
angle, repeat laser iridotomy resulted in deepen¬
ing of the peripheral anterior chamber." This
study provides further evidence that very small
iridotomies may not fully relieve iris bombe.
We have calculated that the minimum func¬
tional iridotomy size should be approximately 15
pm, as previously suggested by Wheeler."
However, our clinical experience, and that of
others,'"" shows that iridotomies in the range
of 50-150 pm diameter may fail to prevent acute
angle closure glaucoma.
Several factors may contribute to the reduc¬
tion in size of an iridotomy of theoretically 'safe'
size below that needed to prevent acute angle
closure glaucoma. Most cases of acute angle
closure glaucoma following Nd-YAG laser
iridotomy have occurred within one month of
treatment. Naveh el al observed rapid diminu¬
tion of Nd-YAG laser iridotomy size within an
hour of treatment in six eyes." In each case a
return to original treatment size occurred within
two weeks. Localised iris oedema round the
treatment site could be responsible.
Re-closure of Nd-YAG laser iridotomies
due to iris pigment epithelium proliferation is
unusual, and tends to occur 1-4 months after
treatment."12""" Re-closure resulted in
acute angle closure glaucoma in two eyes
reported on by Wishart and Hitchings" and
one eye reported on by Gray el al."
Case 2 developed acute angle closure glaucoma
following mydriasis. Pupil dilatation might
reduce the surface area of some iridotomies, and
folds of iris tissue might functionally block an
iridotomy when the pupil is dilated. Mydriatics
might therefore produce acute angle closure
glaucoma in the presence of a patent iridotomy
by two mechanisms - pupil block due to
reduction of iridotomy size, and angle crowding.
To answer the question, How large must an
iridotomy be to prevent acute angle closure
glaucoma? several factors must be considered. In
forms of angle crowding angle closure glaucoma,
such as plateau iris syndrome, a large iridotomy
will not prevent the development of acute angle
closure glaucoma following mydriasis, as pupil
block is not causative.
Theoretical modelling suggests an iridotomy
of 10-15 pm diameter will prevent angle closure
glaucoma due to pupil block. However, an
iridotomy of greater size may fall below this
critical level due to early post-treatment oedema,
late pigment epithelium proliferation, or pupil
dilatation. Wishart and Hitchings reported sub¬
acute angle closure glaucoma in an eye with a 150
pm diameter iridotomy." All other cases of
acute angle closure glaucoma in the presence of a
patent iridotomy have occurred in eyes with an
iridotomy of less than 100 pm in diameter. The
smallest potentially safe size of an iridotomy
would therefore appear to be 100 pm. However,
in order to incorporate a safety margin, we would
recommend that iridotomies should be at least
150-200 pm in diameter.
Provocation tests have not been helpful in
identifying eyes at risk, as eyes developing acute
angle closure glaucoma following Nd-YAG laser
iridotomy have done so before a provocation test
had been performed.812" If provocation tests are
to be employed, we suggest the use of tropi-
camide eyedrops 1% soon after the iridotomy has
been performed, in order to detect cases at risk of
developing acute angle closure glaucoma.
Routine pupil dilatation to prevent posterior
synechiae formation following laser iridotomy
may be more safely achieved with phenylephrine
eyedrops 10%, with measurement of intraocular
pressure following dilatation. Lowe has shown
that phenylephrine very rarely results in a rise in
intraocular pressure following peripheral
iridectomy," and the effect may be quickly
reversed using thymoxamine eyedrops 0 5% if a
pressure rise does occur.
Dr N A Fleck, Department of Engineering, University of
Cambridge, developed the mathematical model. Professor C I
Phillips and Dr J F Cullen, Department of Ophthalmology,
Edinburgh Royal Infirmary, made helpful comments during
preparation of the manuscript. Mr Stuart Gairns, ophthalmic
photographer, assisted in preparation of the illustrations.
This paper forms part of an ongoing research programme
funded by the W H Ross Foundation.
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Argon Laser Pretreatment 4 to 6
Weeks Before Nd:YAG Laser
Iridotomy
B.W. Fleck, MBChB, FRCS
E. Wright, MBChB, DCH
C. McGlynn, AMILT
ABSTRACT
Argon laser pretreatment followed by Nd:YAG laser
iridotomy 4 to 6 weeks later was performed in the
right eye of 10 patients. Primary Nd:YAG laser
iridotomy was performed in the left eye. Significantly
more Nd:YAG laser energy was needed to produce an
iridotomy in pretreated eyes (P < .001). Pretreated
eyes developed a significantly larger pigment epithe¬
lium defect around the iridotomy site and a greater
degree of pigmentation of the inferior part of the
trabecular meshwork 6 months following treatment.
Argon laser pretreatment followed by Nd:YAG laser
iridotomy 4 to 6 weeks later appears to offer no
advantages over primary Nd:YAG laser iridotomy.
Several authors have commented on the relativeease with which Nd:YAG laser iridotomy may b
performed at the site of a failed argon laser iridotomy.13
This has also been our experience. In order to investi¬
gate the possibility of using planned argon laser
pretreatment prior to Nd:YAG laser iridotomy, we
undertook a prospective study in 10 patients in which
argon laser pretreatment was performed in the right
eye, followed by Nd:YAG laser iridotomy 4 to 6 weeks
later. Primary Nd:YAG laser iridotomy was performed
in the left eye.
MATERIALS AND METHODS
The study was approved by the unit ethical commit¬
tee, and informed patient consent was obtained from all
From the Department of Ophthalmology, Royal Infir¬
mary, Edinburgh, Scotland.
Reprint requests should be addressed to B.W. Fleck,
MBChB, FRCS, Department of Ophthalmology, Royal
Infirmary, Edinburgh EH3 9HA, Scotland.
subjects. Ten consecutive patients referred for laser
iridotomy were recruited. Patients with acute angle
closure glaucoma were excluded.
Initial assessment included a review of case records
and current glaucoma control. Goldmann gonioscopy
was performed by one of us (B.W.F.), followed by Posner
four-mirror indentation gonioscopy if any part of the
angle appeared to be closed. Iris color and the presence
or absence of iris crypts were noted.
In the first treatment session, argon laser pretreat¬
ment was performed in the right eye and Nd:YAG laser
iridotomy in the left. In a second session, Nd.YAG laser
iridotomy was performed in the pretreated area of the
right eye. All laser treatments were performed by one
surgeon (B.W.F.).
Acetazolamide 500 mg was given orally, and one drop
of G pilocarpine 2% topically 30 minutes before treat¬
ment.
Argon Laser Pretreatment
A Coherent 9900 argon blue-green laser and an
Abraham 66-diopter iridotomy contact lens were used.
A treatment site was chosen in the superior iris
between the 10 and 2 o'clock positions, two-thirds way
from the pupil to the iris base. An iris crypt was used
where present. A series of superficial burns of the iris
stroma were made, using 2 to 5 pulses of 0.5 to 0.7 mW
power, 0.2-second duration, and 200 to 500-p.m-
diameter spot size.
Nd:YAG Laser Iridotomy
A Zeiss "Visulas" Nd:YAG laser and Zeiss anterior
segment YAG contact lens were used. A treatment site
was chosen in the left eye as symmetrical as possible to
the argon laser pretreatment site in the right eye. If
present, an iris crypt was used. A single 5- to 10-mJ
pulse was delivered to the treatment site. If this pulse
did not penetrate the iris, further single pulses were
delivered to the same site until penetration was
achieved. Patency was assessed by direct observation of
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the posterior chamber or anterior lens capsule. The
iridotomy was inspected and intraocular pressure
measured 2 hours following treatment. Patients were
reviewed 24 hours, 1 week, and 1 month following
treatment.
Four to 6 weeks following argon laser pretreatment,
Nd:YAG laser iridotomy was performed in the pre-
treated area of the right eye. The treatment procedure
was identical to that used for primary Nd:YAG laser
iridotomy. The iridotomy was inspected, and intraocu¬
lar pressure measured 2 hours following treatment,
and patients were reviewed 24 hours, 1 week, and 1
month following treatment.
Follow Up
Patients were reviewed monthly for 3 months, and
then at 3-month intervals. Glaucoma medication was
withdrawn in a stepwise fashion in patients with good
glaucoma control. Medication was reintroduced if in¬
traocular pressure rose above 21 mm Hg. The optic discs
were examined and visual fields assessed every 3
months.
Six months after treatment, Goldmann gonioscopy
was performed by one observer (B.W.F.), followed by
Posner four-mirror indentation gonioscopy if any part
of the angle appeared to be closed. Special attention
was given to the degree of pigmentation of the inferior
part of the trabecular meshwork.
The size of the iridotomy was measured by compar¬
ing it with the 0.2-millimeter spot produced by a
Haig-Streit slit lamp. The area of the iridotomy was
then calculated using the formula: Diameter a X
Diameter b X tt/4. Transillumination of the iris
revealed the extent of pigment epithelium disruption
around the iridotomy, and this area was also measured.
Pilocarpine/phenylephrine provocation testing as de¬
scribed by Mapstone4 was performed.
RESULTS
Details of the patients' age, sex, and diagnosis are
given in Table 1.
Initial Examination
Corrected visual acuity was 6/9 or better in 17 eyes.
One patient had nuclear cataracts, reducing visual
acuity to 6/60 in each eye, and one had a unilateral
nuclear cataract reducing visual acuity to 6/60. Five
patients had light-brown irises and five had gray irises.
Three patients had prominent iris crypts—two had
brown irises and one had gray irises.
Table 2 shows the glaucoma features of each patient
prior to iridotomy. Three patients had a history of
intermittent angle-closure glaucoma, with no abnormal
physical signs. Five patients had chronic angle-closure
glaucoma with raised intraocular pressure and partly
closed angles. One patient had a history of subacute
TABLE 1
Patients' Age/Sex Distribution and Diagnosis
Age (yrs) 64.7 ± 8.7





Open angle glaucoma with narrow angle 1
ACG = angle closure glaucoma
angle-closure glaucoma, and one had open-angle glau¬
coma with narrow angles.
Treatment
All patients had argon laser pretreatment followed
by Nd:YAG laser iridotomy in the right eye. The mean
period between argon laser pretreatment and Nd:YAG
laser iridotomy was 36.6 ± 16 days (range, 14 to 62
days). Nine patients underwent Nd:YAG laser iridot¬
omy in the left eye.
One patient with unilateral chronic angle-closure
glaucoma affecting the right eye declined prophylactic
treatment in the left eye.
Iris Appearance Following
Argon Laser Pretreatment
The immediate effect of argon laser burns was
contracture of the iris stroma. Following treatment, an
elevated area of bunched iris stroma was seen (Fig 1).
The treatment area was light brown in gray irises
and dark brown in brown irises.
One week later, the treated area remained elevated
with scattered pigment to the stroma.
After 4 to 6 weeks, the treated area was less elevated,
but significant atrophy was not evident. Gray irises
appeared to have a dense granular membrane on the
surface of the treated area (Fig 2). The treated area in
brown irises was densely pigmented. After 4 months,
the stroma in the treated area had become atrophic.
Nd:YAG laser iridotomy had been performed in the
argon laser pretreated area prior to this stage (Fig 3).
Transillumination of the iris 6 months after treat¬
ment revealed defects in the pigment epithelium at the
argon-laser-pretreated site. However, these changes
may have been related to the Nd:YAG laser iridotomy
performed in the argon-laser-pretreated area.
Nd:YAG Laser Iridotomy in the
Argon Laser Pretreatment Site
The iris stroma in the argon-laser-pretreated area
proved difficult to cut using the Nd:YAG laser.























1 intermittent + 20 21 25 25 resolution symptoms;
slight increase IOP
2 intermittent + 12 12 15 15 resolution symptoms;
slight increase IOP
3 intermittent + 17 17 16 16 resolution symptoms




5 OAG with — 20 20 T T 23 23 T T no benefit
narrow
angle
6 chronic ACG — 17 17 P + T P + T 20 20 T T reduced medication
7 chronic ACG — 28 18 P 15 16 P + T normalized IOP R eye;
additional
medication
8 chronic ACG — 27 29 P P 19 21 Propine reduced medication;
normalized IOP
9 chronic ACG — 35 15 P P 21 20 withdrawal
medication;
normalized IOP
10 chronic ACG — 18 23 P + Betoptic 10 21 Betoptic reduced medication
ACG = angle closure glaucoma; OAG = open angle glaucoma; P = pilocarpine; T — timolol
FIGURE 1: Argon pretreatment site in a gray iris
immediately following treatment. A pale-brown, ele¬
vated, bunched area of iris is seen at the treatment site
(indicated by arrow).
weeks after argon laser pretreatment. Considerable
fragmentation of the surrounding iris stroma developed
(Fig 4).
Seven cases underwent Nd:YAG laser iridotomy 4 to
6 weeks after argon laser pretreatment. In these cases
FIGURE 2: Argon pretreatment site in a gray iris 28
days after treatment (the same eye as in Figure 1). A
thick granular membrane appears to be present at the
treatment site.
the iris stroma appeared to be "tough" and relatively
resistant to Nd:YAG laser photodisruption (Fig 5). Two
cases underwent Nd:YAG laser iridotomy 8 weeks
following argon laser pretreatment. In these cases the
iris stroma had become atrophic and penetration of the
iris was easily achieved.
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FIGURE 5: Argon laser pretreatment site in a gray iris
56 days after treatment. A dark gray granular mem¬
brane was present on the surface of the pretreatment
site. Nd:YAG laser iridotomy at this site failed. Nd:YAG
laser iridotomy was then performed at a new site
(indicated by arrow).
TABLE 3
Number of Laser Pulses and Total Energy Used in
Treatment
Nd:YAG
Argon Laser After Argon Nd:YAG
Pretreatment Pre Rx Iridotomy
Number of 5.6 ± 4.4 5.4 ± 7.3 2.9 ± 2.0
pulses
Total energy 496 ± 44.1 31.8 ± 29.0 19.4 ± 13.3
(mJ)
formed at a fresh site, and in one eye a patent Nd:YAG
iridotomy was obtained at the argon-laser-pretreated
area during a second treatment session 1 week later.
In two cases, the size of the primary Nd:YAG laser
iridotomy was considered inadequate, and subsequent
Nd:YAG laser enlargement of the iridotomy was per¬
formed.
Operative Complications
Slight iris bleeding occurred at the time of treatment
in five primary Nd:YAG iridotomies and in one argon-
laser-pretreated Nd:YAG iridotomy (not significant by
chi-square test with Yates correction).
Posttreatment intraocular pressure elevation to
above 21 mm Hg did not occur following primary
Nd:YAG laser iridotomy. Intraocular pressure eleva¬
tion to 24 mm Hg and 34 mm Hg, respectively, occurred
2 hours after argon-laser-pretreated Nd:YAG iridotomy
in two patients. Both of these patients had chronic
angle-closure glaucoma.
FIGURE 3: Nd:YAG laser iridotomy in an argon laser
pretreatment site 3 months after argon laser treat¬
ment. Note the stromal atrophy in the argon-laser-
pretreated area around the Nd:YAG laser iridotomy.
FIGURE 4: Nd:YAG laser iridotomy in an argon-laser-
pretreatment site 4 months after argon laser treat¬
ment. The Nd:YAG laser iridotomy was performed 2
weeks after argon laser pretreatment and considerable
fragmentation of the iris stroma occurred.
In every case, marked pigment dispersion from the
pigment epithelium at the argon laser pretreatment
site occurred at the time of Nd:YAG laser iridotomy.
Treatment Parameters
The number of pulses, and the total energy used in
treatment are shown in Table 3.
NdrYAG laser iridotomy performed following argon
laser pretreatment required significantly more total
Nd:YAG laser energy than primary Nd:YAG laser
iridotomy (P < .001, unpaired Student's t-test). There
was no significant difference in the number of Nd:YAG
laser pulses used in each form of treatment.
A patent iris opening was obtained in all primary
Nd:YAG laser iridotomies. However, Nd:YAG iridotomy
at an argon-laser-pretreated site failed in three eyes. In




Trabecular Meshwork Pigmentation 6 Months
Following Treatment
Pigment Interiorly Primary YAG YAG/Argon
Grade 0 6 4
+ 4 3
+ + 0 3
TABLE 5
Iridotomy Area and the Area of the Surrounding Iris
Transillumination Defect
1° Nd:YAG Argon/YAG
Iridotomy area 0.034 ± 0.038 0.0836 ± 0.1578
(mm2)
Surrounding trans- 0.036 ± 0.038 0.456 ± 0.6404
illumination defect
Clinically significant iritis or focal corneal edema did
not occur in any patient.
Follow Up
The mean duration of follow up was 9.4 ±3.1 months
(range, 5 to 14 months). No eye lost more than one line
of visual acuity during the follow-up period, and there
was no progression of preexisting lens opacities or
development of new lens opacities. No focal lens
opacities were seen.
Progression of visual field loss or optic disc cupping
did not occur in any eye. Glaucoma control measurably
improved in eight patients (Table 2). In one patient
with chronic angle-closure glaucoma (patient 7), there
was no measurable improvement in glaucoma control.
The patient with open-angle glaucoma with narrow
angles (patient 5) had slightly worse glaucoma control
following treatment. There was no difference in the
glaucoma outcome of eyes treated with a primary
Nd:YAG laser iridotomy and those treated with argon-
laser-pretreated Nd:YAG laser iridotomy. Pilocarpine/
phenylephrine provocation tests were performed in
both eyes of eight patients. All tests were negative.
Gonioscopy
Goldmann gonioscopy revealed open angles in nine
patients. One chronic angle-closure glaucoma patient
(patient 9) had angle closure throughout 300° superi¬
orly in both eyes. On indentation, small areas of
goniosynechiae were present superiorly in the right
eye, but not in the left. Pigmentation of the inferior part
of the trabecular meshwork was a prominent feature in
eyes with an argon-laser-pretreated Nd:YAG laser
iridotomy (Table 4). In five patients, the inferior part of
the trabecular meshwork was more pigmented in the
eye with an argon-laser-pretreated Nd:YAG laser iri¬
dotomy, and in five patients there was no difference in
the degree of trabecular meshwork pigmentation in the
two eyes. This difference was not statistically signifi¬
cant (chi-square test with Yate's correction).
Iridotomy Area
The area of full-thickness iris patency and of sur¬
rounding iris transillumination defect are shown in
Table 5. There was no significant difference in the mean
iridotomy area of the two groups (unpaired Student's
/-test). However, the area of transillumination defect
was significantly greater in the argon-laser-pretreated
Nd:YAG laser iridotomy group iP < .05).
DISCUSSION
Various combinations of thermal and photodisrup-
tive laser techniques have been used to produce
iridotomies.1"3'5"7 Krasnov used argon laser burns to
coagulate the iris stroma prior to performing Q-
switched ruby laser iridotomy 2 weeks later.5 Zborwski-
Gutman et al used argon laser burns to coagulate the
iris stroma immediately prior to performing Nd:YAG
laser iridotomy.7 However, controlled trials of these
techniques have not been performed.
Several workers have commented that Nd:YAG laser
iridotomymay be performed with relative ease at the site
of a failed argon laser iridotomy.1-3 In contrast, we have
found that Nd:YAG laser iridotomy performed 4 to 6
weeks after argon laser pretreatment requires signifi¬
cantly more Nd:YAG laser energy than primary Nd:YAG
laser iridotomy. In two cases, a Nd:YAG laser iridotomy
was not obtained at the argon-laser-pretreated site.
The timing of Nd:YAG laser iridotomy following
argon laser pretreatment appears to be of some impor¬
tance. In our cases, maximal stromal atrophy did not
occur until approximately 4 months after argon laser
pretreatment.
Histologic studies of human tissue have shown
stromal edema around argon laser iridotomy sites 4 to
24 hours after treatment, with tissue necrosis and
pigment dispersion.8'9 During the next few days ne¬
crotic cells were seen among surviving collagen trabe-
culae, but inflammatory cell infiltration was minimal.
Stromal thinning occurred as early as 17 days following
treatment,8 and this progressed over the next 3 to 4
months. This process may explain why some argon
laser iridotomies progressively enlarge over a period of
months.10 The pigment epithelium was relatively
spared in areas of partial thickness iris burns.8 By 5
months to 2 years following treatment, some degree of
reparative fibrosis was seen.8'9
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The 4- to 6-week delay period used in our study to
allow stromal atrophy to occur was probably insuffi¬
cient. After initial resolution of stromal edema, atrophy
of collagen trabeculae proceeds more slowly. A delay
period of 4 months might be more satisfactory. How¬
ever, undue delay in creating a patent iridotomy
increases the risk of goniosynechiae formation, or the
occurrence of acute angle-closure glaucoma. We have,
therefore, chosen not to repeat the study using a longer
delay period.
We observed considerable pigment dispersion at the
argon laser pretreatment site during Nd:YAG laser
iridotomy. A photographic study of cadaver eyes
showed heaping up of the pigment epithelium around
argon laser iridotomy openings.11 Histologic study of
iris tissue surgically removed from eyes that had
previously undergone argon laser iridotomy showed
migration and proliferation of pigment epithelium
several weeks following argon laser iridotomy.12 In our
patients, it is likely that the pigment epithelium was
loosely adherent to the overlying atrophic stroma at
pretreated sites and was dislodged by the shock wave
produced by Nd:YAG laser photodisruption.
We found no significant pigment epithelium loss
beyond the iridotomy site following primary Nd:YAG
laser iridotomy. Histologic studies of Nd:YAG laser
iridotomies in humans have shown minimal disruption
of surrounding tissues.13-14 Immediately following
Nd:YAG laser iridotomy a very localized area of stromal
necrosis and blood vessel disruption was seen. Pigment
epithelium disruption occurred over a slightly larger
area.13
The inferior part of the trabecular meshwork was
more heavily pigmented in the argon-laser-pretreated
eyes than in the primary Nd:YAG laser iridotomy eyes
6 months following treatment. However, increased
trabecular meshwork pigmentation did not appear to
affect glaucoma control. While there has been concern
that pigment deposition in an already compromised
glaucomatous trabecular meshwork might further re¬
duce outflow facility, Pollack found that outflow facility
in fact increased following argon laser iridotomy in a
group of chronic angle-closure glaucoma patients.12
We found that iris bleeding occurred less frequently
at the time of argon-laser-pretreated Nd:YAG laser
iridotomies than at the time of primary Nd:YAG laser
iridotomies. However, the difference in incidence was
not statistically significant, and iris bleeding produced
no demonstrable adverse effects when it did occur.
Previous studies have produced conflicting results.
Zborwski-Gutman et al found no iris bleeding in 16 eyes
treated with argon laser immediately prior to Nd:YAG
laser iridotomy.7 However, iris bleeding occurred at the
time of Nd:YAG laser iridotomy in failed argon laser
iridotomy sites in 11 of 33 eyes reported by Robin and
Pollack,2 and Drake reported one case of profuse iris
bleeding when a Nd:YAG laser iridotomy was per¬
formed immediately following argon laser pretreat¬
ment.15
Our study failed to demonstrate any beneficial effect
of argon laser pretreatment 4 to 6 weeks prior to
Nd:YAG laser iridotomy. Argon laser pretreatment
resulted in a significant increase in the total amount of
Nd:YAG laser energy required to produce an iridotomy
and was associated with increased pigment dispersion.
Nd:YAG laser iridotomy remains the preferred method
of producing an iris opening in the treatment of
angle-closure glaucoma.
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